{ "version": "2.2", "instance": { "mpw-20231231.htm": { "nsprefix": "mpw", "nsuri": "http://medicalpropertiestrust.com/20231231", "dts": { "inline": { "local": [ "mpw-20231231.htm" ] }, "schema": { "local": [ "mpw-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "keyStandard": 415, "keyCustom": 231, "axisStandard": 45, "axisCustom": 0, "memberStandard": 59, "memberCustom": 499, "hidden": { "total": 43, "http://fasb.org/us-gaap/2023": 34, "http://fasb.org/srt/2023": 3, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 1373, "entityCount": 1, "segmentCount": 576, "elementCount": 1589, "unitCount": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 4102, "http://fasb.org/srt/2023": 752, "http://xbrl.sec.gov/dei/2023": 70, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "dei:DocumentPeriodEndDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "dei:DocumentPeriodEndDate", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R2": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "longName": "100010 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:Land", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:Land", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R4": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "longName": "100030 - Statement - Consolidated Statements of Net Income", "shortName": "Consolidated Statements of Net Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:DirectFinancingLeaseRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R5": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome", "longName": "100040 - Statement - Consolidated Statements of Comprehensive (Loss) Income", "shortName": "Consolidated Statements of Comprehensive (Loss) Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R6": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "longName": "100050 - Statement - Consolidated Statements of Equity / Capital", "shortName": "Consolidated Statements of Equity / Capital", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_76f809a1-9bf8-4855-b138-35c3fc96a705", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76f809a1-9bf8-4855-b138-35c3fc96a705", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R7": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "longName": "100060 - Statement - Consolidated Statements of Equity / Capital (Parenthetical)", "shortName": "Consolidated Statements of Equity / Capital (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R8": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "longName": "100070 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R9": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "longName": "100080 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:InterestPaidCapitalized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:InterestPaidCapitalized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R10": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R11": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_5f1ef6ab-b993-4bbf-b402-9f2ec255f94b", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5f1ef6ab-b993-4bbf-b402-9f2ec255f94b", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganization", "longName": "995455 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "longName": "995465 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities", "longName": "995475 - Disclosure - Real Estate and Other Activities", "shortName": "Real Estate and Other Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebt", "longName": "995485 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxes", "longName": "995495 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnit", "longName": "995505 - Disclosure - Earnings Per Share/Unit", "shortName": "Earnings Per Share/Unit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwards", "longName": "995515 - Disclosure - Stock Awards", "shortName": "Stock Awards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "longName": "995525 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnerSCapital", "longName": "995535 - Disclosure - Common Stock/Partner's Capital", "shortName": "Common Stock/Partner's Capital", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments", "longName": "995545 - Disclosure - Fair Value of Financial Instruments", "shortName": "Fair Value of Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLessee", "longName": "995555 - Disclosure - Leases (Lessee)", "shortName": "Leases (Lessee)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssets", "longName": "995565 - Disclosure - Other Assets", "shortName": "Other Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEvents", "longName": "995575 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIValuationAndQualifyingAccounts", "longName": "995585 - Disclosure - Schedule II: Valuation and Qualifying Accounts", "shortName": "Schedule II: Valuation and Qualifying Accounts", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSCHEDULEIIIREALESTATEINVESTMENTSANDACCUMULATEDDEPRECIATION", "longName": "995595 - Disclosure - SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION", "shortName": "SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSCHEDULEIVMORTGAGELOANSONREALESTATE", "longName": "995605 - Disclosure - SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE", "shortName": "SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995615 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "995625 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables", "longName": "995635 - Disclosure - Real Estate and Other Activities (Tables)", "shortName": "Real Estate and Other Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtTables", "longName": "995645 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables", "longName": "995655 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables", "longName": "995665 - Disclosure - Earnings Per Share/Unit (Tables)", "shortName": "Earnings Per Share/Unit (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsTables", "longName": "995675 - Disclosure - Stock Awards (Tables)", "shortName": "Stock Awards (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables", "longName": "995685 - Disclosure - Fair Value of Financial Instruments (Tables)", "shortName": "Fair Value of Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeTables", "longName": "995695 - Disclosure - Leases (Lessee) (Tables)", "shortName": "Leases (Lessee) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R37": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsTables", "longName": "995705 - Disclosure - Other Assets (Tables)", "shortName": "Other Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "longName": "995715 - Disclosure - Organization - Additional Information (Detail)", "shortName": "Organization - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "longName": "995725 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "longName": "995735 - Disclosure - Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "shortName": "Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_5b48a9fc-46ed-4e64-aa7f-0ab103358753", "name": "us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5b48a9fc-46ed-4e64-aa7f-0ab103358753", "name": "us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail", "longName": "995745 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail)", "shortName": "Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_6bc23b23-f797-40c5-aca2-8c264d630fce", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_6bc23b23-f797-40c5-aca2-8c264d630fce", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail", "longName": "995755 - Disclosure - Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail)", "shortName": "Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "div", "us-gaap:LoanCommitmentsPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_7711f04b-dc26-417f-a9c3-cc7f52fa8a4a", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "div", "us-gaap:LoanCommitmentsPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R43": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "longName": "995765 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R44": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "longName": "995775 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_00aa0910-b1c6-4eac-845f-eb01785f7bae", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R45": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "longName": "995785 - Disclosure - Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "C_802be760-a019-4c2c-b7f2-cbe33c94ec4a", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_1089b78a-a29d-46a6-8690-82c935a16925", "name": "mpw:CapitalRestructuringCosts", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R46": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "longName": "995795 - Disclosure - Real Estate and Other Activities - 2022 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2022 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "C_1084f4db-36d0-403a-8a2f-2705050f58f3", "name": "us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b2fffe31-e72d-41b6-bbd9-edbe21a66ade", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R47": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "longName": "995805 - Disclosure - Real Estate and Other Activities - 2021 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2021 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "C_70549385-828a-4270-bc7c-073a6062ed47", "name": "mpw:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_542eb4f6-f8bb-4b8f-923d-545f2e6193cf", "name": "us-gaap:EquityMethodInvestmentAggregateCost", "unitRef": "U_CHF", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R48": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "longName": "995815 - Disclosure - Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "shortName": "Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "longName": "995825 - Disclosure - Real Estate and Other Activities - Development Activities - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Development Activities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "C_0c05077a-ae6a-4eb3-b1e8-dbfede2370f3", "name": "mpw:RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0c05077a-ae6a-4eb3-b1e8-dbfede2370f3", "name": "mpw:RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R50": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "longName": "995835 - Disclosure - Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "C_cfdbaed6-c719-4d0d-9972-e4ba0acdf77f", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_802be760-a019-4c2c-b7f2-cbe33c94ec4a", "name": "mpw:StraightLineRentReceivables", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R51": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "longName": "995845 - Disclosure - Real Estate and Other Activities - Disposals - 2022 Activity Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2022 Activity Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "C_cfdbaed6-c719-4d0d-9972-e4ba0acdf77f", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_51156b4d-c83a-454d-a900-f995465a5fee", "name": "mpw:NumberOfAncillaryPropertiesSold", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R52": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "longName": "995855 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_0c8ff35f-e778-418e-8b4f-4be566e258fb", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R53": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "longName": "995865 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "C_a0981144-0da6-48cc-a4da-5935a9ef7a88", "name": "us-gaap:GainLossOnSaleOfInvestments", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_825282e1-3a51-4e1b-863b-a51a7af4dfde", "name": "mpw:StraightLineRentWriteOffs", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "div", "div", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R54": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "longName": "995875 - Disclosure - Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "C_7711f04b-dc26-417f-a9c3-cc7f52fa8a4a", "name": "mpw:NumberOfOperationsSold", "unitRef": "U_Operator", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "longName": "995885 - Disclosure - Real Estate and Other Activities - Intangible Assets - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Intangible Assets - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:IntangibleLeaseAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R56": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail", "longName": "995895 - Disclosure - Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail)", "shortName": "Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R57": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "longName": "995905 - Disclosure - Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R58": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "longName": "995915 - Disclosure - Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail)", "shortName": "Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "longName": "995925 - Disclosure - Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "shortName": "Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R60": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails", "longName": "995935 - Disclosure - Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:PercentageOfVacantOnLeasedProperty", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R61": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "longName": "995945 - Disclosure - Real Estate and Other Activities - Prospect - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Prospect - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c9ee0782-ce72-493a-859c-28ae58cf5342", "name": "mpw:RentalRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R62": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "longName": "995955 - Disclosure - Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "C_a8d2e371-c45c-4f61-ac67-44cd6ae39805", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_a8d2e371-c45c-4f61-ac67-44cd6ae39805", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R63": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails", "longName": "995965 - Disclosure - Real Estate and Other Activities - Other Tenant Matters - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Tenant Matters - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "C_441f0286-d3b7-445c-96a4-e308f9b9fbea", "name": "mpw:NumberOfOtherDomesticProperty", "unitRef": "U_Operator", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_7b5f2a9e-b897-4eab-8f90-649a48ba6abd", "name": "mpw:PercentageOfAssetsRepresentingPropertiesLeasedAndLoanToInternationJointVentures", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R64": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "longName": "995975 - Disclosure - Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "C_5f1ef6ab-b993-4bbf-b402-9f2ec255f94b", "name": "mpw:PaymentsOfPartialCashRent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5f1ef6ab-b993-4bbf-b402-9f2ec255f94b", "name": "mpw:PaymentsOfPartialCashRent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R65": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "longName": "995985 - Disclosure - Real Estate and Other Activities - Summary of Details Related to Investments (Details)", "shortName": "Real Estate and Other Activities - Summary of Details Related to Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_3a2e3cc4-dce7-40d9-b71a-12565daae67d", "name": "mpw:AmountOfUnpaidRentLeaseIncentivesRentReceivablesUnpaidInterestReceivablesAndImpairmentCharges", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfDetailsRelatedToInvestmentsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R66": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "longName": "995995 - Disclosure - Real Estate and Other Activities - Summary of Details Related to Investments (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Summary of Details Related to Investments (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "C_3a2e3cc4-dce7-40d9-b71a-12565daae67d", "name": "mpw:ImpairmentOfEquityInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "mpw:SummaryOfDetailsRelatedToInvestmentsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3a2e3cc4-dce7-40d9-b71a-12565daae67d", "name": "mpw:ImpairmentOfEquityInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "mpw:SummaryOfDetailsRelatedToInvestmentsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R67": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "longName": "996005 - Disclosure - Real Estate and Other Activities - Alecto Healthcare Services LLC - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Alecto Healthcare Services LLC - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "C_b75310f6-5ffd-44c9-814d-a02b7c8d083c", "name": "mpw:NumberOfPropertiesLeased", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_b75310f6-5ffd-44c9-814d-a02b7c8d083c", "name": "mpw:NumberOfPropertiesLeased", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R68": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "longName": "996015 - Disclosure - Real Estate and Other Activities - Prospect Medical Holdings Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Prospect Medical Holdings Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "longName": "996025 - Disclosure - Real Estate and Other Activities - Alecto Facilities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Alecto Facilities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "C_802be760-a019-4c2c-b7f2-cbe33c94ec4a", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R70": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "longName": "996035 - Disclosure - Real Estate and Other Activities - Watsonville Community Hospital - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Watsonville Community Hospital - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R71": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "longName": "996045 - Disclosure - Real Estate and Other Activities - Other Leasing Activities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Other Leasing Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:PercentageOfVacantOnLeasedProperty", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "longName": "996055 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "C_5786fa1b-e713-4d75-9a41-9e51ed599948", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5786fa1b-e713-4d75-9a41-9e51ed599948", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R73": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "longName": "996065 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_71dd1171-2516-492e-bb1f-31bc8cfbe97c", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R74": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "longName": "996075 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_d2253bf1-a70c-4532-a624-53675a86e114", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R75": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "longName": "996085 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "C_8c8ca156-d26f-4d1b-be4e-464183121385", "name": "mpw:FavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_CHF", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_8c8ca156-d26f-4d1b-be4e-464183121385", "name": "mpw:FavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_CHF", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R76": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "longName": "996105 - Disclosure - Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "C_74fbea2d-50a5-4698-98d6-b13a285aa92a", "name": "mpw:OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_74fbea2d-50a5-4698-98d6-b13a285aa92a", "name": "mpw:OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R77": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "longName": "996115 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk - (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_f420f173-5a5f-4340-ad79-2869f9d8ff3c", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R78": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "longName": "996125 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R79": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "longName": "996135 - Disclosure - Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "C_482b44e3-2ab4-4a33-88b4-924206342d15", "name": "mpw:RevenuesEarnedFromTenants", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_482b44e3-2ab4-4a33-88b4-924206342d15", "name": "mpw:RevenuesEarnedFromTenants", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R80": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "longName": "996145 - Disclosure - Debt - Summary of Debt (Detail)", "shortName": "Debt - Summary of Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R81": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail", "longName": "996155 - Disclosure - Debt - Summary of Debt (Parenthetical) (Detail)", "shortName": "Debt - Summary of Debt (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6399213f-e93f-467f-ae16-9359dc0b6892", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R82": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "longName": "996165 - Disclosure - Debt - Principal Payments Due for Debt (Detail)", "shortName": "Debt - Principal Payments Due for Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R83": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "longName": "996175 - Disclosure - Debt - Credit Facility - Additional Information (Detail)", "shortName": "Debt - Credit Facility - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:AdjustmentsToApplicableMarginPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "5", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:AdjustmentsToApplicableMarginPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "5", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R84": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "longName": "996195 - Disclosure - Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "shortName": "Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "C_fa63c2d4-7b55-42a6-88ac-d019b146b21f", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_fa63c2d4-7b55-42a6-88ac-d019b146b21f", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R85": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "longName": "996205 - Disclosure - Debt - Australian Term Loan - Additional Information (Detail)", "shortName": "Debt - Australian Term Loan - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "C_5fa57032-2ea4-4c7b-8b85-32faa495f44f", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_AUD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5fa57032-2ea4-4c7b-8b85-32faa495f44f", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_AUD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "longName": "996215 - Disclosure - Debt - Interest Rate Swaps - Additional Information (Detail)", "shortName": "Debt - Interest Rate Swaps - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DerivativeAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DerivativeAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R87": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "longName": "996225 - Disclosure - Debt - Basic Terms of Senior Unsecured Notes (Details)", "shortName": "Debt - Basic Terms of Senior Unsecured Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "C_f829cfcd-2f80-4569-b01e-0c903be8799d", "name": "mpw:DebtInstrumentOfferingCompletionDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_f829cfcd-2f80-4569-b01e-0c903be8799d", "name": "mpw:DebtInstrumentOfferingCompletionDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R88": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "longName": "996235 - Disclosure - Debt - Senior Unsecured Notes - Additional Information (Detail)", "shortName": "Debt - Senior Unsecured Notes - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "C_b6429558-f5c5-4b77-b2d4-916ab767d3ad", "name": "mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_b6429558-f5c5-4b77-b2d4-916ab767d3ad", "name": "mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R89": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "longName": "996245 - Disclosure - Debt - Additional Information (Detail)", "shortName": "Debt - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_8850de72-0fc7-4606-a545-ac672a6236b4", "name": "mpw:DebtInstrumentRedemptionAmount", "unitRef": "U_EUR", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R90": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "longName": "996255 - Disclosure - Debt - 2023 Activity - Additional Information (Details)", "shortName": "Debt - 2023 Activity - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ce690537-98c9-4db7-b893-901077b92b5e", "name": "mpw:ProceedsFromTheSaleOfFirstTranchePrepay", "unitRef": "U_AUD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R91": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "longName": "996265 - Disclosure - Debt - Covenants - Additional Information (Detail)", "shortName": "Debt - Covenants - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R92": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "longName": "996275 - Disclosure - Income Taxes - Additional Information (Detail)", "shortName": "Income Taxes - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R93": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail", "longName": "996285 - Disclosure - Income Taxes - Schedule of Income Tax Benefit (Expense) (Detail)", "shortName": "Income Taxes - Schedule of Income Tax Benefit (Expense) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R94": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn", "longName": "996295 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail)", "shortName": "Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R95": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesParentheticalDetail", "longName": "996305 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail)", "shortName": "Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null }, "R96": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail", "longName": "996315 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail)", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R97": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "longName": "996335 - Disclosure - Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail)", "shortName": "Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "C_77936418-ea5c-4983-bdb9-2e8fadc60d34", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_77936418-ea5c-4983-bdb9-2e8fadc60d34", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R98": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail", "longName": "996345 - Disclosure - Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail)", "shortName": "Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:OrdinaryDividendPerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R99": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails", "longName": "996355 - Disclosure - Income Taxes - Schedule of Per Share Distributions to Stockholders (Parenthetical) (Details)", "shortName": "Income Taxes - Schedule of Per Share Distributions to Stockholders (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:QualifiedBusinessIncomeDeductionDividendsPerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "div", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:QualifiedBusinessIncomeDeductionDividendsPerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "div", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R100": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "longName": "996365 - Disclosure - Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "shortName": "Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:UndistributedEarningAllocatedToParticipatingSecurities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R101": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "longName": "996375 - Disclosure - Earnings Per Share/Unit - Calculation of Earnings Per Share (Parenthetical) (Detail)", "shortName": "Earnings Per Share/Unit - Calculation of Earnings Per Share (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R102": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "longName": "996385 - Disclosure - Stock Awards - Additional Information (Detail)", "shortName": "Stock Awards - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R103": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "longName": "996395 - Disclosure - Stock Awards - Stock-based Award Activity (Detail)", "shortName": "Stock Awards - Stock-based Award Activity (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "C_dd581352-8887-492f-a4ea-c927b6f0ff43", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_602d5609-caf8-4e5d-83c6-5c1bb1638c57", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R104": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "longName": "996405 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "C_cfdbaed6-c719-4d0d-9972-e4ba0acdf77f", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_e35945fa-0e3c-43dc-8cd7-29c1ef8409ae", "name": "mpw:NumberOfFacilitiesSold", "unitRef": "U_Facility", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R105": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "longName": "996415 - Disclosure - Common Stock/Partners' Capital - Additional Information (Detail)", "shortName": "Common Stock/Partners' Capital - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_eb9f587d-a2dd-493b-bd93-620cc815fec0", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R106": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "longName": "996425 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:InterestAndRentReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:Loans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R107": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "longName": "996435 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2ee2f25d-e030-4611-b073-a881aa406dba", "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "div", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R108": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "longName": "996445 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)", "shortName": "Fair Value of Financial Instruments - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:IncreaseDecreaseInRealEstateImpairmentReserveRelatedToDisposals", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_748b17f2-be45-4905-b14c-b4765fc5635b", "name": "mpw:MarketCapitalizationPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R109": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "longName": "996455 - Disclosure - Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "shortName": "Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "C_a66b8065-66c4-4d6d-8b35-cc7e98f3b7b0", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_a66b8065-66c4-4d6d-8b35-cc7e98f3b7b0", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R110": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "longName": "996465 - Disclosure - Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail)", "shortName": "Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "C_089723de-10be-44fd-92ad-7ad1029562ed", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_089723de-10be-44fd-92ad-7ad1029562ed", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R111": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "longName": "996475 - Disclosure - Leases (Lessee) - Summary of Lease Expense (Detail)", "shortName": "Leases (Lessee) - Summary of Lease Expense (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:LeaseCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R112": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "longName": "996485 - Disclosure - Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail)", "shortName": "Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b4a842e3-c4be-40ce-ad15-676debf66e0e", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R113": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "longName": "996495 - Disclosure - Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail)", "shortName": "Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R114": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "longName": "996505 - Disclosure - Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail)", "shortName": "Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:FinanceLeaseRightOfUseAsset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:FinanceLeaseRightOfUseAsset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R115": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail", "longName": "996515 - Disclosure - Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail)", "shortName": "Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OperatingLeasePayments", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:OperatingLeasePayments", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R116": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail", "longName": "996525 - Disclosure - Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail)", "shortName": "Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:DebtIssueCostsNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:DebtIssueCostsNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R117": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail", "longName": "996535 - Disclosure - Other Assets - Additional Information (Detail)", "shortName": "Other Assets - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:IncreaseDecreaseInFundingOnCorporateAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:IncreaseDecreaseInFundingOnCorporateAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R118": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "longName": "996545 - Disclosure - Subsequent Events - Additional Information (Detail)", "shortName": "Subsequent Events - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "C_1084f4db-36d0-403a-8a2f-2705050f58f3", "name": "us-gaap:ProceedsFromSaleOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_5610f4ee-c74f-4537-b5d0-4ca94f1b566e", "name": "mpw:ProceedsFromSaleOfNoncontrollingInterestsInTenantAndHospitals", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R119": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail", "longName": "996555 - Disclosure - Schedule II - Schedule of Valuation and Qualifying Accounts (Detail)", "shortName": "Schedule II - Schedule of Valuation and Qualifying Accounts (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_76f809a1-9bf8-4855-b138-35c3fc96a705", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R120": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "longName": "996565 - Disclosure - Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail)", "shortName": "Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:IncreaseDecreaseInAccountsReceivableReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:IncreaseDecreaseInAccountsReceivableReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R121": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "longName": "996575 - Disclosure - Schedule III - Real Estate Investments and Accumulated Depreciation (Detail)", "shortName": "Schedule III - Real Estate Investments and Accumulated Depreciation (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:RealEstateAndAccumulatedDepreciationInitialCostOfLand", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "us-gaap:RealEstateAndAccumulatedDepreciationInitialCostOfLand", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R122": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationParentheticalDetail", "longName": "996585 - Disclosure - Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail)", "shortName": "Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:RealEstateFederalIncomeTaxBasis", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:RealEstateFederalIncomeTaxBasis", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R123": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail", "longName": "996595 - Disclosure - Schedule III - Changes in Total Real Estate Assets (Detail)", "shortName": "Schedule III - Changes in Total Real Estate Assets (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:RealEstateGrossAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "mpw:RealEstateAcquisitions", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R124": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail", "longName": "996605 - Disclosure - Schedule III - Changes in Accumulated Depreciation (Detail)", "shortName": "Schedule III - Changes in Accumulated Depreciation (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "mpw:RealEstateAssetsAccumulatedDepreciation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_76f809a1-9bf8-4855-b138-35c3fc96a705", "name": "mpw:RealEstateAssetsAccumulatedDepreciation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R125": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIiiChangesInAccumulatedDepreciationParentheticalDetail", "longName": "996615 - Disclosure - Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail)", "shortName": "Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:ConstructionAndBuildingImprovementsInProgress", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:ConstructionAndBuildingImprovementsInProgress", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R126": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "longName": "996625 - Disclosure - Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail)", "shortName": "Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:MortgageLoansOnRealEstateFaceAmountOfMortgages", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:MortgageLoansOnRealEstateFaceAmountOfMortgages", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R127": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail", "longName": "996635 - Disclosure - Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail)", "shortName": "Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "div", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true, "unique": true } }, "R128": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail", "longName": "996645 - Disclosure - Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Detail)", "shortName": "Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "C_3d0ec554-898f-4b73-8791-92e9c4e17942", "name": "us-gaap:MortgageLoansOnRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4148d45c-dae1-445d-b9a3-e6deccc88ad8", "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "unique": true } }, "R129": { "role": "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "longName": "996655 - Disclosure - Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Parenthetical) (Detail)", "shortName": "Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "C_231e5166-e592-492d-afae-4dcfc673a8b7", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20231231.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "country_AU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AU", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia [Member]" } } }, "auth_ref": [] }, "stpr_AZ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "AZ", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "ARIZONA", "terseLabel": "Arizona [Member]" } } }, "auth_ref": [] }, "mpw_AberdeenUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AberdeenUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Aberdeen United Kingdom.", "label": "Aberdeen United Kingdom [Member]", "terseLabel": "Aberdeen, UK [Member]", "verboseLabel": "Aberdeen, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingStandardsUpdate201602Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdate201602Member", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02", "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)." } } }, "auth_ref": [ "r655" ] }, "us-gaap_AccountingStandardsUpdate201613Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdate201613Member", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "Accounting Standards Update 2016-13", "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." } } }, "auth_ref": [ "r415" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Total", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r135" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss), foreign currency translation adjustment, net of tax", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance", "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance", "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses." } } }, "auth_ref": [ "r273", "r274", "r275", "r276", "r630" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r39", "r40", "r153", "r269", "r763", "r798", "r802" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r22", "r40", "r603", "r606", "r688", "r793", "r794", "r1126", "r1127", "r1128", "r1150", "r1151", "r1152" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible lease assets (in years)", "verboseLabel": "Capitalized lease intangibles, weighted average life (in years)", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r170" ] }, "mpw_AcquiredRealEstatePurchasePriceAllocationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcquiredRealEstatePurchasePriceAllocationPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Acquired real estate purchase price allocation.", "label": "Acquired Real Estate Purchase Price Allocation Policy [Text Block]", "terseLabel": "Acquired Real Estate Purchase Price Allocation" } } }, "auth_ref": [] }, "mpw_AcquisitionLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcquisitionLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Acquisition loan.", "label": "Acquisition Loan [Member]", "terseLabel": "Acquisition Loans [Member]", "verboseLabel": "Acquisition Loans [Member]" } } }, "auth_ref": [] }, "mpw_AcquisitionLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcquisitionLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Acquisition loans.", "label": "Acquisition Loans", "terseLabel": "Acquisition loans" } } }, "auth_ref": [] }, "mpw_AcquisitionLoansAndOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcquisitionLoansAndOtherLoans", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Acquisition loans and other loans.", "label": "Acquisition Loans And Other Loans", "terseLabel": "Other loans" } } }, "auth_ref": [] }, "mpw_AcuteCareCampusMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcuteCareCampusMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Acute Care Campus [Member]", "label": "Acute Care Campus [Member]", "documentation": "Acute care campus." } } }, "auth_ref": [] }, "mpw_AcuteCareHospitalAndOnCampusMedicalOfficeBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcuteCareHospitalAndOnCampusMedicalOfficeBuildingsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Acute care hospital and on campus medical office buildings.", "label": "Acute Care Hospital And On Campus Medical Office Buildings [Member]", "terseLabel": "Acute Care Hospital and On Campus Medical Office Buildings [Member]" } } }, "auth_ref": [] }, "mpw_AcuteCareHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AcuteCareHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Acute care hospital.", "label": "Acute Care Hospital [Member]", "terseLabel": "Acute Care Hospital [Member]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r1053" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r148" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r550", "r551", "r552", "r818", "r1150", "r1151", "r1152", "r1210", "r1241" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r1059" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r1059" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r1059" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r1059" ] }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Axis]", "terseLabel": "Accounting Standards Update", "documentation": "Information by amendment to accounting standards." } } }, "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r319", "r320", "r321", "r322", "r331", "r378", "r379", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r454", "r550", "r551", "r552", "r570", "r571", "r572", "r573", "r584", "r585", "r586", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r628", "r629", "r633", "r634", "r635", "r636", "r650", "r651", "r656", "r657", "r658", "r659", "r684", "r685", "r686", "r687", "r688", "r733", "r734", "r735", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ] }, "mpw_AdjustmentsToApplicableMarginPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AdjustmentsToApplicableMarginPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to applicable margin", "label": "Adjustments to Applicable Margin Percentage", "documentation": "Adjustments to applicable margin percentage." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "mpw_AdvancementOfRedevelopmentRecoveryReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AdvancementOfRedevelopmentRecoveryReceivables", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advancement of redevelopment recovery receivables", "label": "Advancement Of Redevelopment Recovery Receivables", "documentation": "Advancement of redevelopment recovery receivables." } } }, "auth_ref": [] }, "mpw_AevisVictoriaSAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AevisVictoriaSAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Aevis Victoria SA.", "label": "Aevis Victoria S A [Member]", "terseLabel": "Aevis Victoria SA [Member]" } } }, "auth_ref": [] }, "mpw_AffiliatesOfStewardHealthCareSystemLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AffiliatesOfStewardHealthCareSystemLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Affiliates of Steward Health Care System LLC.", "label": "Affiliates of Steward Health Care System L L C [Member]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1023", "r1035", "r1045", "r1071" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r1026", "r1038", "r1048", "r1074" ] }, "mpw_AlectoHealthcareServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AlectoHealthcareServicesLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Alecto Healthcare Services LLC [Member]", "documentation": "Alecto healthcare services llc." } } }, "auth_ref": [] }, "mpw_AlectoHealthcareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AlectoHealthcareServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Alecto healthcare services.", "label": "Alecto Healthcare Services [Member]", "terseLabel": "Alecto Healthcare Services [Member]" } } }, "auth_ref": [] }, "mpw_AlgecirasSpainMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AlgecirasSpainMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Algeciras, Spain.", "label": "Algeciras, Spain [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r1059" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r1066" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r1030", "r1039", "r1049", "r1066", "r1075", "r1079", "r1087" ] }, "mpw_AllOtherCountriesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AllOtherCountriesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "All Other Countries [Member]", "documentation": "All other countries." } } }, "auth_ref": [] }, "mpw_AllOtherStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AllOtherStatesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "All Other States [Member]", "documentation": "All other states." } } }, "auth_ref": [] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r1085" ] }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Summary of Credit Loss Reserves", "documentation": "Tabular disclosure of allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r70", "r1166" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Write-off of previously reserved accounts receivable", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r431" ] }, "mpw_AlternateBaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AlternateBaseRateMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Alternate Base Rate [Member]", "label": "Alternate Base Rate [Member]", "terseLabel": "Alternate Base Rate [Member]" } } }, "auth_ref": [] }, "mpw_AltoonaWIMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AltoonaWIMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Altoona, WI.", "label": "Altoona W I [Member]", "terseLabel": "Altoona, WI [Member]" } } }, "auth_ref": [] }, "mpw_AltrinchamUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AltrinchamUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Altrincham, United Kingdom.", "label": "Altrincham, United Kingdom [Member]", "terseLabel": "Altrincham, UK [Member]" } } }, "auth_ref": [] }, "mpw_AlvinTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AlvinTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Alvin Texas.", "label": "Alvin Texas [Member]", "terseLabel": "Alvin, TX [Member]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "verboseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs and debt discount", "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r488", "r653", "r977", "r978", "r1135" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r11", "r75", "r78" ] }, "mpw_AmountOfUnpaidRentLeaseIncentivesRentReceivablesUnpaidInterestReceivablesAndImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AmountOfUnpaidRentLeaseIncentivesRentReceivablesUnpaidInterestReceivablesAndImpairmentCharges", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Amount of Unpaid Rent, Lease Incentives, Rent Receivables, Unpaid Interest Receivables and Impairment Charges", "documentation": "Amount of unpaid rent, lease incentives, rent receivables, unpaid interest receivables and impairment charges." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Potential common shares/units inclusion of shares", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r344" ] }, "mpw_ApplicableMarginForRevolvingLoans": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ApplicableMarginForRevolvingLoans", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Applicable margin for revolving loans.", "label": "Applicable Margin For Revolving Loans", "terseLabel": "Applicable margin for revolving loans" } } }, "auth_ref": [] }, "mpw_ApplicableMarginForTermLoans": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ApplicableMarginForTermLoans", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Applicable margin for term loans.", "label": "Applicable Margin For Term Loans", "terseLabel": "Applicable margin for term loan" } } }, "auth_ref": [] }, "mpw_ArnoldUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ArnoldUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Arnold, UK.", "label": "Arnold U K [Member]", "terseLabel": "Arnold, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r588" ] }, "mpw_AshteadUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AshteadUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ashtead united kingdom.", "label": "Ashtead United Kingdom [Member]", "terseLabel": "Ashtead, UK [Member]" } } }, "auth_ref": [] }, "mpw_AsprisChildrensServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AsprisChildrensServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Aspris children's services.", "label": "Aspris Children's Services [Member]", "terseLabel": "Aspris Children's Services [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r982", "r1156", "r1157", "r1158" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Total Assets", "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r192", "r265", "r299", "r352", "r366", "r372", "r414", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r590", "r594", "r632", "r758", "r855", "r994", "r1011", "r1171", "r1172", "r1221" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Securities or Other Assets Sold under Agreements to Repurchase [Axis]", "documentation": "Information by securities or other assets sold under repurchase agreements. Repurchase agreements are agreements under which the transferor (repo party) transfers a security to a transferee (repo counterparty or reverse party) in exchange for cash and concurrently agrees to reacquire that security at a future date for an amount equal to the cash exchanged plus a stipulated interest factor." } } }, "auth_ref": [ "r302" ] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Assets Sold under Agreements to Repurchase, Type [Domain]", "documentation": "This is the type of such assets (for example, US Treasury Obligations, US Government agency obligations and loans, and so forth). This item may be presented as an element in the table that is disclosed when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceed 10 percent of total assets, as of the most recent balance sheet date." } } }, "auth_ref": [ "r302" ] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Assets, Total [Member]", "terseLabel": "Total Gross Assets [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_AtTheMarketEquityOfferingProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AtTheMarketEquityOfferingProgramMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "At-the-market equity offering program.", "label": "At The Market Equity Offering Program [Member]", "terseLabel": "At-the-Market Equity Offering Program [Member]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1017", "r1018", "r1031" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "auth_ref": [ "r1017", "r1018", "r1031" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "auth_ref": [ "r1017", "r1018", "r1031" ] }, "mpw_AuroraCoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AuroraCoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Aurora, CO.", "label": "Aurora Co [Member]", "terseLabel": "Aurora, CO [Member]" } } }, "auth_ref": [] }, "mpw_AustinTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AustinTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Austin, TX.", "label": "Austin T X [Member]", "terseLabel": "Austin, TX [Member]" } } }, "auth_ref": [] }, "mpw_AustraliaTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AustraliaTransactionMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Australia Transaction [Member]", "label": "Australia Transaction [Member]", "documentation": "Australia Transaction Member." } } }, "auth_ref": [] }, "mpw_AvondaleAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AvondaleAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Avondale, AZ.", "label": "Avondale A Z [Member]", "terseLabel": "Avondale, AZ [Member]" } } }, "auth_ref": [] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "terseLabel": "Award Date", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Award Date [Domain]", "terseLabel": "Award Date", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r1082" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r1083" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r1078" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r1078" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r1078" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r1078" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r1078" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r1078" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r1081" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1080" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r1079" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r1079" ] }, "mpw_AyerMAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AyerMAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ayer, MA.", "label": "Ayer M A [Member]", "terseLabel": "Ayer, MA [Member]" } } }, "auth_ref": [] }, "mpw_AyrUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "AyrUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ayr, UK [Member]", "label": "Ayr U K [Member]", "terseLabel": "Ayr, UK [Member]" } } }, "auth_ref": [] }, "mpw_BadOeynhausenGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BadOeynhausenGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bad Oeynhausen Germany.", "label": "Bad Oeynhausen Germany [Member]", "terseLabel": "Bad Oeynhausen, Germany [Member]" } } }, "auth_ref": [] }, "mpw_BadSalzuflenGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BadSalzuflenGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bad Salzuflen Germany.", "label": "Bad Salzuflen Germany [Member]", "terseLabel": "Bad Salzuflen, Germany [Member]" } } }, "auth_ref": [] }, "mpw_BakersfieldCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BakersfieldCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bakersfield California.", "label": "Bakersfield California [Member]", "terseLabel": "Bakersfield, California [Member]", "verboseLabel": "Bakersfield, CA [Member]" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r122", "r123" ] }, "mpw_BankOfAmericaNAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BankOfAmericaNAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bank of America, N.A.", "label": "Bank Of America N A [Member]", "terseLabel": "Bank of America, N.A" } } }, "auth_ref": [] }, "mpw_BarbyGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BarbyGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Barby, Germany [Member]", "label": "Barby Germany [Member]", "documentation": "Barby Germany [Member]" } } }, "auth_ref": [] }, "mpw_BarclaysBankPLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BarclaysBankPLCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Barclays Bank PLC.", "label": "Barclays Bank P L C [Member]", "terseLabel": "Barclays Bank PLC [Member]" } } }, "auth_ref": [] }, "mpw_BasingstokeUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BasingstokeUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Basingstoke, United Kingdom.", "label": "Basingstoke United Kingdom [Member]", "terseLabel": "Basingstoke, UK [Member]" } } }, "auth_ref": [] }, "mpw_BassenheimGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BassenheimGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bassenheim, Germany.", "label": "Bassenheim Germany [Member]", "terseLabel": "Bassenheim, Germany [Member]" } } }, "auth_ref": [] }, "mpw_BathUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BathUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bath United kingdom.", "label": "Bath United Kingdom [Member]", "terseLabel": "Bath, UK [Member]" } } }, "auth_ref": [] }, "mpw_BeckenhamUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BeckenhamUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Beckenham, United Kingdom.", "label": "Beckenham United Kingdom [Member]", "terseLabel": "Beckenham, UK [Member]" } } }, "auth_ref": [] }, "mpw_BedfordUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BedfordUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bedford United Kingdom.", "label": "Bedford United Kingdom [Member]", "terseLabel": "Bedford, UK [Member]" } } }, "auth_ref": [] }, "mpw_BehavioralHealthFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BehavioralHealthFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Behavioral health facilities.", "label": "Behavioral Health Facilities [Member]", "terseLabel": "Behavioral Health Facilities [Member]", "verboseLabel": "Behavioral health facilities" } } }, "auth_ref": [] }, "mpw_BehavioralHealthHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BehavioralHealthHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Behavioral Health Hospitals [Member]", "label": "Behavioral Health Hospitals [Member]", "documentation": "Behavioral health hospitals." } } }, "auth_ref": [] }, "mpw_BellflowerCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BellflowerCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bellflower, California.", "label": "Bellflower California [Member]", "terseLabel": "Bellflower, CA [Member]" } } }, "auth_ref": [] }, "mpw_BennettsvilleSouthCarolinaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BennettsvilleSouthCarolinaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bennettsville, South Carolina.", "label": "Bennettsville South Carolina [Member]", "terseLabel": "Bennettsville, SC [Member]" } } }, "auth_ref": [] }, "mpw_BigSpringTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BigSpringTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Big Spring, Texas.", "label": "Big Spring Texas [Member]", "terseLabel": "Big Spring, TX [Member]" } } }, "auth_ref": [] }, "mpw_BirminghamUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BirminghamUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Birmingham United Kingdom.", "label": "Birmingham United Kingdom [Member]", "terseLabel": "Birmingham, UK [Member]" } } }, "auth_ref": [] }, "mpw_BlackburnUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BlackburnUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Blackburn United Kingdom.", "label": "Blackburn United Kingdom [Member]", "terseLabel": "Blackburn, UK [Member]" } } }, "auth_ref": [] }, "mpw_BloomingtonIndianaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BloomingtonIndianaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bloomington, Indiana.", "label": "Bloomington Indiana [Member]", "terseLabel": "Bloomington, IN [Member]" } } }, "auth_ref": [] }, "mpw_BlueSpringsMOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BlueSpringsMOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Blue Springs, MO.", "label": "Blue Springs M O [Member]", "terseLabel": "Blue Springs, MO [Member]" } } }, "auth_ref": [] }, "mpw_BoardmanOhioMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BoardmanOhioMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Boardman, Ohio.", "label": "Boardman Ohio [Member]", "terseLabel": "Boardman, OH [Member]" } } }, "auth_ref": [] }, "mpw_BoiseIDMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BoiseIDMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Boise, ID.", "label": "Boise I D [Member]", "terseLabel": "Boise, ID [Member]" } } }, "auth_ref": [] }, "mpw_BoltonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BoltonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bolton United Kingdom.", "label": "Bolton United Kingdom [Member]", "terseLabel": "Bolton, UK [Member]" } } }, "auth_ref": [] }, "mpw_BoontonTownshipNJMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BoontonTownshipNJMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Boonton Township NJ.", "label": "Boonton Township N J [Member]", "terseLabel": "Boonton Township, NJ [Member]" } } }, "auth_ref": [] }, "mpw_BossierCityLosAngelesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BossierCityLosAngelesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bossier City, Los Angeles.", "label": "Bossier City Los Angeles [Member]", "terseLabel": "Bossier City, LA [Member]" } } }, "auth_ref": [] }, "mpw_BowlingGreenKYMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BowlingGreenKYMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bowling green, KY.", "label": "Bowling Green K Y [Member]", "terseLabel": "Bowling Green, KY [Member]" } } }, "auth_ref": [] }, "mpw_BrandisGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BrandisGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Brandis, Germany [Member]", "documentation": "Brandis, Germany." } } }, "auth_ref": [] }, "mpw_BraunfelsGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BraunfelsGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Braunfels, Germany.", "terseLabel": "Braunfels Germany", "label": "Braunfels, Germany [Member]" } } }, "auth_ref": [] }, "us-gaap_BridgeLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BridgeLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Loan", "label": "Bridge Loan", "documentation": "Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing." } } }, "auth_ref": [ "r140", "r193" ] }, "mpw_BristolUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BristolUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bristol, UK.", "label": "Bristol U K [Member]", "terseLabel": "Bristol, UK [Member]" } } }, "auth_ref": [] }, "mpw_BromleyUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BromleyUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bromley, UK.", "label": "Bromley U K [Member]", "terseLabel": "Bromley, UK [Member]" } } }, "auth_ref": [] }, "mpw_BroomfieldCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BroomfieldCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Broomfield, CO.", "label": "Broomfield C O [Member]", "terseLabel": "Broomfield, CO [Member]" } } }, "auth_ref": [] }, "us-gaap_BuildingAndBuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingAndBuildingImprovementsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "terseLabel": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r172" ] }, "us-gaap_BuildingsAndImprovementsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingsAndImprovementsGross", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings and improvements", "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [ "r172" ] }, "mpw_BundooraAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BundooraAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bundoora, Australia.", "label": "Bundoora Australia [Member]", "terseLabel": "Bundoora, Australia [Member]" } } }, "auth_ref": [] }, "mpw_BuryUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BuryUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bury, UK.", "label": "Bury U K [Member]", "terseLabel": "Bury, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r583", "r985", "r986" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r100", "r101", "r583", "r985", "r986" ] }, "mpw_BusinessAcquisitionIncurredDeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BusinessAcquisitionIncurredDeferredIncomeTaxLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Business acquisition incurred deferred income tax liabilities.", "label": "Business Acquisition Incurred Deferred Income Tax Liabilities", "terseLabel": "Incurred deferred income tax liabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r583" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price of acquisition", "totalLabel": "Business Combination, Consideration Transferred, Total", "verboseLabel": "Funded for interim mortgage loan", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r15" ] }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredOther1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Consideration of other transaction costs", "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash." } } }, "auth_ref": [ "r16" ] }, "mpw_BusinessCombinationConsiderationTransferredWithAdditionalAcquisitionLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BusinessCombinationConsiderationTransferredWithAdditionalAcquisitionLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price of acquisition loan", "label": "Business Combination Consideration Transferred With Additional Acquisition Loan", "documentation": "Business combination consideration transferred with additional acquisition loan." } } }, "auth_ref": [] }, "mpw_BusinessCombinationLoansPaidDownOnAcquisitionLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BusinessCombinationLoansPaidDownOnAcquisitionLoans", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Business combination loans paid down on acquisition loans.", "label": "Business Combination Loans Paid Down On Acquisition Loans", "negatedLabel": "Loans repaid", "verboseLabel": "Advanced to the mortgage loan", "terseLabel": "Loans repaid" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Total assets acquired", "verboseLabel": "Acquisition loan", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total", "label": "Additional mortgage loan", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r103" ] }, "mpw_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deferred tax liabilities and other liabilities.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Deferred Tax Liabilities and Other Liabilities", "terseLabel": "Deferred income tax liabilities and other liabilities, incurred" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Liabilities assumed", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r103" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total net assets acquired", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r102", "r103" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "mpw_BussageUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "BussageUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Bussage, UK.", "label": "Bussage U K [Member]", "terseLabel": "Bussage, UK [Member]" } } }, "auth_ref": [] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California [Member]" } } }, "auth_ref": [] }, "stpr_CA-BC": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA-BC", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "BRITISH COLUMBIA", "terseLabel": "British Pound Sterling [Member]" } } }, "auth_ref": [] }, "country_CH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CH", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Switzerland [Member]", "label": "SWITZERLAND" } } }, "auth_ref": [] }, "country_CO": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CO", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "COLOMBIA", "terseLabel": "Colombia [Member]" } } }, "auth_ref": [] }, "mpw_COVID19PandemicMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "COVID19PandemicMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "COVID - 19 pandemic.", "label": "C O V I D19 Pandemic [Member]", "terseLabel": "COVID-19 Pandemic [Member]" } } }, "auth_ref": [] }, "stpr_CT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CT", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "CONNECTICUT", "terseLabel": "Connecticut [Member]" } } }, "auth_ref": [] }, "mpw_CadizSpainMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CadizSpainMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cadiz, Spain.", "label": "Cadiz Spain [Member]", "terseLabel": "Cadiz, Spain [Member]" } } }, "auth_ref": [] }, "mpw_CampbelltownAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CampbelltownAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Campbelltown Australia.", "label": "Campbelltown Australia [Member]", "terseLabel": "Campbelltown, Australia [Member]" } } }, "auth_ref": [] }, "mpw_CanterburyUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CanterburyUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Canterbury United Kingdom.", "label": "Canterbury United Kingdom [Member]", "terseLabel": "Canterbury, UK [Member]" } } }, "auth_ref": [] }, "mpw_CapitalRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CapitalRestructuringCosts", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Capital restructuring costs", "label": "Capital Restructuring Costs", "documentation": "Capital restructuring costs." } } }, "auth_ref": [] }, "mpw_CaremaxIncorporatedMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CaremaxIncorporatedMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "CareMax Incorporated.", "label": "CareMax Incorporated [Member]", "terseLabel": "Caremax [Member]" } } }, "auth_ref": [] }, "mpw_CarmarthenUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CarmarthenUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Carmarthen, UK.", "label": "Carmarthen United Kingdom [Member]", "terseLabel": "Carmarthen, UK [Member]" } } }, "auth_ref": [] }, "mpw_CarrolltonTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CarrolltonTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Carrollton, TX.", "label": "Carrollton T X [Member]", "terseLabel": "Carrollton, TX [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r51", "r262", "r959" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r52" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "verboseLabel": "Cash, cash equivalents, and restricted cash are comprised of the following:" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "totalLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "terseLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r51", "r165", "r297" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash, cash equivalents, and restricted cash for the year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r165" ] }, "mpw_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cash paid for amounts included in the measurement of lease liabilities.", "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "auth_ref": [] }, "mpw_CashProcceds": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CashProcceds", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cash procceds", "documentation": "Cash procceds.", "label": "Cash Procceds" } } }, "auth_ref": [] }, "mpw_CasperWyomingMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CasperWyomingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Casper, Wyoming.", "label": "Casper Wyoming [Member]", "terseLabel": "Casper, WY [Member]" } } }, "auth_ref": [] }, "mpw_CaterhamUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CaterhamUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Caterham UK.", "label": "Caterham United Kingdom [Member]", "terseLabel": "Caterham, UK [Member]" } } }, "auth_ref": [] }, "mpw_CatholicHealthInitiativesColoradoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CatholicHealthInitiativesColoradoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Catholic health initiatives colorado.", "label": "Catholic Health Initiatives Colorado [Member]", "terseLabel": "Catholic Health Initiatives Colorado [Member]" } } }, "auth_ref": [] }, "mpw_CayceScMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CayceScMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cayce, SC [Member]", "label": "Cayce, SC [Member]", "documentation": "Cayce, SC [Member]" } } }, "auth_ref": [] }, "mpw_CertainObligationsAndReceivableSatisfiedAndRealEstateSold": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CertainObligationsAndReceivableSatisfiedAndRealEstateSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Certain obligations and receivables satisfied and real estate sold", "label": "Certain obligations and receivable satisfied and real estate sold", "documentation": "Certain obligations and receivables satisfied and real estate sold." } } }, "auth_ref": [] }, "mpw_ChandlerAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ChandlerAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Chandler AZ.", "label": "Chandler A Z [Member]", "terseLabel": "Chandler, AZ [Member]" } } }, "auth_ref": [] }, "mpw_ChangeInInvestmentFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ChangeInInvestmentFairValueAdjustments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value adjustments", "label": "Change in Investment Fair Value Adjustments", "documentation": "Change in investment fair value adjustments." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r1057" ] }, "mpw_CheadleUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CheadleUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cheadle, UK.", "label": "Cheadle United Kingdom [Member]", "terseLabel": "Cheadle, UK [Member]" } } }, "auth_ref": [] }, "mpw_CherawSouthCarolinaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CherawSouthCarolinaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cheraw, South Carolina.", "label": "Cheraw South Carolina [Member]", "terseLabel": "Cheraw, SC [Member]" } } }, "auth_ref": [] }, "mpw_CircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CircleHealthMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Circle Health Group.", "label": "Circle Health [Member]", "terseLabel": "Circle [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "mpw_ClarksvilleTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ClarksvilleTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Clarksville, TX.", "label": "Clarksville Texas [Member]", "terseLabel": "Clarksville, TX [Member]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r266", "r267", "r268", "r350", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r808", "r809", "r810", "r811", "r979", "r1094", "r1137" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1058" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r1058" ] }, "us-gaap_CollateralAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collateral Held [Axis]", "documentation": "Information by category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [ "r971" ] }, "us-gaap_CollateralDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collateral Held [Domain]", "documentation": "Category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [] }, "mpw_CologneGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CologneGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Cologne Germany.", "label": "Cologne Germany [Member]", "terseLabel": "Cologne Germany [Member]" } } }, "auth_ref": [] }, "mpw_ColoradoSpringsCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ColoradoSpringsCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Colorado Springs, CO.", "label": "Colorado Springs C O [Member]", "terseLabel": "Colorado Springs CO [Member]" } } }, "auth_ref": [] }, "mpw_ColumbusOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ColumbusOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Columbus, OH.", "label": "Columbus O H [Member]", "terseLabel": "Columbus OH [Member]" } } }, "auth_ref": [] }, "mpw_CommerceCityTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommerceCityTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commerce City, TX.", "label": "Commerce City T X [Member]", "terseLabel": "Commerce City, TX [Member]" } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommitmentAndContingenciesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "terseLabel": "Commitment And Contingencies [Line Items]" } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommitmentAndContingenciesTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "terseLabel": "Commitment And Contingencies [Table]" } } }, "auth_ref": [] }, "mpw_CommitmentFeeAdjustmentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommitmentFeeAdjustmentPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commitment fee adjustment percentage.", "label": "Commitment Fee Adjustment Percentage", "terseLabel": "Commitment fee" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r36", "r136", "r759", "r842" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r173", "r458", "r459", "r941", "r1169" ] }, "mpw_CommonSpiritMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommonSpiritMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Common Spirit [Member]", "documentation": "Common spirit." } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareCashPaid", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Common share distribution", "totalLabel": "Total", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r178" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends (Distributions) declared per common share / unit", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r178" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Units [Member]", "verboseLabel": "Common Par Value [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r997", "r998", "r999", "r1001", "r1002", "r1003", "r1004", "r1150", "r1151", "r1210", "r1237", "r1241" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r147" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r147", "r843" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r147" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r23", "r147", "r843", "r861", "r1241", "r1242" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 598,991 shares at December 31, 2023 and 597,476 shares at December 31, 2022", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r147", "r762", "r994" ] }, "mpw_CommonUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CommonUnitsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Common units.", "label": "Common Units [Member]", "terseLabel": "Common Units" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r1063" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r1062" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r1064" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r1061" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r93" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive (loss) income attributable to MPT common stockholders (Operating Partnership Partners)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r41", "r280", "r282", "r291", "r752", "r775" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to non-controlling interests", "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r9", "r106", "r118", "r280", "r282", "r290", "r751", "r774" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive (loss) income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r118", "r185", "r280", "r282", "r289", "r750", "r773" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r61", "r64", "r129", "r130", "r377", "r940" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r61", "r64", "r129", "r130", "r377", "r803", "r940" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r61", "r64", "r129", "r130", "r377", "r940", "r1101" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of total assets", "verboseLabel": "Percentage of concentration risk", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r61", "r64", "r129", "r130", "r377" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r61", "r64", "r129", "r130", "r377", "r940" ] }, "mpw_ConroeTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ConroeTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Conroe, TX.", "label": "Conroe T X [Member]", "terseLabel": "Conroe, TX [Member]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r231", "r306", "r590", "r591", "r594", "r595", "r692", "r951", "r1121", "r1122", "r1123", "r1170", "r1173", "r1174" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r231", "r306", "r590", "r591", "r594", "r595", "r692", "r951", "r1121", "r1122", "r1123", "r1170", "r1173", "r1174" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r107", "r964" ] }, "mpw_ConstructionAndBuildingImprovementsInProgress": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ConstructionAndBuildingImprovementsInProgress", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIiiChangesInAccumulatedDepreciationParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Construction and building improvements in progress", "label": "Construction and Building Improvements In Progress", "documentation": "Construction and building improvements in progress." } } }, "auth_ref": [] }, "mpw_ConstructionInProgressEquipmentAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ConstructionInProgressEquipmentAndOther", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Construction in progress equipment and other.", "label": "Construction In Progress Equipment And Other", "negatedLabel": "Construction in progress and other" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue", "totalLabel": "Contract with Customer, Liability, Total", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r501", "r502", "r503" ] }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Principal Payments Due on Debt", "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation." } } }, "auth_ref": [ "r1141" ] }, "mpw_ConverseTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ConverseTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Converse,TX.", "label": "Converse T X [Member]", "terseLabel": "Converse, TX [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible loan", "label": "Convertible Debt", "totalLabel": "Convertible Debt, Total", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r29", "r196", "r1234" ] }, "mpw_CoralGablesFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CoralGablesFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Coral Gables, FL.", "label": "Coral Gables F L [Member]", "terseLabel": "Coral Gables, FL [Member]" } } }, "auth_ref": [] }, "us-gaap_CorporateJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Corporate Joint Venture [Member]", "terseLabel": "Joint Venture [Member]", "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project." } } }, "auth_ref": [] }, "us-gaap_CorporateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Corporate Segment [Member]", "terseLabel": "Corporate [Member]", "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items." } } }, "auth_ref": [ "r1155" ] }, "mpw_CostMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CostMethodInvestmentOwnershipPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Cost method investment ownership percentage.", "label": "Cost Method Investment Ownership Percentage", "terseLabel": "Ownership interest in joint venture under the cost method" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Costs Incurred as of December 31, 2023", "label": "Cost of Goods and Services Sold", "totalLabel": "Cost of Goods and Services Sold, Total", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r158", "r731" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r157" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "auth_ref": [] }, "mpw_CostsOfLeasedAndRentedPropertyOrEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CostsOfLeasedAndRentedPropertyOrEquipment", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "documentation": "Costs of leased and rented property or equipment.", "label": "Costs Of Leased And Rented Property Or Equipment", "terseLabel": "Property-related" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r252", "r303", "r304", "r476", "r495", "r691", "r960", "r962" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "mpw_CreditRatingMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CreditRatingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Credit rating.", "label": "Credit Rating [Member]", "terseLabel": "Credit Rating" } } }, "auth_ref": [] }, "mpw_CrownPointINMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CrownPointINMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Crown point IN.", "label": "Crown Point I N [Member]", "terseLabel": "Crown Point, IN [Member]" } } }, "auth_ref": [] }, "mpw_CroydonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CroydonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Croydon, UK.", "label": "Croydon United Kingdom [Member]", "terseLabel": "Croydon, UK [Member]" } } }, "auth_ref": [] }, "mpw_CumulativeBenefitCatchupFromAdjustingPayoutProbability": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "CumulativeBenefitCatchupFromAdjustingPayoutProbability", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative benefit catchup from adjusting payout probability", "label": "Cumulative Benefit Catchup From Adjusting Payout Probability", "documentation": "Cumulative benefit catchup from adjusting payout probability." } } }, "auth_ref": [] }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards." } } }, "auth_ref": [ "r256", "r318", "r325", "r331", "r419", "r425", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r606", "r607", "r608", "r613", "r616", "r618", "r619", "r686" ] }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption", "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards." } } }, "auth_ref": [ "r256", "r318", "r325", "r331", "r419", "r425", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r606", "r607", "r608", "r613", "r616", "r618", "r619", "r686" ] }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption", "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards." } } }, "auth_ref": [ "r256", "r318", "r325", "r331", "r419", "r425", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r606", "r607", "r608", "r613", "r616", "r618", "r619", "r686" ] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "negatedLabel": "Domestic", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1103", "r1140", "r1209" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Current Foreign Tax Expense (Benefit)", "negatedLabel": "Foreign", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r1103", "r1140" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit)", "negatedTotalLabel": "Total income tax expense", "totalLabel": "Current Income Tax Expense (Benefit), Total", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r183", "r569", "r577", "r1140" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current income tax (expense) benefit:" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]", "verboseLabel": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r62", "r377" ] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "DE", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Germany [Member]", "label": "GERMANY" } } }, "auth_ref": [] }, "mpw_DahlenGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DahlenGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dahlen Germany.", "label": "Dahlen Germany [Member]", "terseLabel": "Dahlen, Germany [Member]" } } }, "auth_ref": [] }, "mpw_DallasTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DallasTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dallas, Texas.", "label": "Dallas Texas [Member]", "terseLabel": "Dallas, TX [Member]" } } }, "auth_ref": [] }, "mpw_DarlingtonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DarlingtonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Darlington, United Kingdom.", "label": "Darlington United Kingdom [Member]", "terseLabel": "Darlington, United Kingdom [Member]" } } }, "auth_ref": [] }, "mpw_DarlingtonUnitedKingdomOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DarlingtonUnitedKingdomOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Darlington United Kingdom.", "label": "Darlington United Kingdom One [Member]", "terseLabel": "Darlington UK [Member]" } } }, "auth_ref": [] }, "mpw_DebtAndEquitySecuritiesReceivedForCertainObligationsRealEstateAndRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtAndEquitySecuritiesReceivedForCertainObligationsRealEstateAndRevenue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Debt and equity securities received for certain obligations, real estate, and revenue", "label": "Debt and equity securities received for certain obligations, real estate, and revenue", "documentation": "Debt and equity securities received for certain obligations, real estate, and revenue." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r29", "r141", "r142", "r193", "r196", "r306", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r654", "r974", "r975", "r976", "r977", "r978", "r1138" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount", "label": "Long-Term Debt, Gross", "terseLabel": "Debt", "totalLabel": "Total", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r29", "r196", "r490" ] }, "mpw_DebtInstrumentEffectiveDate": { "xbrltype": "dateItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentEffectiveDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument effective date.", "label": "Debt Instrument Effective Date", "terseLabel": "Debt instrument effective date" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "verboseLabel": "Par Value", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r132", "r134", "r473", "r654", "r975", "r976" ] }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Frequency of Periodic Payment", "terseLabel": "Interest Payment Frequency", "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual)." } } }, "auth_ref": [ "r35", "r138" ] }, "mpw_DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument interest rate adjustable based on pricing grid percentage.", "label": "Debt Instrument Interest Rate Adjustable Based On Pricing Grid Percentage", "terseLabel": "Applicable margin adjustable based on pricing grid, percentage" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest rate at end of period", "verboseLabel": "Effective interest rate", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r33", "r132", "r492", "r654" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Senior unsecured notes, interest rate", "verboseLabel": "Senior unsecured notes, interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r33", "r474" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r306", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r654", "r974", "r975", "r976", "r977", "r978", "r1138" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r225", "r974", "r1211" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Debt instrument amendment extended maturity date description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r34" ] }, "mpw_DebtInstrumentMaturityYear": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentMaturityYear", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument maturity year.", "label": "Debt Instrument Maturity Year", "terseLabel": "Senior unsecured notes, maturity year" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r35", "r306", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r654", "r974", "r975", "r976", "r977", "r978", "r1138" ] }, "mpw_DebtInstrumentOfferingCompletionDate": { "xbrltype": "dateItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentOfferingCompletionDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument offering completion date.", "label": "Debt Instrument Offering Completion Date", "terseLabel": "Offering Completion Date" } } }, "auth_ref": [] }, "mpw_DebtInstrumentPercentageOfParValue": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentPercentageOfParValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument percentage of par value.", "label": "Debt Instrument Percentage Of Par Value", "terseLabel": "% of Par Value" } } }, "auth_ref": [] }, "mpw_DebtInstrumentPercentageOfReferenceRateForCalculationOfFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentPercentageOfReferenceRateForCalculationOfFixedInterestRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument percentage of reference rate for calculation of fixed interest rate.", "label": "Debt Instrument Percentage Of Reference Rate For Calculation Of Fixed Interest Rate", "terseLabel": "Reference rate" } } }, "auth_ref": [] }, "mpw_DebtInstrumentPurchaseYieldPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentPurchaseYieldPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase yield average percentage", "label": "Debt Instrument Purchase Yield Percentage", "documentation": "Debt instrument purchase yield percentage." } } }, "auth_ref": [] }, "mpw_DebtInstrumentRedemptionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentRedemptionAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument redemption amount.", "label": "Debt Instrument Redemption Amount", "terseLabel": "Senior unsecured notes redemption amount including accrued and unpaid interest" } } }, "auth_ref": [] }, "mpw_DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument repurchase price percentage on principal amount plus accrued and unpaid interest.", "label": "Debt Instrument Repurchase Price Percentage On Principal Amount Plus Accrued And Unpaid Interest", "terseLabel": "Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r35", "r86", "r89", "r131", "r132", "r134", "r137", "r176", "r177", "r306", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r654", "r974", "r975", "r976", "r977", "r978", "r1138" ] }, "mpw_DebtInstrumentVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtInstrumentVariableInterestRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt Instrument variable interest rate.", "label": "Debt Instrument Variable Interest Rate", "terseLabel": "Variable interest rate" } } }, "auth_ref": [] }, "mpw_DebtIssueCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtIssueCostsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt issue costs, net.", "label": "Debt Issue Costs Net", "terseLabel": "Debt issue costs, net" } } }, "auth_ref": [] }, "mpw_DebtRefinancingAndUnutilizedFinancingBenefitCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtRefinancingAndUnutilizedFinancingBenefitCosts", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Debt refinancing and unutilized financing (benefit) costs", "negatedLabel": "Debt refinancing and unutilized financing benefit (costs)", "label": "Debt Refinancing And Unutilized Financing (Benefit) Costs", "documentation": "Debt refinancing and unutilized financing (benefit) costs." } } }, "auth_ref": [] }, "mpw_DebtRefinancingCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DebtRefinancingCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt refinancing charge.", "label": "Debt Refinancing Charge", "terseLabel": "Debt refinancing costs" } } }, "auth_ref": [] }, "mpw_DecreaseInAccountsReceivableAndOtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DecreaseInAccountsReceivableAndOtherReserves", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Decrease in accounts receivable and other reserves.", "label": "Decrease In Accounts Receivable And Other Reserves", "terseLabel": "Decrease in accounts receivable and other reserves" } } }, "auth_ref": [] }, "us-gaap_DeferredChargesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredChargesPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Costs", "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges." } } }, "auth_ref": [ "r264" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "negatedLabel": "Domestic", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1140", "r1208", "r1209" ] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance offset cost", "verboseLabel": "Accelerated amortization debt issue costs", "label": "Debt Issuance Costs, Gross", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r133" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt issue costs and discount, net", "totalLabel": "Debt Issuance Costs, Net, Total", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r133", "r1176" ] }, "mpw_DeferredFinancingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DeferredFinancingCostsPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Deferred financing costs.", "label": "Deferred Financing Costs Policy [Text Block]", "terseLabel": "Deferred Financing Costs" } } }, "auth_ref": [] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Foreign Income Tax Expense (Benefit)", "negatedLabel": "Foreign", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r183", "r1140", "r1208" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "negatedTotalLabel": "Total income tax expense", "totalLabel": "Deferred Income Tax Expense (Benefit), Total", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r11", "r183", "r223", "r576", "r577", "r1140" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred income tax (expense) benefit:" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities", "totalLabel": "Deferred Tax Liabilities, Gross, Total", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r144", "r145", "r194", "r563" ] }, "us-gaap_DeferredRentReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRentReceivablesNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Rent Receivables, Net", "terseLabel": "Cash rent", "documentation": "Amount of excess of rental income recognized over rental payment required by lease." } } }, "auth_ref": [ "r210", "r211", "r212", "r1216" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r564" ] }, "us-gaap_DeferredTaxAssetsInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInvestments", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Partnership investments", "label": "Deferred Tax Assets, Investments", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total net deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1206" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Operating loss and interest deduction carry forwards", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r99", "r1207" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Other", "terseLabel": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r99", "r1207" ] }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation", "label": "Deferred Tax Assets, Property, Plant and Equipment", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r565" ] }, "mpw_DeferredTaxAssetsValuationAllowancesExpectedNotRealized": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DeferredTaxAssetsValuationAllowancesExpectedNotRealized", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Deferred tax assets valuation allowances expected not realized.", "label": "Deferred Tax Assets Valuation Allowances Expected Not Realized", "terseLabel": "Valuation allowance not expected to be realized" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax asset (liability)", "totalLabel": "Deferred Tax Liabilities, Net, Total", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r95", "r1206" ] }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesInvestments", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Investments", "negatedLabel": "Partnership investments", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "mpw_DeferredTaxLiabilitiesOneTimeAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DeferredTaxLiabilitiesOneTimeAdjustment", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities one time adjustment.", "label": "Deferred Tax Liabilities One Time Adjustment", "terseLabel": "Deferred tax liabilities, one time adjustment" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r99", "r1207" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property and equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r99", "r1207" ] }, "mpw_DeferredTaxLiabilityNetUnbilledRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DeferredTaxLiabilityNetUnbilledRevenue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "lang": { "en-us": { "role": { "documentation": "Deferred tax liability net unbilled revenue", "label": "Deferred Tax Liability Net Unbilled Revenue", "negatedLabel": "Net unbilled revenue" } } }, "auth_ref": [] }, "mpw_DenverCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DenverCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Denver, CO.", "label": "Denver C O [Member]", "terseLabel": "Denver, CO [Member]" } } }, "auth_ref": [] }, "mpw_DenvilleNJMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DenvilleNJMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Denville, NJ.", "label": "Denville N J [Member]", "terseLabel": "Denville, NJ [Member]" } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": -1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Real estate depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total", "negatedLabel": "Real estate depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r11", "r79" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Total", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r11", "r357" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r596" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Asset", "terseLabel": "Derivative asset", "totalLabel": "Derivative Asset, Total", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r271", "r272", "r631", "r821", "r822", "r823", "r825", "r826", "r828", "r829", "r830", "r832", "r833", "r849", "r850", "r906", "r909", "r910", "r911", "r912", "r913", "r962", "r999", "r1238" ] }, "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income." } } }, "auth_ref": [ "r597" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred gains from our interest rate swap and foreign currency translation in AOCI", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "totalLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total", "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments." } } }, "auth_ref": [ "r26", "r124" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Liability", "terseLabel": "Derivative liability", "totalLabel": "Derivative Liability, Total", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r271", "r272", "r631", "r821", "r822", "r823", "r825", "r828", "r829", "r830", "r832", "r833", "r856", "r858", "r859", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r962", "r1238" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r596" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Investments and Hedging Activities", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r24", "r119", "r120", "r121", "r125", "r305" ] }, "mpw_DetroitMichiganMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DetroitMichiganMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Detroit, Michigan.", "label": "Detroit Michigan [Member]", "terseLabel": "Detroit, MI [Member]" } } }, "auth_ref": [] }, "mpw_DevelopmentProjectAmountSpentOnCombinedBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DevelopmentProjectAmountSpentOnCombinedBasis", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Development project amount spent on combined basis", "label": "Development Project Amount Spent On Combined Basis", "documentation": "Development project amount spent on combined basis." } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsEstimatedRentCommencementDate": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DevelopmentProjectsEstimatedRentCommencementDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "Development projects estimated rent commencement date.", "label": "Development Projects Estimated Rent Commencement Date", "terseLabel": "Estimated Rent Commencement Date" } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsOriginalCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DevelopmentProjectsOriginalCommitmentAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "Development projects original commitment amount.", "terseLabel": "Expected commence rent", "verboseLabel": "Commitment", "label": "Total commitment" } } }, "auth_ref": [] }, "mpw_DewsburryUkMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DewsburryUkMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Dewsburry, UK", "label": "Dewsburry, UK [Member]", "documentation": "Dewsburry, UK." } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Lease Income [Table Text Block]", "terseLabel": "Components of Total Investment in Financing Leases", "documentation": "Tabular disclosure of components of lease income from direct financing lease." } } }, "auth_ref": [ "r348", "r680" ] }, "us-gaap_DirectFinancingLeaseLeaseReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Lease Receivable", "terseLabel": "Minimum lease payments receivable", "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease." } } }, "auth_ref": [ "r682" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLease", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss", "totalLabel": "Net investment in direct financing leases", "documentation": "Amount, before allowance for credit loss, of net investment in direct financing lease." } } }, "auth_ref": [ "r222", "r433", "r682", "r1165" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLeasesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]", "terseLabel": "Direct Financing Lease Net Investment In Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseRevenue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Revenue", "terseLabel": "Income from financing leases", "documentation": "Amount of direct financing lease revenue." } } }, "auth_ref": [ "r348", "r681" ] }, "mpw_DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "documentation": "Direct financing lease, unearned income and allowance for credit loss.", "label": "Direct Financing Lease Unearned Income And Allowance For Credit Loss", "negatedLabel": "Less: Unearned income and allowance for credit loss" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseUnguaranteedResidualAsset", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Unguaranteed Residual Asset", "terseLabel": "Estimated residual values", "verboseLabel": "Estimated unguaranteed residual values", "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor." } } }, "auth_ref": [ "r682" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwards" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock Awards", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r514", "r518", "r545", "r546", "r549", "r988" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "mpw_DiscountForLackOfMarketabilityPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DiscountForLackOfMarketabilityPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Discount for Lack of Marketability Percentage", "label": "Discount for Lack of Marketability Percentage", "terseLabel": "Discount for lack of marketability percentage on Springstone equity investment" } } }, "auth_ref": [] }, "mpw_DiscountOnSaleOfTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DiscountOnSaleOfTermLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Discount on sale of term loan", "label": "Discount on Sale of Term Loan", "documentation": "Discount on sale of term loan." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r260" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Not Discontinued Operations [Member]", "documentation": "Disposal group that is not classified as discontinued operations." } } }, "auth_ref": [] }, "mpw_DissUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DissUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Diss, UK.", "label": "Diss U K [Member]", "terseLabel": "Diss, UK [Member]" } } }, "auth_ref": [] }, "mpw_DistributionUnrecapturedSectionOneTwoFiveZeroGainPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DistributionUnrecapturedSectionOneTwoFiveZeroGainPerShare", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Distribution, unrecaptured section one two five zero gain per share", "label": "Distribution Unrecaptured Section One Two Five Zero Gain Per Share", "terseLabel": "Unrecaptured Sec. 1250 gain" } } }, "auth_ref": [] }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendPayableDateToBePaidDayMonthAndYear", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend paid date", "label": "Dividends Payable, Date to be Paid", "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Dividends, Common Stock, Cash", "negatedLabel": "Dividends (Distributions) declared", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r178" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends Payable", "terseLabel": "Dividends declared, unpaid", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r142", "r143", "r195", "r1008", "r1233" ] }, "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableDateDeclaredDayMonthAndYear", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend declared date", "label": "Dividends Payable, Date Declared", "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format." } } }, "auth_ref": [ "r53" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "terseLabel": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1017", "r1018", "r1031" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1017", "r1018", "r1031", "r1067" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "terseLabel": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1052" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "verboseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r1015" ] }, "mpw_DorchesterUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DorchesterUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dorchester, UK.", "label": "Dorchester U K [Member]", "terseLabel": "Dorchester, UK [Member]" } } }, "auth_ref": [] }, "mpw_DormagenGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DormagenGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dormagen, Germany.", "label": "Dormagen Germany [Member]", "terseLabel": "Dormagen Germany [Member]" } } }, "auth_ref": [] }, "mpw_DoverNJMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DoverNJMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dover, NJ.", "label": "Dover N J [Member]", "terseLabel": "Dover NJ [Member]" } } }, "auth_ref": [] }, "mpw_DroitwichUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DroitwichUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Droitwich, UK.", "label": "Droitwich United Kingdom [Member]", "terseLabel": "Droitwich, UK [Member]" } } }, "auth_ref": [] }, "mpw_DublinOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "DublinOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Dublin, OH.", "label": "Dublin O H [Member]", "terseLabel": "Dublin, OH [Member]" } } }, "auth_ref": [] }, "country_ES": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "ES", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "SPAIN", "terseLabel": "Spain [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per common share - basic and diluted" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners), basic", "totalLabel": "Earnings Per Share, Basic, Total", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r292", "r323", "r324", "r325", "r326", "r327", "r333", "r335", "r341", "r342", "r343", "r347", "r619", "r620", "r753", "r776", "r967" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per common share (units) basic" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r335", "r339", "r341" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners), diluted", "totalLabel": "Earnings Per Share, Diluted, Total", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r292", "r323", "r324", "r325", "r326", "r327", "r335", "r341", "r342", "r343", "r347", "r619", "r620", "r753", "r776", "r967" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings per common share (units) diluted" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share/Units", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r55", "r56" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnit" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share/Unit", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r332", "r344", "r345", "r346" ] }, "mpw_EconomicLossOnSaleOfTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EconomicLossOnSaleOfTermLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Economic loss on sale of term loan", "label": "Economic Loss On Sale of Term Loan", "documentation": "Economic loss on sale of term loan." } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r640" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Income tax at the US statutory federal rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r301", "r558", "r579" ] }, "mpw_EffectiveIncomeTaxRateReconciliationImpactOfUkReitConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationImpactOfUkReitConversion", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Impact of UK REIT conversion", "label": "Effective Income Tax Rate Reconciliation, Impact of UK REIT conversion", "documentation": "Effective income tax rate reconciliation, impact of uk reit conversion." } } }, "auth_ref": [] }, "mpw_EighteenEightyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenEightyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen eighty five.", "label": "Eighteen Eighty Five [Member]", "terseLabel": "1885 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenEightySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenEightySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "1887 [Member]", "documentation": "Eighteen eighty seven.", "label": "Eighteen Eighty Seven [Member]" } } }, "auth_ref": [] }, "mpw_EighteenEightySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenEightySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen eighty six.", "label": "Eighteen Eighty Six [Member]", "terseLabel": "1886 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenElevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen eleven.", "label": "Eighteen Eleven [Member]", "terseLabel": "1811 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenFiftyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenFiftyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen fifty.", "label": "Eighteen Fifty [Member]", "terseLabel": "1850 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenFortyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenFortyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen Forty.", "label": "Eighteen Forty [Member]", "terseLabel": "1840 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenFortyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenFortyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen forty nine.", "label": "Eighteen Forty Nine [Member]", "terseLabel": "1849 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenHundredMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenHundredMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen hundred.", "label": "Eighteen Hundred [Member]", "terseLabel": "1800 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenNinetyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenNinetyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen Ninety.", "label": "Eighteen Ninety [Member]", "terseLabel": "1890 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenNinetyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenNinetyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen ninety two.", "label": "Eighteen Ninety Two [Member]", "terseLabel": "1892 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenSixtyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenSixtyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "1864 [Member]", "label": "Eighteen Sixty Four [Member]", "documentation": "Eighteen sixty four." } } }, "auth_ref": [] }, "mpw_EighteenThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenThirtyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen thirty.", "label": "Eighteen Thirty [Member]", "terseLabel": "1830 [Member]" } } }, "auth_ref": [] }, "mpw_EighteenTwentyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EighteenTwentyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Eighteen twenty.", "label": "Eighteen Twenty [Member]", "terseLabel": "1820 [Member]" } } }, "auth_ref": [] }, "mpw_ElPasoTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ElPasoTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "El Paso, TX.", "label": "El Paso Texas [Member]", "terseLabel": "El Paso, TX [Member]" } } }, "auth_ref": [] }, "mpw_EmployeeRestrictedEquityAwardsVestingActivityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EmployeeRestrictedEquityAwardsVestingActivityLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "documentation": "Employee Restricted Equity Awards Vesting Activity [Line Items]", "label": "Employee Restricted Equity Awards Vesting Activity [Line Items]", "terseLabel": "Employee Restricted Equity Awards Vesting Activity [Line Items]" } } }, "auth_ref": [] }, "mpw_EmployeeRestrictedEquityAwardsVestingActivityTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EmployeeRestrictedEquityAwardsVestingActivityTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "documentation": "Employee Restricted Equity Awards Vesting Activity [Table]", "label": "Employee Restricted Equity Awards Vesting Activity [Table]", "terseLabel": "Employee Restricted Equity Awards Vesting Activity [Table]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Stock-based compensation expense, unrecognized cost", "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r548" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Stock-based compensation expense, unrecognized cost, reorganization period (in years)", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r548" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "mpw_EnglewoodCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EnglewoodCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Englewood, CO.", "label": "Englewood C O [Member]", "terseLabel": "Englewood, CO [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1092" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "terseLabel": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1014" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1014" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1093" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r23", "r256", "r284", "r285", "r286", "r315", "r316", "r317", "r320", "r328", "r330", "r349", "r419", "r425", "r500", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r605", "r606", "r608", "r618", "r643", "r644", "r645", "r646", "r647", "r648", "r688", "r793", "r794", "r795", "r818", "r883" ] }, "mpw_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EquityIncentivePlanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Equity incentive plan member.", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "mpw_EquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EquityInvestment", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investment", "label": "Equity Investment", "documentation": "Equity investment." } } }, "auth_ref": [] }, "mpw_EquityInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EquityInvestmentsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Equity investments.", "label": "Equity Investments [Member]", "terseLabel": "Equity Investments [Member]" } } }, "auth_ref": [] }, "mpw_EquityInvestmentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EquityInvestmentsPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments percentage", "label": "Equity Investments Percentage", "documentation": "Equity investments percentage." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r411", "r412", "r413" ] }, "us-gaap_EquityMethodInvestmentAggregateCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentAggregateCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity investment", "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting." } } }, "auth_ref": [ "r30" ] }, "mpw_EquityMethodInvestmentAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EquityMethodInvestmentAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments in Unconsolidated Operating Entities [Member]", "documentation": "Equity method investment and other loans.", "label": "Equity Method Investment And Other Loans [Member]", "terseLabel": "Equity Method Investment and Other Loans [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership interest", "verboseLabel": "Percentage of equity investment", "label": "Passive equity interest", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r411" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "terseLabel": "Equity investments unrealized gain/loss", "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r777", "r1163" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r74", "r1005", "r1006", "r1007", "r1244" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r1060" ] }, "mpw_ErnestHealthIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ErnestHealthIncMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Ernest Health, Inc.", "label": "Ernest Health Inc [Member]", "terseLabel": "Ernest [Member]", "verboseLabel": "Ernest Health Inc [Member]" } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r1023", "r1035", "r1045", "r1071" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r1020", "r1032", "r1042", "r1068" ] }, "mpw_EssexUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EssexUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Essex, UK.", "label": "Essex U K [Member]", "terseLabel": "Essex, UK [Member]" } } }, "auth_ref": [] }, "mpw_EstimatedFeesToSellTheHospitals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EstimatedFeesToSellTheHospitals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fees to sell the hospitals", "label": "Estimated Fees To Sell The Hospitals", "documentation": "Estimated fees to Sell the hospitals." } } }, "auth_ref": [] }, "mpw_EuroDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EuroDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "EURO denominated borrowings.", "label": "EURO Denominated Borrowings [Member]", "terseLabel": "EURO-denominated Borrowings [Member]" } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r1243", "r1245", "r1246", "r1248" ] }, "mpw_EuxtonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "EuxtonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Euxton United Kingdom.", "label": "Euxton United Kingdom [Member]", "terseLabel": "Euxton, UK [Member]" } } }, "auth_ref": [] }, "mpw_ExceptedProceedsInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ExceptedProceedsInCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Excepted proceeds in cash", "label": "Excepted Proceeds in Cash", "documentation": "Excepted proceeds in cash." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r1066" ] }, "mpw_ExpectedLeaseUpPeriodsForEstimatingLostRentals": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ExpectedLeaseUpPeriodsForEstimatingLostRentals", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Expected lease-up periods for estimating lost rentals.", "label": "Expected Lease Up Periods For Estimating Lost Rentals", "verboseLabel": "Expected lease-up periods for estimating lost rentals, in months" } } }, "auth_ref": [] }, "mpw_ExpirationOfOperatingLossCarryforwardsDescription": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ExpirationOfOperatingLossCarryforwardsDescription", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Expiration of operating loss carryforwards, description.", "label": "Expiration Of Operating Loss Carryforwards Description", "terseLabel": "Expiration periods" } } }, "auth_ref": [] }, "country_FI": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "FI", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "FINLAND", "terseLabel": "Finland [Member]" } } }, "auth_ref": [] }, "stpr_FL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "FL", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "FLORIDA", "terseLabel": "Florida [Member]" } } }, "auth_ref": [] }, "mpw_FacilitiesAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FacilitiesAcquired", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Facilities acquired by the Prime", "label": "Facilities Acquired", "documentation": "Facilities acquired." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Summary of Fair Value Information of Financial Instruments", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r127", "r128" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r481", "r505", "r506", "r507", "r508", "r509", "r510", "r624", "r699", "r700", "r701", "r975", "r976", "r982", "r983", "r984" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r623", "r624", "r625", "r626", "r627" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r622" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2 Inputs [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r481", "r505", "r510", "r624", "r700", "r975", "r976", "r982", "r983", "r984" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3 Inputs [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r481", "r505", "r506", "r507", "r508", "r509", "r510", "r624", "r701", "r975", "r976", "r982", "r983", "r984" ] }, "mpw_FairValueMeasurementDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FairValueMeasurementDiscountRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate on investment", "label": "Fair Value Measurement Discount Rate", "documentation": "Fair value measurement discount rate." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r481", "r505", "r506", "r507", "r508", "r509", "r510", "r699", "r700", "r701", "r975", "r976", "r982", "r983", "r984" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r622", "r627" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r14", "r27" ] }, "mpw_FallRiverMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FallRiverMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Fall river Massachusetts.", "label": "Fall River Massachusetts [Member]", "terseLabel": "Fall River, MA [Member]" } } }, "auth_ref": [] }, "mpw_FavorableFairMarketValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FavorableFairMarketValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Favorable fair market value adjustment on investment", "label": "Favorable Fair Market Value Adjustment On Investment", "documentation": "Favorable fair market value adjustment on investment." } } }, "auth_ref": [] }, "mpw_FavorableNonCashFairValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FavorableNonCashFairValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Favorable non-cash fair value adjustment on investment.", "label": "Favorable Non Cash Fair Value Adjustment On Investment", "terseLabel": "Favorable non-cash fair value adjustment on investment" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r663", "r669", "r993" ] }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestPaymentOnLiability", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows used for finance leases", "documentation": "Amount of interest paid on finance lease liability." } } }, "auth_ref": [ "r664", "r672" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": "mpw_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability", "terseLabel": "Finance Leases, Present value of lease liabilities", "totalLabel": "Finance Lease, Liability, Total", "verboseLabel": "Financing leases", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r661", "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid", "totalLabel": "Finance Leases, Total undiscounted minimum lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Leases, Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leases, 2024", "label": "Finance Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leases, 2028", "label": "Finance Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leases, 2027", "label": "Finance Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leases, 2026", "label": "Finance Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leases, 2025", "label": "Finance Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes finance lease liability." } } }, "auth_ref": [ "r662" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Finance Leases, Less: interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r676" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance leases", "totalLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r660" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r663", "r669", "r993" ] }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]", "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset." } } }, "auth_ref": [ "r662" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance leases", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r675", "r993" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance leases", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r674", "r993" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r427", "r428", "r433", "r434", "r435", "r436", "r437", "r438", "r489", "r498", "r609", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r772", "r972", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1159", "r1160", "r1161", "r1162" ] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Financial instruments measured at fair value on recurring basis.", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]" } } }, "auth_ref": [] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]" } } }, "auth_ref": [] }, "mpw_FinancingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FinancingLeasesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "documentation": "Financing leases.", "label": "Financing Leases [Member]", "terseLabel": "Financing Leases [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of the year", "terseLabel": "Credit loss reserve", "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r17", "r226", "r227", "r228", "r270", "r426", "r429", "r432", "r1230" ] }, "mpw_FinancingReceivableAllowanceForCreditLossesPeriodDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FinancingReceivableAllowanceForCreditLossesPeriodDecrease", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable allowance for credit losses period decrease.", "label": "Financing Receivable Allowance for Credit Losses Period Decrease", "terseLabel": "Decrease in credit loss reserves on financing-type receivables" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Increase in credit loss reserves on financing-type receivables", "totalLabel": "Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease), Total", "documentation": "Amount of increase (decrease) in allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r71", "r1166" ] }, "mpw_FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentSold": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentSold", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable allowances of credit losses related to financial instrument sold.", "label": "Financing Receivable Allowances Of Credit Losses Related To Financial Instrument Sold", "terseLabel": "Expected credit loss reserve related to financial instruments sold, repaid, or satisfied" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated amortization, net", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r263", "r450" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r171" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r171" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r171" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r171" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r171" ] }, "mpw_FiniteLivedIntangibleAssetsAmortizationExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Finite Lived Intangible Assets Amortization Expenses", "label": "Finite Lived Intangible Assets Amortization Expenses", "terseLabel": "Amortization expense related to intangible lease assets" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r448", "r449", "r450", "r451", "r732", "r736" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r76", "r77" ] }, "mpw_FirestoneTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FirestoneTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Firestone, Texas.", "label": "Firestone Texas [Member]", "terseLabel": "Firestone, TX [Member]" } } }, "auth_ref": [] }, "mpw_FirstLienSecuredLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FirstLienSecuredLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First lien secured loan", "label": "First Lien Secured Loan", "documentation": "First lien secured loan." } } }, "auth_ref": [] }, "us-gaap_FirstMortgageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FirstMortgageMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "First Mortgage [Member]", "terseLabel": "Long-Term First Mortgage Loan [Member]", "documentation": "Loan secured by real property that has a first (highest) lien on such property in the event of default by the borrower." } } }, "auth_ref": [ "r1012" ] }, "mpw_FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Five point five zero zero percentage senior unsecured notes due two thousand twenty four.", "label": "Five Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "5.500% Senior Unsecured Notes due 2024 [Member]" } } }, "auth_ref": [] }, "mpw_FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "5.250% Senior Unsecured Notes due 2026 [Member]", "documentation": "Five point two five zero percentage senior unsecured notes due two thousand twenty six.", "label": "Five Point Two Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]" } } }, "auth_ref": [] }, "mpw_FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "5.000% Senior Unsecured Notes due 2027 [Member]", "documentation": "Five point zero zero zero percentage senior unsecured notes due two thousand twenty seven.", "label": "Five Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Seven [Member]" } } }, "auth_ref": [] }, "mpw_FlagstaffArizonaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FlagstaffArizonaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Flagstaff Arizona.", "label": "Flagstaff Arizona [Member]", "terseLabel": "Flagstaff, AZ [Member]" } } }, "auth_ref": [] }, "mpw_FlorenceAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FlorenceAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Florence, AZ.", "label": "Florence A Z [Member]", "terseLabel": "Florence, AZ [Member]" } } }, "auth_ref": [] }, "mpw_FloridablancaColombiaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FloridablancaColombiaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Floridablanca, Colombia.", "label": "Floridablanca Colombia [Member]", "terseLabel": "Floridablanca, Colombia [Member]" } } }, "auth_ref": [] }, "mpw_FolsomCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FolsomCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Folsom California.", "label": "Folsom California [Member]", "terseLabel": "Folsom, CA [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "terseLabel": "United Kingdom [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation and Transactions", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r637" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1075" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1075" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1075" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1075" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1075" ] }, "mpw_FortWorthTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FortWorthTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Fort Worth, TX.", "label": "Fort Worth T X [Member]", "terseLabel": "Fort Worth, TX [Member]" } } }, "auth_ref": [] }, "mpw_FountainCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FountainCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Fountain, CO.", "label": "Fountain C O [Member]", "terseLabel": "Fountain, CO [Member]" } } }, "auth_ref": [] }, "mpw_FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "4.625% Senior Unsecured Notes due 2029 [Member]", "documentation": "Four point six two five percentage senior unsecured notes due two thousand twenty nine.", "label": "Four Point Six Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Nine [Member]" } } }, "auth_ref": [] }, "mpw_FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Four point zero zero zero percentage senior unsecured notes due two thousand twenty two.", "label": "Four Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "4.000% Senior Unsecured Notes Due 2022 [Member]" } } }, "auth_ref": [] }, "mpw_FreestandingERUrgentCareFacilitiesAndBehavioralHealthFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FreestandingERUrgentCareFacilitiesAndBehavioralHealthFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Freestanding ER/urgent care facilities and behavioral health facilities.", "label": "Freestanding E R Urgent Care Facilities And Behavioral Health Facilities [Member]", "terseLabel": "Freestanding ER/Urgent Care Facilities and Behavioral Health Facilities [Member]" } } }, "auth_ref": [] }, "mpw_FreestandingERUrgentCareFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FreestandingERUrgentCareFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Freestanding E R Urgent Care Facilities [Member]", "documentation": "Freestanding E R urgent care facilities." } } }, "auth_ref": [] }, "mpw_FreestandingErUrgentCareAndLongTermAcuteCareFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FreestandingErUrgentCareAndLongTermAcuteCareFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Freestanding ER urgent care and long term acute care facilities.", "label": "Freestanding ER Urgent Care and Long Term Acute Care Facilities [Member]", "terseLabel": "Freestanding ER/Urgent Care and Long-Term Acute Care Facilities [Member]" } } }, "auth_ref": [] }, "mpw_FresnoCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FresnoCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Fresno, California.", "label": "Fresno California [Member]", "terseLabel": "Fresno, CA [Member]" } } }, "auth_ref": [] }, "mpw_FromeUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FromeUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Frome, UK.", "label": "Frome U K [Member]", "terseLabel": "Frome, UK [Member]" } } }, "auth_ref": [] }, "mpw_FromeUKOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FromeUKOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Frome, UK.", "label": "Frome U K One [Member]", "terseLabel": "Frome, UK [Member]" } } }, "auth_ref": [] }, "mpw_FurnitureEquipmentAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FurnitureEquipmentAndOtherMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Furniture, Equipment And Other [Member]", "label": "Furniture Equipment And Other [Member]", "terseLabel": "Furniture, equipment and other [Member]" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableCurrentNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Payments, 2024", "documentation": "Future Minimum Payments Receivable, Current Net", "label": "Future Minimum Payments Receivable Current Net" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableInFiveYearsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableInFiveYearsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Payments, 2028", "documentation": "Future Minimum Payments Receivable, in Five Years Net", "label": "Future Minimum Payments Receivable In Five Years Net" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableInFourYearsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableInFourYearsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Payments, 2027", "documentation": "Future Minimum Payments Receivable, in Four Years Net", "label": "Future Minimum Payments Receivable In Four Years Net" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableInThreeYearsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableInThreeYearsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Payments, 2026", "documentation": "Future Minimum Payments Receivable, in Three Years Net", "label": "Future Minimum Payments Receivable In Three Years Net" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableInTwoYearsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableInTwoYearsNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net Payments, 2025", "documentation": "Future Minimum Payments Receivable, In Two Years Net", "label": "Future Minimum Payments Receivable In Two Years Net" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable Net", "label": "Future Minimum Payments Receivable Net", "totalLabel": "Net Payments, Total undiscounted minimum lease payments" } } }, "auth_ref": [] }, "mpw_FutureMinimumPaymentsReceivableThereafterNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "FutureMinimumPaymentsReceivableThereafterNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, Thereafter Net", "label": "Future Minimum Payments Receivable Thereafter Net", "terseLabel": "Net Payments, Thereafter" } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom [Member]", "verboseLabel": "British Pound Sterling [Member]" } } }, "auth_ref": [] }, "mpw_GBPDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GBPDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "GBP-denominated Borrowings [Member]", "label": "G B P Denominated Borrowings [Member]", "documentation": "GBP-denominated Borrowings [Member]" } } }, "auth_ref": [] }, "mpw_GainLossOnDispositionOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GainLossOnDispositionOfRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) Income from real estate dispositions, net", "documentation": "Gain loss on disposition of real estate.", "label": "Gain Loss on Disposition of Real Estate" } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Real Estate, Discontinued Operations", "verboseLabel": "Gain (loss) on real estate dispositions", "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations." } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfInvestments", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Gain (Loss) on Sale of Investments, Total", "label": "Gain (Loss) on Sale of Investments", "terseLabel": "Gains", "negatedLabel": "Gain on sale of equity investments", "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities." } } }, "auth_ref": [ "r11" ] }, "mpw_GainesboroughUkMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GainesboroughUkMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Gainesborough UK [Member]", "documentation": "Gainesborough UK." } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on prepayment of Debt", "label": "Gain (Loss) on Extinguishment of Debt", "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r11", "r81", "r82" ] }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "terseLabel": "(loss) gain on sale of real estate", "negatedLabel": "(Loss) gain on sale of real estate", "label": "Gains (Losses) on Sales of Investment Real Estate", "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes." } } }, "auth_ref": [ "r215", "r216", "r217", "r1129", "r1130", "r1135", "r1231", "r1240" ] }, "mpw_GardenaCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GardenaCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Gardena, CA.", "label": "Gardena C A [Member]", "terseLabel": "Gardena, CA [Member]" } } }, "auth_ref": [] }, "mpw_GeneralAcuteCareFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GeneralAcuteCareFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "General Acute Care Facility [Member]", "label": "General Acute Care Facility [Member]", "documentation": "General acute care facility." } } }, "auth_ref": [] }, "mpw_GeneralAcuteCareHospitalAndHealthcareSystemMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GeneralAcuteCareHospitalAndHealthcareSystemMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "General Acute Care Hospital and Healthcare System.", "label": "General Acute Care Hospital and Healthcare System [Member]", "terseLabel": "General Acute Care Hospital And Healthcare System" } } }, "auth_ref": [] }, "mpw_GeneralAcuteCareHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GeneralAcuteCareHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "General acute care hospitals.", "label": "General Acute Care Hospitals [Member]", "terseLabel": "General Acute Care Hospitals [Member]", "verboseLabel": "General Acute Care Facilities [Member]" } } }, "auth_ref": [] }, "mpw_GeneralAcuteHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GeneralAcuteHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "General acute hospital.", "label": "General Acute Hospital [Member]", "terseLabel": "General Acute Hospital [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r159", "r865" ] }, "us-gaap_GeneralPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partner [Member]", "terseLabel": "General Partner [Member]", "documentation": "Party to a partnership business who has unlimited liability." } } }, "auth_ref": [] }, "us-gaap_GeneralPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "General partner - issued and outstanding - 5,991 units at December 31, 2023 and 5,976 units at December 31, 2022", "label": "General Partners' Capital Account", "totalLabel": "General Partners' Capital Account, Total", "documentation": "The amount of the general partner's ownership interest." } } }, "auth_ref": [ "r179" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partners' Capital Account, Units Issued", "terseLabel": "General partner, units issued", "documentation": "The number of general partner units issued." } } }, "auth_ref": [ "r179" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partners' Capital Account, Units Outstanding", "terseLabel": "General partner, units outstanding", "documentation": "The number of general partner units outstanding." } } }, "auth_ref": [ "r179" ] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r63", "r940" ] }, "mpw_GeorgetownTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GeorgetownTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Georgetown, TX.", "label": "Georgetown T X [Member]", "terseLabel": "Georgetown, TX [Member]" } } }, "auth_ref": [] }, "mpw_GilbertArizonaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GilbertArizonaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Gilbert, Arizona.", "label": "Gilbert Arizona [Member]", "terseLabel": "Gilbert, AZ [Member]" } } }, "auth_ref": [] }, "mpw_GlasgowUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GlasgowUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Glasgow, UK.", "label": "Glasgow United Kingdom [Member]", "terseLabel": "Glasgow, UK [Member]" } } }, "auth_ref": [] }, "mpw_GlenWaverlyAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GlenWaverlyAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Glen Waverly Australia.", "label": "Glen Waverly Australia [Member]", "terseLabel": "Glen Waverly, Australia [Member]" } } }, "auth_ref": [] }, "mpw_GlendaleAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GlendaleAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Glendale, AZ.", "label": "Glendale A Z [Member]", "terseLabel": "Glendale,AZ [Member]" } } }, "auth_ref": [] }, "mpw_GlobalAssetManagerMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GlobalAssetManagerMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Global Asset Manager [Member]", "documentation": "Global Asset Manager." } } }, "auth_ref": [] }, "mpw_GloucesterUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GloucesterUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Gloucester United Kingdom.", "label": "Gloucester United Kingdom [Member]", "terseLabel": "Gloucester, UK [Member]" } } }, "auth_ref": [] }, "mpw_GodalmingUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GodalmingUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Godalming, UK.", "label": "Godalming U K [Member]", "terseLabel": "Godalming, UK [Member]" } } }, "auth_ref": [] }, "mpw_GoodyearArizonaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GoodyearArizonaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Goodyear Arizona.", "label": "Goodyear Arizona [Member]", "terseLabel": "Goodyear, AZ [Member]" } } }, "auth_ref": [] }, "mpw_GreatMissendenUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GreatMissendenUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Great Missenden, UK.", "label": "Great Missenden United Kingdom [Member]", "terseLabel": "Great Missenden, UK [Member]" } } }, "auth_ref": [] }, "mpw_GrefathGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GrefathGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Grefath, Germany.", "label": "Grefath Germany [Member]", "terseLabel": "Grefath, Germany [Member]" } } }, "auth_ref": [] }, "mpw_GrossInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GrossInvestmentInRealEstateAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Gross investment in real estate assets", "label": "Gross Investment In Real Estate Assets", "totalLabel": "Gross investment in real estate assets" } } }, "auth_ref": [] }, "mpw_GuildfordUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "GuildfordUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Guildford, UK.", "label": "Guildford United Kingdom [Member]", "terseLabel": "Guildford, UK [Member]" } } }, "auth_ref": [] }, "mpw_HCAHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HCAHealthcareMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "HCA healthcare.", "label": "H C A Healthcare [Member]", "terseLabel": "HCA Healthcare [Member]" } } }, "auth_ref": [] }, "mpw_HalsallUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HalsallUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Halsall United Kingdom.", "label": "Halsall United Kingdom [Member]", "terseLabel": "Halsall, UK [Member]" } } }, "auth_ref": [] }, "mpw_HalsenHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HalsenHealthcareMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Halsen healthcare.", "label": "Halsen Healthcare [Member]", "terseLabel": "Halsen Healthcare [Member]" } } }, "auth_ref": [] }, "mpw_HarrowUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HarrowUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Harrow, UK.", "label": "Harrow United Kingdom [Member]", "terseLabel": "Harrow, UK [Member]" } } }, "auth_ref": [] }, "mpw_HartsvilleSouthCarolinaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HartsvilleSouthCarolinaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hartsville south Carolina.", "label": "Hartsville South Carolina [Member]", "terseLabel": "Hartsville, SC [Member]" } } }, "auth_ref": [] }, "mpw_HassocksUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HassocksUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hassocks, UK.", "label": "Hassocks U K [Member]", "terseLabel": "Hassocks, UK [Member]" } } }, "auth_ref": [] }, "mpw_HastingsPAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HastingsPAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hastings PA.", "label": "Hastings P A [Member]", "terseLabel": "Hastings, PA [Member]" } } }, "auth_ref": [] }, "mpw_HausmanTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HausmanTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hausman, TX.", "label": "Hausman T X [Member]", "terseLabel": "Hausman, TX [Member]" } } }, "auth_ref": [] }, "mpw_HaverhillMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HaverhillMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Haverhill, Massachusetts.", "label": "Haverhill Massachusetts [Member]", "terseLabel": "Haverhill, MA [Member]" } } }, "auth_ref": [] }, "mpw_HeidelbergGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HeidelbergGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Heidelberg Germany.", "label": "Heidelberg Germany [Member]", "terseLabel": "Heidelberg, Germany [Member]" } } }, "auth_ref": [] }, "mpw_HelotesTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HelotesTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Helotes Texas.", "label": "Helotes Texas [Member]", "terseLabel": "Helotes, TX [Member]" } } }, "auth_ref": [] }, "mpw_HelsinkiFinlandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HelsinkiFinlandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Helsinki, Finland.", "label": "Helsinki Finland [Member]", "terseLabel": "Helsinki, Finland [Member]" } } }, "auth_ref": [] }, "mpw_HemelHempsteadUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HemelHempsteadUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hemel Hempstead, UK.", "label": "Hemel Hempstead U K [Member]", "terseLabel": "Hemel Hempstead, UK [Member]" } } }, "auth_ref": [] }, "mpw_HialeahFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HialeahFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hialeah, FL.", "label": "Hialeah F L [Member]", "terseLabel": "Hialeah, FL [Member]" } } }, "auth_ref": [] }, "mpw_HighlandHillsOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HighlandHillsOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Highland Hills, OH.", "label": "Highland Hills O H [Member]", "terseLabel": "Highland Hills, OH [Member]" } } }, "auth_ref": [] }, "mpw_HighlandVillageTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HighlandVillageTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Highland Village, TX.", "label": "Highland Village T X [Member]", "terseLabel": "Highland Village TX [Member]" } } }, "auth_ref": [] }, "mpw_HighlandsRanchColoradoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HighlandsRanchColoradoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Highlands Ranch Colorado.", "label": "Highlands Ranch Colorado [Member]", "terseLabel": "Highlands Ranch, CO [Member]" } } }, "auth_ref": [] }, "mpw_HillCountyTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HillCountyTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hill County, TX.", "label": "Hill County T X [Member]", "terseLabel": "Hill County, TX [Member]" } } }, "auth_ref": [] }, "mpw_HinckleyUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HinckleyUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hinckley, UK.", "label": "Hinckley U K [Member]", "terseLabel": "Hinckley, UK [Member]" } } }, "auth_ref": [] }, "mpw_HmHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HmHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "documentation": "HM Hospital.", "label": "HM Hospital [Member]", "terseLabel": "HM Hospital [Member]" } } }, "auth_ref": [] }, "mpw_HookUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HookUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hook, UK.", "label": "Hook U K [Member]", "terseLabel": "Hook, UK [Member]" } } }, "auth_ref": [] }, "mpw_HooverAlMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HooverAlMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hoover, AL.", "label": "Hoover Al [Member]", "terseLabel": "Hoover, AL [Member]" } } }, "auth_ref": [] }, "mpw_HopeARMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HopeARMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hope, AR.", "label": "Hope A R [Member]", "terseLabel": "Hope, AR [Member]" } } }, "auth_ref": [] }, "mpw_HotSpringsARMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HotSpringsARMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Hot Springs, AR.", "label": "Hot Springs A R [Member]", "terseLabel": "Hot Springs, AR [Member]" } } }, "auth_ref": [] }, "mpw_HoustonTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HoustonTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Houston, TX.", "label": "Houston T X [Member]", "terseLabel": "Houston, TX [Member]" } } }, "auth_ref": [] }, "mpw_HoustonTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HoustonTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Houston, Texas.", "label": "Houston Texas [Member]", "terseLabel": "Houston, TX [Member]", "verboseLabel": "Houston, Texas [Member]" } } }, "auth_ref": [] }, "mpw_HuntingtonParkCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "HuntingtonParkCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Huntington Park, CA.", "label": "Huntington Park C A [Member]", "terseLabel": "Huntington Park, CA [Member]" } } }, "auth_ref": [] }, "stpr_ID": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "ID", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "IDAHO" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1017", "r1018", "r1031" ] }, "mpw_IdahoFallsIDMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IdahoFallsIDMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Idaho Falls, ID.", "label": "Idaho Falls I D [Member]", "terseLabel": "Idaho Falls, ID [Member]" } } }, "auth_ref": [] }, "mpw_ImedHospitalesOneFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImedHospitalesOneFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales One Facility.", "label": "IMED Hospitales One Facility [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "mpw_ImedHospitalesThreeFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImedHospitalesThreeFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED hospitales Three facility.", "label": "IMED Hospitales Three Facility [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "mpw_ImedHospitalesTwoFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImedHospitalesTwoFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales Two Facilities.", "label": "IMED Hospitales Two Facilities [Member]", "terseLabel": "IMED [Member]" } } }, "auth_ref": [] }, "mpw_ImpairmentChargeOnEquityInvestmentAndOtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImpairmentChargeOnEquityInvestmentAndOtherAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Impairment Charge on Equity Investment and Other Assets [Member]", "documentation": "Impairment charge on equity investment and other assets." } } }, "auth_ref": [] }, "mpw_ImpairmentChargeOnRealEstateAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImpairmentChargeOnRealEstateAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Impairment Charge on Real Estate Assets [Member]", "documentation": "Impairment charge on real estate assets." } } }, "auth_ref": [] }, "mpw_ImpairmentChargesEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImpairmentChargesEquity", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity impairment charges", "label": "Impairment Charges Equity", "documentation": "Impairment charges equity." } } }, "auth_ref": [] }, "mpw_ImpairmentOfEquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ImpairmentOfEquityInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of equity investment", "label": "Impairment of Equity Investment", "documentation": "Impairment of equity investment." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Net impairment charge", "label": "Impairment of Real Estate", "verboseLabel": "Real estate impairment charge", "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value." } } }, "auth_ref": [ "r1135", "r1167" ] }, "us-gaap_IncomeApproachValuationTechniqueMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeApproachValuationTechniqueMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Valuation Approach [Member]", "label": "Valuation, Income Approach [Member]", "documentation": "Valuation approach converting future amounts to single current discounted amount." } } }, "auth_ref": [ "r25" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Amount of domestic income (loss) before income taxes", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r300", "r578" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Income before income tax", "terseLabel": "(Loss) income before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income tax", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r154", "r201", "r352", "r365", "r371", "r373", "r754", "r768", "r969" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Amount of foreign income (loss) before income taxes", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r300", "r578" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Earnings from equity interests", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r11", "r155", "r200", "r359", "r410", "r767" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r452", "r455", "r866" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r455", "r866" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r20" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "mpw_IncomeTaxBenefitRelatedToTheInitialLoanImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Income tax benefit related to the initial loan impairment.", "label": "Income Tax Benefit Related To The Initial Loan Impairment", "terseLabel": "Income tax benefit related to the initial loan impairment" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r301", "r553", "r559", "r561", "r567", "r574", "r580", "r581", "r582", "r813" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxBenefitExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Income tax benefit (expense)", "negatedLabel": "Income tax benefit (expense)", "label": "Income Tax Expense (Benefit)", "totalLabel": "Income Tax Expense (Benefit), Total", "terseLabel": "Income tax expense (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r214", "r224", "r329", "r330", "r360", "r557", "r575", "r778" ] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]", "terseLabel": "Decrease (increase) in income tax resulting from:" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r283", "r555", "r556", "r561", "r562", "r566", "r568", "r807" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedLabel": "Change in valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1205" ] }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Change in the corporate income tax rate , charge", "negatedLabel": "Statutory tax rate change", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates." } } }, "auth_ref": [ "r554", "r558" ] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "negatedLabel": "Foreign rate differential", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)." } } }, "auth_ref": [ "r1205" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit (expense) at the U.S. statutory federal rate (21% in 2023, 2022, and 2021)", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r558" ] }, "mpw_IncomeTaxReconciliationIncreaseDecreaseInEquityInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncomeTaxReconciliationIncreaseDecreaseInEquityInvestments", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation increase (decrease) in equity investments.", "label": "Income Tax Reconciliation Increase Decrease In Equity Investments", "negatedLabel": "Equity investments" } } }, "auth_ref": [] }, "mpw_IncomeTaxReconciliationInterestDisallowance": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncomeTaxReconciliationInterestDisallowance", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation interest disallowance.", "label": "Income Tax Reconciliation Interest Disallowance", "negatedLabel": "Interest disallowance" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "negatedLabel": "Other items, net", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1205" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "negatedLabel": "State income taxes, net of federal benefit", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r1205" ] }, "us-gaap_IncomeTaxReconciliationTaxExemptIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationTaxExemptIncome", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseBenefitFromTheStatutoryIncomeTaxRateToTheEffectiveTaxRateBasedOn" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount", "terseLabel": "U.S. earnings not subject to federal income tax", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes." } } }, "auth_ref": [ "r1205" ] }, "mpw_IncomeTaxesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncomeTaxesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "auth_ref": [] }, "mpw_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncomeTaxesTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Table]", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r10" ] }, "mpw_IncreaseDecreaseInAccountsReceivableAndOtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInAccountsReceivableAndOtherReserves", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in accounts receivable and other reserves.", "label": "Increase Decrease In Accounts Receivable And Other Reserves", "terseLabel": "Increase in accounts receivable and other reserves" } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInAccountsReceivableReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInAccountsReceivableReserves", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in accounts receivable reserves", "documentation": "Increase (decrease) in accounts receivable reserves.", "label": "Increase Decrease In Accounts Receivable Reserves" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r730", "r1134" ] }, "us-gaap_IncreaseDecreaseInDerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDerivativeAssets", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Derivative Assets", "terseLabel": "Increase in derivative assets", "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as assets that are due to be disposed of within one year (or the normal operating cycle, if longer)." } } }, "auth_ref": [ "r1134" ] }, "mpw_IncreaseDecreaseInEquityInvestmentImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInEquityInvestmentImpairments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in equity investment impairments", "label": "Increase Decrease In Equity Investment Impairments", "documentation": "Increase decrease in equity investment impairments." } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInEquityInvestmentImpairmentsRelatedToDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInEquityInvestmentImpairmentsRelatedToDisposals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investment impairments reserves related to disposals", "documentation": "Increase decrease in equity investment impairments related to disposals.", "label": "Increase Decrease In Equity Investment Impairments Related To Disposals" } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInFundingOnCorporateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInFundingOnCorporateAssets", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate funding", "label": "Increase (Decrease) in funding on corporate assets", "documentation": "Increase (Decrease) in funding on corporate assets." } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInInterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInInterestAndRentReceivable", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Increase decrease in interest and rent receivable.", "label": "Increase Decrease In Interest And Rent Receivable", "negatedLabel": "Interest and rent receivables" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets", "totalLabel": "Increase (Decrease) in Other Operating Assets, Total", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r10" ] }, "mpw_IncreaseDecreaseInRealEstateImpairmentReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInRealEstateImpairmentReserve", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in real estate impairment reserves", "documentation": "Increase decrease in real estate impairment reserve.", "label": "Increase Decrease In Real Estate Impairment Reserve" } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInRealEstateImpairmentReserveRelatedToDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInRealEstateImpairmentReserveRelatedToDisposals", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of assets", "documentation": "Increase decrease in real estate impairment reserve related to disposals.", "label": "Increase Decrease In Real Estate Impairment Reserve Related To Disposals", "terseLabel": "Increase (decrease) in real estate impairment reserves related to disposals" } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInRecoveryReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInRecoveryReceivable", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in recovery receivables", "label": "Increase (Decrease) in recovery receivable", "documentation": "Increase (Decrease) in recovery receivable." } } }, "auth_ref": [] }, "mpw_IncreaseDecreaseInStraightLineRentReceivableReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IncreaseDecreaseInStraightLineRentReceivableReserves", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) In Straight-Line Rent Receivable Reserves", "terseLabel": "Increase in straight-line rent receivable reserves", "documentation": "increase (decrease) in straight-line rent receivable reserves." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive potential common shares", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r336", "r337", "r338", "r343", "r517" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r1030", "r1039", "r1049", "r1066", "r1075", "r1079", "r1087" ] }, "mpw_InflationBasedPercentageForAmendedLease": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InflationBasedPercentageForAmendedLease", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Inflation-based percentage for amended lease", "label": "Inflation-based Percentage for Amended Lease", "documentation": "Inflation-based percentage for amended lease." } } }, "auth_ref": [] }, "mpw_InfracoreMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InfracoreMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "documentation": "Infracore.", "label": "Infracore [Member]", "terseLabel": "Infracore [Member]" } } }, "auth_ref": [] }, "mpw_InpatientRehabilitationHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InpatientRehabilitationHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inpatient Rehabilitation Hospital [Member]", "label": "Inpatient Rehabilitation Hospital [Member]", "documentation": "Inpatient Rehabilitation Hospital." } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r1085" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r1019", "r1091" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r1019", "r1091" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r1019", "r1091" ] }, "mpw_IntangibleLeaseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IntangibleLeaseAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Intangible lease assets.", "label": "Intangible Lease Assets", "terseLabel": "Intangible lease assets" } } }, "auth_ref": [] }, "mpw_IntangibleLeaseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "IntangibleLeaseAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Intangible Lease Assets", "label": "Intangible Lease Assets [Member]", "terseLabel": "Intangible Lease Assets [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Interest and Other Income", "terseLabel": "Interest and other income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "mpw_InterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InterestAndRentReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Interest and rent receivables, net", "documentation": "Interest and rent receivable.", "terseLabel": "Interest and rent receivables", "verboseLabel": "Interest and rent receivables, Book value" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "terseLabel": "Interest", "totalLabel": "Interest Expense, Total", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r133", "r204", "r287", "r356", "r652", "r867", "r1009", "r1239" ] }, "mpw_InterestMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InterestMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "documentation": "Interest.", "label": "Interest [Member]", "terseLabel": "Interest [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid, including capitalized interest of $14,178 in 2023, $6,454 in 2022,and $3,289 in 2021", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r1136" ] }, "us-gaap_InterestPaidCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidCapitalized", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Capitalized, Investing Activities", "terseLabel": "Interest paid, capitalized", "documentation": "Amount of cash paid for interest capitalized, classified as investing activity." } } }, "auth_ref": [ "r963", "r1136" ] }, "mpw_InterimCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InterimCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Interim credit facility.", "label": "Interim Credit Facility [Member]", "terseLabel": "Interim Credit Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterimPeriodCostsNotAllocableDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Interim Period, Costs Not Allocable [Domain]", "terseLabel": "Interim Period, Costs Not Allocable", "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred." } } }, "auth_ref": [ "r58" ] }, "mpw_InternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "International joint venture.", "label": "International Joint Venture [Member]", "terseLabel": "International Joint Venture [Member]" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyDividendDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyDividendDistribution", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Investment Company, Dividend Distribution, Total", "label": "Investment Company, Dividend Distribution", "terseLabel": "Distribution on Steward equity investment", "verboseLabel": "Distribution on equity investment", "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital." } } }, "auth_ref": [ "r814", "r817", "r818", "r882" ] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeDividend", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment Income, Dividend", "terseLabel": "Dividend income", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r160" ] }, "us-gaap_InvestmentOwnedAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Cost", "verboseLabel": "Original Cost", "documentation": "Cost of the investment." } } }, "auth_ref": [ "r806", "r828", "r829", "r892", "r894", "r902", "r920", "r999", "r1011", "r1238" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "periodEndLabel": "Investment Owned, Fair Value, Ending Balance", "periodStartLabel": "Investment Owned, Fair Value, Beginning Balance", "label": "Investment Owned, Fair Value", "terseLabel": "Fair Value", "verboseLabel": "Real estate fair value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r806", "r821", "r822", "r823", "r825", "r827", "r828", "r829", "r831", "r834", "r835", "r846", "r847", "r887", "r890", "r891", "r893", "r900", "r901", "r903", "r904", "r905", "r916", "r917", "r919", "r921", "r922", "r999", "r1011", "r1238" ] }, "mpw_InvestmentReceivedInLieuOfCash": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentReceivedInLieuOfCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment received in lieu of cash", "label": "Investment Received in Lieu of Cash", "documentation": "Investment received in lieu of cash." } } }, "auth_ref": [] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Investment Type [Axis]", "terseLabel": "Investment Type", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r822", "r824", "r825", "r828", "r831", "r887", "r890", "r896", "r901", "r903", "r914", "r915", "r921", "r923", "r924", "r925", "r926", "r999" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Investments [Domain]", "terseLabel": "Investments", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r822", "r824", "r825", "r828", "r831", "r887", "r890", "r896", "r901", "r903", "r914", "r915", "r921", "r923", "r924", "r925", "r926", "r999" ] }, "us-gaap_InvestmentTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Type [Extensible Enumeration]", "documentation": "Indicates type of investment. Includes, but is not limited to, common stock, preferred stock, convertible security, fixed income security, government security, option purchased, warrant, loan participation and assignment, commercial paper, bankers' acceptance, certificates of deposit, short-term security, repurchase agreement, and other investment company." } } }, "auth_ref": [ "r822", "r828", "r888", "r890", "r895", "r896", "r897", "r903", "r918", "r921" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments", "totalLabel": "Investments, Total", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r756" ] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure", "terseLabel": "Total investments", "totalLabel": "Investments, Fair Value Disclosure, Total", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r623" ] }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "terseLabel": "Estimated Increase (Decrease) in Fair Value", "totalLabel": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease), Total", "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates." } } }, "auth_ref": [ "r1247" ] }, "mpw_InvestmentsInFinancingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentsInFinancingLeasesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Investments in financing leases.", "label": "Investments In Financing Leases [Member]", "terseLabel": "Investments in Financing Leases [Member]" } } }, "auth_ref": [] }, "mpw_InvestmentsInOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentsInOtherLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Investments in other loans.", "label": "Investments in Other Loans", "terseLabel": "Other loans" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedEntitiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentsInUnconsolidatedEntitiesPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Investments In unconsolidated entities.", "label": "Investments In Unconsolidated Entities Policy [Text Block]", "terseLabel": "Investments in Unconsolidated Entities" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedOperatingEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentsInUnconsolidatedOperatingEntities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities", "label": "Investments In Unconsolidated Operating Entities", "terseLabel": "Investments in unconsolidated operating entities" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedOperatingEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "InvestmentsInUnconsolidatedOperatingEntitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities [Member]", "label": "Investments In Unconsolidated Operating Entities [Member]" } } }, "auth_ref": [] }, "mpw_JohnstownPAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "JohnstownPAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Johnstown PA.", "label": "Johnstown P A [Member]", "terseLabel": "Johnstown, PA [Member]" } } }, "auth_ref": [] }, "mpw_KansasCityKSMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KansasCityKSMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Kansas City KS.", "label": "Kansas City K S [Member]", "terseLabel": "Kansas City, KS [Member]" } } }, "auth_ref": [] }, "mpw_KansasCityMOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KansasCityMOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Kansas City, MO.", "label": "Kansas City M O [Member]", "terseLabel": "Kansas City, MO [Member]" } } }, "auth_ref": [] }, "mpw_KatyTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KatyTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Katy, TX.", "label": "Katy T X [Member]", "terseLabel": "Katy, TX [Member]" } } }, "auth_ref": [] }, "mpw_KingswoodAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KingswoodAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Kingswood Australia.", "label": "Kingswood Australia [Member]", "terseLabel": "Kingswood, Australia [Member]" } } }, "auth_ref": [] }, "mpw_KuhlungsbornGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KuhlungsbornGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Kuhlungsborn Germany [Member]", "documentation": "Kuhlungsborn Germany." } } }, "auth_ref": [] }, "mpw_KuopioFinlandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "KuopioFinlandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Kuopio, finland.", "label": "Kuopio, Finland [Member]", "terseLabel": "Kuopio, Finland [Member]" } } }, "auth_ref": [] }, "mpw_LafayetteINMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LafayetteINMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lafayette IN.", "label": "Lafayette I N [Member]", "terseLabel": "Lafayette, IN [Member]" } } }, "auth_ref": [] }, "us-gaap_Land": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Land", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Land", "terseLabel": "Land", "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale." } } }, "auth_ref": [ "r1125" ] }, "us-gaap_LandAndLandImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandAndLandImprovementsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Land and Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]", "documentation": "Real estate held and assets that are an addition or improvement to real estate held." } } }, "auth_ref": [] }, "mpw_LanderWyomingMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LanderWyomingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lander, Wyoming.", "label": "Lander Wyoming [Member]", "terseLabel": "Lander, WY [Member]" } } }, "auth_ref": [] }, "mpw_LauderdaleLakesFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LauderdaleLakesFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lauderdale Lakes, FL.", "label": "Lauderdale Lakes F L [Member]", "terseLabel": "Lauderdale Lakes, FL [Member]" } } }, "auth_ref": [] }, "mpw_LawtonOklahomaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LawtonOklahomaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lawton, Oklahoma.", "label": "Lawton Oklahoma [Member]", "terseLabel": "Lawton, OK [Member]" } } }, "auth_ref": [] }, "mpw_LaytonUtahMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LaytonUtahMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Layton, Utah.", "label": "Layton Utah [Member]", "terseLabel": "Layton, UT [Member]" } } }, "auth_ref": [] }, "mpw_LeagueCityTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeagueCityTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "League City TX.", "label": "League City T X [Member]", "terseLabel": "League City, TX [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Lease, Cost", "totalLabel": "Total lease cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r668", "r993" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Finance lease cost:" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Lease Expense", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1215" ] }, "mpw_LeaseIntangiblesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeaseIntangiblesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Lease intangibles.", "label": "Lease Intangibles [Member]", "terseLabel": "Lease Intangibles [Member]" } } }, "auth_ref": [] }, "mpw_LeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeaseLiabilitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lease liabilities.", "label": "Lease Liabilities [Abstract]", "terseLabel": "Lease liabilities:" } } }, "auth_ref": [] }, "mpw_LeasePurchaseOptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeasePurchaseOptionValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lease purchase option value", "label": "Lease Purchase Option Value", "documentation": "Lease purchase option value." } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r172" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeasesAcquiredInPlaceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAcquiredInPlaceMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "In-place lease intangibles [Member]", "label": "Leases, Acquired-in-Place [Member]", "documentation": "This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired." } } }, "auth_ref": [] }, "mpw_LeasesAnnualRentEscalationsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeasesAnnualRentEscalationsPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Leases annual rent escalations percentage.", "label": "Leases Annual Rent Escalations Percentage", "terseLabel": "Annual rent escalations" } } }, "auth_ref": [] }, "mpw_LeawoodKansasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeawoodKansasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Leawood, Kansas.", "label": "Leawood Kansas [Member]", "terseLabel": "Leawood, KS [Member]" } } }, "auth_ref": [] }, "mpw_LeedsUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LeedsUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Leeds, UK.", "label": "Leeds U K [Member]", "terseLabel": "Leeds, UK [Member]" } } }, "auth_ref": [] }, "mpw_LehiUtMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LehiUtMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lehi UT [Member]", "label": "Lehi Ut [Member]", "terseLabel": "Lehi, UT [Member]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r667" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee Lease Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r667" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases (Lessee)", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r666" ] }, "mpw_LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and finance lease real estate right of use asset net.", "label": "Lessee Operating Lease And Finance Lease Real Estate Right Of Use Asset Net", "totalLabel": "Total real estate right of use assets", "verboseLabel": "Right-of-use-assets" } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and finance lease right of use asset net.", "label": "Lessee Operating Lease And Finance Lease Right Of Use Asset Net", "totalLabel": "Total right of use assets" } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseAndFinanceLeaseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LesseeOperatingLeaseAndFinanceLeaseTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLessee" ], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and financing lease.", "label": "Lessee Operating Lease And Finance Lease [Text Block]", "terseLabel": "Leases (Lessee)" } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseExtendedExpirationYearOfContract": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LesseeOperatingLeaseExtendedExpirationYearOfContract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease extended expiration year of contract.", "label": "Lessee Operating Lease Extended Expiration Year Of Contract", "terseLabel": "Lease extension expiration year" } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseInitialFixedTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LesseeOperatingLeaseInitialFixedTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease initial fixed term of contract.", "label": "Lessee Operating Lease Initial Fixed Term Of Contract", "terseLabel": "Lease extension expiration term" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Operating Leases, Total undiscounted minimum lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Operating Leases, Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases, 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases, 2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases, 2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases, 2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases, 2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Operating Leases, Less: interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r676" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Initial lease term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1214" ] }, "us-gaap_LessorLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Lease, Description [Line Items]", "terseLabel": "Lessor Lease Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r679" ] }, "us-gaap_LessorLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Lease, Description [Table]", "terseLabel": "Lessor Lease Description [Table]", "documentation": "Disclosure of information about lessor's leases." } } }, "auth_ref": [ "r679" ] }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceived", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payment to be Received", "totalLabel": "Future minimum lease payments to be received", "documentation": "Amount of lease payments to be received by lessor for operating lease." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]", "terseLabel": "Summary of Total Future Minimum Lease Payments to be Received", "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease." } } }, "auth_ref": [ "r1217" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseRenewalTerm", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Term of lease extension, years", "verboseLabel": "Lease renewal term", "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1218" ] }, "us-gaap_LessorOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Term of lease", "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1218" ] }, "mpw_LewistonIDMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LewistonIDMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lewiston, ID.", "label": "Lewiston I D [Member]", "terseLabel": "Lewiston, ID [Member]" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r32", "r299", "r414", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r591", "r594", "r595", "r632", "r841", "r968", "r1011", "r1171", "r1221", "r1222" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity / Capital", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r152", "r198", "r766", "r994", "r1139", "r1164", "r1213" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "mpw_LifePointMasterLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LifePointMasterLeaseMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "LifePoint master lease.", "label": "Life Point Master Lease [Member]", "terseLabel": "LifePoint Master Lease [Member]" } } }, "auth_ref": [] }, "mpw_LifepointBehavioralHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LifepointBehavioralHealthMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lifepoint Behavioral Health [Member]", "label": "Lifepoint Behavioral Health [Member]", "documentation": "Lifepoint behavioral health." } } }, "auth_ref": [] }, "mpw_LifepointBehavioralMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LifepointBehavioralMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lifepoint Behavioral [Member]", "label": "Lifepoint Behavioral [Member]", "documentation": "Lifepoint behavioral." } } }, "auth_ref": [] }, "mpw_LifepointTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LifepointTransactionMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lifepoint Transaction.", "label": "Lifepoint Transaction [Member]" } } }, "auth_ref": [] }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest", "terseLabel": "Percentage of ownership of general partner", "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP)." } } }, "auth_ref": [ "r59" ] }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest", "verboseLabel": "Percentage of ownership limited partner", "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP)." } } }, "auth_ref": [ "r59" ] }, "us-gaap_LimitedPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partner [Member]", "terseLabel": "Limited Partner [Member]", "documentation": "Party to a partnership business who has limited liability." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccount", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partners - issued and outstanding - 593,000 units at December 31, 2023 and 591,500 units at December 31, 2022", "label": "Limited Partners' Capital Account", "totalLabel": "Limited Partners' Capital Account, Total", "documentation": "The amount of the limited partners' ownership interests." } } }, "auth_ref": [ "r179" ] }, "us-gaap_LimitedPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partners' Capital Account, Units Issued", "terseLabel": "Limited Partners, units issued", "documentation": "The number of limited partner units issued." } } }, "auth_ref": [ "r179" ] }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partners' Capital Account, Units Outstanding", "terseLabel": "Limited Partners, units outstanding", "documentation": "The number of limited partner units outstanding." } } }, "auth_ref": [ "r179" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Line of Credit", "terseLabel": "Line of credit", "verboseLabel": "Credit facilities, amount outstanding", "totalLabel": "Long-Term Line of Credit, Total", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r29", "r196", "r1234" ] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit, terminated date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r31" ] }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Line of Credit Facility, Increase (Decrease), Net, Total", "label": "Line of Credit Facility, Increase (Decrease), Net", "terseLabel": "Increase in revolving credit facility", "documentation": "Amount of increase (decrease) of the credit facility." } } }, "auth_ref": [ "r1138" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, Borrowing capacity", "verboseLabel": "Line of credit facility, Borrowing capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r31" ] }, "mpw_LittleElmTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LittleElmTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Little Elm, TX.", "label": "Little Elm T X [Member]", "terseLabel": "Little Elm, TX [Member]" } } }, "auth_ref": [] }, "mpw_LiverpoolAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LiverpoolAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Liverpool Australia.", "label": "Liverpool Australia [Member]", "terseLabel": "Liverpool, Australia [Member]" } } }, "auth_ref": [] }, "us-gaap_LoanCommitmentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoanCommitmentsPolicy", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loan Commitments, Policy [Policy Text Block]", "terseLabel": "Loans", "documentation": "Disclosure of accounting policy for loan commitments accounted for as derivatives, including the methods and assumptions used to estimate fair value and any associated hedging strategies." } } }, "auth_ref": [ "r28", "r188" ] }, "mpw_LoanTerm": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LoanTerm", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Loan term.", "label": "Loan Term", "terseLabel": "Loan term" } } }, "auth_ref": [] }, "mpw_Loans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "Loans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Loans.", "label": "Loans", "terseLabel": "Loans, Book value" } } }, "auth_ref": [] }, "us-gaap_LoansAndLeasesReceivableAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansAndLeasesReceivableAllowance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Loans and Leases Receivable, Allowance", "terseLabel": "Cumulative effect of change in accounting principle", "verboseLabel": "Credit loss reserve", "documentation": "Amount of allowance to cover probable credit losses on loans and leases. Includes carryover of or adjustments to the allowance for loan losses in connection with business combinations. Excludes allowance for loans and leases covered under loss sharing agreements." } } }, "auth_ref": [ "r17", "r19", "r73", "r1104" ] }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansHeldForSaleFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Loan, Held-for-Sale, Fair Value Disclosure", "terseLabel": "Loans, Fair value", "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables." } } }, "auth_ref": [] }, "mpw_LoansLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LoansLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Loans.", "label": "Loans [Line Items]", "terseLabel": "Loans [Line Items]" } } }, "auth_ref": [] }, "us-gaap_LoansMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Loans [Member]", "documentation": "When a lender gives money or property over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors." } } }, "auth_ref": [ "r69", "r966" ] }, "mpw_LoansOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LoansOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, Net One [Member]", "label": "Loans One [Member]", "documentation": "Loans one." } } }, "auth_ref": [] }, "mpw_LoansTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LoansTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Loans [Table]", "label": "Loans [Table]", "terseLabel": "Loans [Table]" } } }, "auth_ref": [] }, "mpw_LoansTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LoansTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, Net Two [Member]", "label": "Loans Two [Member]", "documentation": "Loans two." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_LondonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LondonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "London, United Kingdom.", "label": "London United Kingdom [Member]", "terseLabel": "London, UK [Member]" } } }, "auth_ref": [] }, "mpw_LondonUnitedKingdomOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LondonUnitedKingdomOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "London, UK.", "label": "London United Kingdom One [Member]", "terseLabel": "London, UK [Member]" } } }, "auth_ref": [] }, "mpw_LongTermAcuteCareHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LongTermAcuteCareHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Long-term acute care hospital.", "label": "Long-term Acute Care Hospital [Member]", "terseLabel": "Long Term Acute Care Hospital" } } }, "auth_ref": [] }, "mpw_LongTermCapitalGainLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LongTermCapitalGainLossPerShare", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "lang": { "en-us": { "role": { "documentation": "Long-term capital gain (loss) per share.", "label": "Long-term Capital Gain (Loss) Per Share", "terseLabel": "Long-term capital gain" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Debt, net", "totalLabel": "Debt, net", "negatedLabel": "Debt, net Book value", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r29", "r196", "r480", "r491", "r975", "r976", "r1234" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Fair Value", "negatedLabel": "Debt, net Fair value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r1177" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r484" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r484" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r484" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r484" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r13", "r306", "r484" ] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt [Text Block]", "terseLabel": "Debt", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r174" ] }, "mpw_LongTermIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LongTermIncentivePlanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Long term incentive plan.", "label": "Long Term Incentive Plan [Member]", "terseLabel": "Long Term Incentive Plan [Member]" } } }, "auth_ref": [] }, "mpw_LongmontColoradoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LongmontColoradoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Longmont Colorado.", "label": "Longmont Colorado [Member]", "terseLabel": "Longmont, CO [Member]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r35" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r35", "r80" ] }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtWeightedAverageInterestRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Credit facilities, weighted average interest rate", "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time." } } }, "auth_ref": [] }, "mpw_LosAngelesCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LosAngelesCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Los Angeles, CA.", "label": "Los Angeles C A [Member]", "terseLabel": "Los Angeles, CA [Member]" } } }, "auth_ref": [] }, "mpw_LosAngelesCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LosAngelesCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Los Angeles, California.", "label": "Los Angeles California [Member]", "terseLabel": "Los Angeles, California [Member]" } } }, "auth_ref": [] }, "mpw_LossesFromRentReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LossesFromRentReceivablesPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Losses from rent receivables.", "label": "Losses From Rent Receivables Policy [Text Block]", "terseLabel": "Losses from Rent Receivables" } } }, "auth_ref": [] }, "mpw_LubbockTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LubbockTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lubbock TX.", "label": "Lubbock T X [Member]", "terseLabel": "Lubbock, TX [Member]" } } }, "auth_ref": [] }, "mpw_LynwoodCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "LynwoodCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lynwood, CA.", "label": "Lynwood C A [Member]", "terseLabel": "Lynwood, CA [Member]" } } }, "auth_ref": [] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "MA", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Massachusetts [Member]", "label": "MASSACHUSETTS" } } }, "auth_ref": [] }, "mpw_MPTTRSIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MPTTRSIncMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "MPT TRS, Inc", "label": "M P T T R S Inc [Member]", "terseLabel": "MPT TRS, Inc [Member]" } } }, "auth_ref": [] }, "mpw_MacquarieAssetManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MacquarieAssetManagementMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Macquarie Asset Management.", "label": "Macquarie Asset Management [Member]", "terseLabel": "Macquarie Asset Management [Member]" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r377", "r981", "r1178", "r1235", "r1236" ] }, "us-gaap_MajorPropertyClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Major Property Class [Axis]", "terseLabel": "Major Property Class", "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class." } } }, "auth_ref": [ "r213" ] }, "us-gaap_MajorPropertyClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Major Property Class [Domain]", "terseLabel": "Major Property Class", "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date." } } }, "auth_ref": [ "r213" ] }, "mpw_MalagaSPMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MalagaSPMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Malaga, SP.", "label": "Malaga S P [Member]", "terseLabel": "Malaga, SP [Member]" } } }, "auth_ref": [] }, "mpw_MandevilleLouisianaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MandevilleLouisianaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Mandeville Louisiana.", "label": "Mandeville Louisiana [Member]", "terseLabel": "Mandeville, LA [Member]" } } }, "auth_ref": [] }, "us-gaap_MarketApproachValuationTechniqueMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketApproachValuationTechniqueMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market Valuation Approach [Member]", "label": "Valuation, Market Approach [Member]", "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities." } } }, "auth_ref": [ "r25" ] }, "mpw_MarketBasedAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MarketBasedAwardsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Market-Based Awards [Member]", "label": "Market-Based Awards [Member]", "documentation": "Market-based awards." } } }, "auth_ref": [] }, "mpw_MarketCapitalizationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MarketCapitalizationPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Market capitalization percentage", "label": "Market Capitalization Percentage", "documentation": "Market capitalization percentage." } } }, "auth_ref": [] }, "mpw_MarketCapitalizationRate": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MarketCapitalizationRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market capitalization rate", "documentation": "Market capitalization rate.", "label": "Market Capitalization Rate" } } }, "auth_ref": [] }, "mpw_MarketConditionsBasedAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MarketConditionsBasedAwardsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Market Conditions Based Awards [Member]", "label": "Market Conditions Based Awards [Member]", "terseLabel": "Market Conditions Based Awards [Member]" } } }, "auth_ref": [] }, "mpw_MarreroLouisianaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MarreroLouisianaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Marrero Louisiana.", "label": "Marrero Louisiana [Member]", "terseLabel": "Marrero, LA [Member]" } } }, "auth_ref": [] }, "mpw_MassachusettsBasedGeneralAcuteCareHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MassachusettsBasedGeneralAcuteCareHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Massachusetts based general acute care hospitals.", "label": "Massachusetts Based General Acute Care Hospitals [Member]", "terseLabel": "Massachusetts-based General Acute Care Hospitals [Member]" } } }, "auth_ref": [] }, "mpw_MaximumIncrementalCreditFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MaximumIncrementalCreditFacility", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Maximum incremental credit facility", "label": "Maximum Incremental Credit Facility", "terseLabel": "Maximum incremental credit facility" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r512", "r729", "r790", "r832", "r833", "r889", "r895", "r898", "r899", "r918", "r955", "r956", "r970", "r979", "r987", "r996", "r1175", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228" ] }, "mpw_MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of entity's assets invested on single property.", "label": "Maximum Percentage Of Entitys Assets Invested On Single Property", "terseLabel": "Maximum percentage of entity's assets invested on single property" } } }, "auth_ref": [] }, "mpw_MaximumPercentageOfUnencumberedAssets": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MaximumPercentageOfUnencumberedAssets", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of unencumbered assets.", "label": "Maximum Percentage Of Unencumbered Assets", "terseLabel": "Maximum percentage of total unencumbered assets" } } }, "auth_ref": [] }, "mpw_McKinneyTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "McKinneyTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "McKinney, TX.", "label": "Mc Kinney T X [Member]", "terseLabel": "Mc Kinney T X", "verboseLabel": "McKinney, Texas [Member]" } } }, "auth_ref": [] }, "mpw_McminnvilleOregonMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "McminnvilleOregonMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "McMinnville Oregon.", "label": "Mcminnville Oregon [Member]", "terseLabel": "Mcminnville, OR [Member]" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r1058" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1058" ] }, "mpw_MedianKlinikenSARLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MedianKlinikenSARLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "MEDIAN [Member]", "documentation": "Median Kliniken S A R L [Member]", "label": "Median Kliniken S A R L [Member]" } } }, "auth_ref": [] }, "mpw_MedicalPropertiesTrustLimitedLiabilityCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MedicalPropertiesTrustLimitedLiabilityCompanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Medical properties trust LLC.", "label": "Medical Properties Trust Limited Liability Company [Member]", "terseLabel": "Medical Properties Trust, LLC. [Member]" } } }, "auth_ref": [] }, "mpw_MelbourneFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MelbourneFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Melbourne, FL.", "label": "Melbourne F L [Member]", "terseLabel": "Melbourne, FL [Member]" } } }, "auth_ref": [] }, "mpw_MeltonMowbrayUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MeltonMowbrayUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Melton Mowbray, UK.", "label": "Melton Mowbray U K [Member]", "terseLabel": "Melton Mowbray, UK [Member]" } } }, "auth_ref": [] }, "mpw_MesaArizonaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MesaArizonaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Mesa - Arizona.", "label": "Mesa Arizona [Member]", "terseLabel": "Mesa, AZ [Member]" } } }, "auth_ref": [] }, "mpw_MethodistHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MethodistHealthcareMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Methodist healthcare.", "label": "Methodist Healthcare [Member]", "terseLabel": "Methodist [Member]" } } }, "auth_ref": [] }, "mpw_MethuenMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MethuenMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Methuen Massachusetts.", "label": "Methuen Massachusetts [Member]", "terseLabel": "Methuen, MA [Member]" } } }, "auth_ref": [] }, "mpw_MeyersdalePennsylvaniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MeyersdalePennsylvaniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Meyersdale, Pennsylvania.", "label": "Meyersdale Pennsylvania [Member]", "terseLabel": "Meyersdale, PA [Member]" } } }, "auth_ref": [] }, "mpw_MiamiFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MiamiFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Miami, FL.", "label": "Miami F L [Member]", "terseLabel": "Miami, FL [Member]" } } }, "auth_ref": [] }, "mpw_MiltonKeynesUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MiltonKeynesUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Milton Keynes United Kingdom.", "label": "Milton Keynes United Kingdom [Member]", "terseLabel": "Milton Keynes, UK [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r512", "r729", "r790", "r832", "r833", "r889", "r895", "r898", "r899", "r918", "r955", "r956", "r970", "r979", "r987", "r996", "r1175", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228" ] }, "mpw_MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage of reconciling items quantitative threshold of the statutory tax", "label": "Minimum Percentage Of Reconciling Items Quantitative Threshold Of The Statutory Tax", "documentation": "Minimum percentage of reconciling items quantitative threshold of the statutory tax." } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r38", "r197", "r299", "r414", "r464", "r466", "r467", "r468", "r471", "r472", "r632", "r765", "r845" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to non-controlling interests, net", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r178" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r1078" ] }, "mpw_MonmouthUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MonmouthUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Monmouth, UK.", "label": "Monmouth U K [Member]", "terseLabel": "Monmouth, UK [Member]" } } }, "auth_ref": [] }, "mpw_MontclairNJMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MontclairNJMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Montclair, NJ.", "label": "Montclair N J [Member]", "terseLabel": "Montclair, NJ [Member]" } } }, "auth_ref": [] }, "mpw_MontclairNewJerseyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MontclairNewJerseyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Montclair New Jersey.", "label": "Montclair New Jersey [Member]", "terseLabel": "Montclair New Jersey" } } }, "auth_ref": [] }, "mpw_MortgageLoanOnRealEstateFinalMaturityYear": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MortgageLoanOnRealEstateFinalMaturityYear", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "documentation": "Mortgage Loan on Real Estate, Final Maturity Year", "label": "Mortgage Loan On Real Estate Final Maturity Year", "terseLabel": "Final Maturity Date" } } }, "auth_ref": [] }, "us-gaap_MortgageLoansOnRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year", "verboseLabel": "Carrying Amount of Mortgages", "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r934" ] }, "srt_MortgageLoansOnRealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]" } } }, "auth_ref": [] }, "mpw_MortgageLoansOnRealEstateAdditionsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MortgageLoansOnRealEstateAdditionsGross", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate additions gross.", "label": "Mortgage Loans On Real Estate Additions Gross", "terseLabel": "Mortgage loans on real estate including additions during year" } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateByLoanDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSCHEDULEIVMORTGAGELOANSONREALESTATE" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Text Block]", "terseLabel": "SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE", "documentation": "The entire disclosure for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, information for each mortgage loan receivable equaling or exceeding 3 percent of carrying amount of mortgage." } } }, "auth_ref": [ "r251", "r939" ] }, "srt_MortgageLoansOnRealEstateCollectionsOfPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipal", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal", "negatedLabel": "Collection of principal", "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from collection of principal." } } }, "auth_ref": [ "r244", "r936" ] }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net", "terseLabel": "Mortgage loans", "totalLabel": "Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total", "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio." } } }, "auth_ref": [ "r755" ] }, "mpw_MortgageLoansOnRealEstateDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MortgageLoansOnRealEstateDeductions", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate Deductions.", "label": "Mortgage Loans On Real Estate Deductions", "negatedLabel": "Deductions during year" } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateDescriptionLoanCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateDescriptionLoanCategoryAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category [Axis]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category", "documentation": "Information by loan category for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r243", "r935" ] }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property", "documentation": "Information by type of real estate property." } } }, "auth_ref": [ "r230", "r243", "r935", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950" ] }, "mpw_MortgageLoansOnRealEstateExchangeRateFluctuations": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MortgageLoansOnRealEstateExchangeRateFluctuations", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate exchange rate fluctuations.", "label": "Mortgage Loans On Real Estate Exchange Rate Fluctuations", "terseLabel": "Exchange rate fluctuations" } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateFaceAmountOfMortgages": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateFaceAmountOfMortgages", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages", "terseLabel": "Face Amount of Mortgages", "documentation": "Amount of contractual principal due at origination of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r250", "r933" ] }, "srt_MortgageLoansOnRealEstateFederalIncomeTaxBasis1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateFederalIncomeTaxBasis1", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Federal Income Tax Basis", "terseLabel": "Carrying amount of mortgages, federal income tax purposes", "documentation": "Amount of federal income tax basis of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r246", "r938" ] }, "srt_MortgageLoansOnRealEstateInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateInterestRate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate", "terseLabel": "Loans, Weighted Average Interest Rate", "verboseLabel": "Interest Rate", "documentation": "Interest rate of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r247", "r930" ] }, "srt_MortgageLoansOnRealEstateLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]", "terseLabel": "Mortgage Loans on Real Estate [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r251", "r939" ] }, "srt_MortgageLoansOnRealEstateLoanCategoryDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateLoanCategoryDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category [Domain]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category", "documentation": "Loan category for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "Real Estate [Domain]", "terseLabel": "Real Estate", "documentation": "Land and any structures permanently fixed to it." } } }, "auth_ref": [ "r230", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950" ] }, "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstateNewMortgageLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan", "terseLabel": "New mortgage loans and additional advances on existing loans", "verboseLabel": "Mortgage loan", "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment." } } }, "auth_ref": [ "r936" ] }, "srt_MortgageLoansOnRealEstatePeriodicPaymentTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstatePeriodicPaymentTerms", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Periodic Payment Terms, Description", "terseLabel": "Periodic Payment Terms", "documentation": "Description of contractual payment terms of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, whether mortgage loan is payable at level or varying amount to maturity, balloon payment requirement at maturity, and prepayment penalty." } } }, "auth_ref": [ "r248", "r931" ] }, "srt_MortgageLoansOnRealEstatePriorLiens1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstatePriorLiens1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Prior Lien, Amount", "terseLabel": "Prior Liens", "documentation": "Amount of prior lien on real estate securing mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r249", "r932" ] }, "srt_MortgageLoansOnRealEstateScheduleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateScheduleTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]", "terseLabel": "Mortgage Loans On Real Estate Schedule [Table]", "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r251", "r939" ] }, "srt_MortgageLoansOnRealEstateWriteDownOrReserveByLoanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateWriteDownOrReserveByLoanAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Write-down or Reserve by Loan [Axis]", "documentation": "Information by mortgage loan written down or reserved for, within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [ "r245", "r937" ] }, "srt_MortgageLoansOnRealEstateWriteDownOrReserveLoanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateWriteDownOrReserveLoanDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Write-down or Reserve, Loan [Domain]", "documentation": "Mortgage loan written down or reserved for, within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate." } } }, "auth_ref": [] }, "mpw_MortgagesAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MortgagesAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage and Other Loans [Member]", "label": "Mortgages and Other Loans [Member]", "documentation": "Mortgages and other loans." } } }, "auth_ref": [] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Mortgages [Member]", "terseLabel": "Mortgage Loans [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "mpw_MountPleasantSCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MountPleasantSCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Mount Pleasant, SC.", "label": "Mount Pleasant S C [Member]", "terseLabel": "Mount Pleasant, SC [Member]" } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLPMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "MptOperatingPartnershipLPMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "documentation": "MPT Operating Partnership L.P", "label": "Mpt Operating Partnership L P [Member]", "terseLabel": "MPT Operating Partnership, L.P. [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r1086" ] }, "stpr_NJ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "NJ", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "NEW JERSEY" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r377", "r981", "r1178", "r1235", "r1236" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r1059" ] }, "us-gaap_NatureOfExpenseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfExpenseAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "label": "Nature of Expense [Axis]", "terseLabel": "Financing Leases [Member]", "documentation": "Information by type of cost or expense." } } }, "auth_ref": [ "r58" ] }, "mpw_NegativeHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NegativeHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "documentation": "Negative Hundred Basis Points.", "label": "Negative Hundred Basis Points [Member]", "terseLabel": "- 100 Basis Points [Member]" } } }, "auth_ref": [] }, "mpw_NetBookValueOfLeasedProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NetBookValueOfLeasedProperty", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net book value of leased property", "label": "Net Book Value Of Leased Property", "documentation": "Net book value of leased property." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used for) provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r296" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used for) investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r296" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r165", "r166", "r167" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "auth_ref": [] }, "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NetDeferredTaxAssetNetOperatingLossCarryforward", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Net deferred tax asset, net operating loss carryforward.", "label": "Net Deferred Tax Asset Net Operating Loss Carryforward", "totalLabel": "Net deferred tax asset - NOL carryforwards" } } }, "auth_ref": [] }, "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NetIncomeLessParticipatingSecuritiesShareInEarnings", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Net (loss) income, less participating securities' share in earnings", "documentation": "Net income less participating securities share in earnings.", "label": "Net Income Less Participating Securities Share In Earnings" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r156", "r167", "r202", "r261", "r279", "r281", "r286", "r299", "r319", "r323", "r324", "r325", "r326", "r329", "r330", "r340", "r352", "r365", "r371", "r373", "r414", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r620", "r632", "r771", "r863", "r880", "r881", "r969", "r1009", "r1171" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net income attributable to non-controlling interests", "negatedTerseLabel": "Non-controlling interests\u2019 share in earnings", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r117", "r187", "r279", "r281", "r329", "r330", "r770", "r1128" ] }, "us-gaap_NetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentInLease", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0, "order": 4.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Investment in financing leases", "totalLabel": "Total investment in financing leases", "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases." } } }, "auth_ref": [ "r222", "r433", "r677", "r1165" ] }, "mpw_NetInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NetInvestmentInRealEstateAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Net Investment In Real Estate Assets", "label": "Net Investment In Real Estate Assets", "totalLabel": "Net investment in real estate assets" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Developments", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "mpw_NewBraunfelsTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NewBraunfelsTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "New Braunfels Texas.", "label": "New Braunfels Texas [Member]", "terseLabel": "New Braunfels, TX [Member]" } } }, "auth_ref": [] }, "mpw_NewOrleansLouisianaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NewOrleansLouisianaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "New Orleans Louisiana.", "label": "New Orleans Louisiana [Member]", "terseLabel": "New Orleans, LA [Member]" } } }, "auth_ref": [] }, "mpw_NewarkNewJerseyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NewarkNewJerseyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Newark New Jersey .", "label": "Newark New Jersey [Member]", "terseLabel": "Newark, NJ [Member]" } } }, "auth_ref": [] }, "mpw_NewburghINMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NewburghINMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Newburgh, IN.", "label": "Newburgh I N [Member]", "terseLabel": "Newburgh, IN [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty eight.", "label": "Nineteen Eighty Eight [Member]", "terseLabel": "1988 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty five.", "label": "Nineteen Eighty Five [Member]", "terseLabel": "1985 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty four.", "label": "Nineteen Eighty Four [Member]", "terseLabel": "1984 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty.", "label": "Nineteen Eighty [Member]", "terseLabel": "1980 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty Nine.", "label": "Nineteen Eighty Nine [Member]", "terseLabel": "1989 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty one.", "label": "Nineteen Eighty One [Member]", "terseLabel": "1981 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty seven.", "label": "Nineteen Eighty Seven [Member]", "terseLabel": "1987 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty six.", "label": "Nineteen Eighty Six [Member]", "terseLabel": "1986 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty three.", "label": "Nineteen Eighty Three [Member]", "terseLabel": "1983 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty two.", "label": "Nineteen Eighty Two [Member]", "terseLabel": "1982 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenEightyTwoOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenEightyTwoOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty two one.", "label": "Nineteen Eighty Two One [Member]", "terseLabel": "1982 One [Member]" } } }, "auth_ref": [] }, "mpw_NineteenElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenElevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen eleven.", "label": "Nineteen Eleven [Member]", "terseLabel": "1911 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty eight.", "label": "Nineteen Fifty Eight [Member]", "terseLabel": "1958 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty five.", "label": "Nineteen Fifty Five [Member]", "terseLabel": "1955 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty .", "label": "Nineteen Fifty [Member]", "terseLabel": "1950 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty nine.", "label": "Nineteen Fifty Nine [Member]", "terseLabel": "1959 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty one.", "label": "Nineteen Fifty One [Member]", "terseLabel": "1951 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty seven.", "label": "Nineteen Fifty Seven [Member]", "terseLabel": "1957 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty six.", "label": "Nineteen Fifty Six [Member]", "terseLabel": "1956 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty three.", "label": "Nineteen Fifty Three [Member]", "terseLabel": "1953 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFiftyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFiftyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen Fifty Two.", "label": "Nineteen Fifty Two [Member]", "terseLabel": "1952 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenFortyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenFortyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen forty.", "label": "Nineteen Forty [Member]", "terseLabel": "1940 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenHundredMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenHundredMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen hundred.", "label": "Nineteen Hundred [Member]", "terseLabel": "1900 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNineteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNineteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen nineteen.", "label": "Nineteen Nineteen [Member]", "terseLabel": "1919 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety eight.", "label": "Nineteen Ninety Eight [Member]", "terseLabel": "1998 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety five.", "label": "Nineteen Ninety Five [Member]", "terseLabel": "1995 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety four.", "label": "Nineteen Ninety Four [Member]", "terseLabel": "1994 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety.", "label": "Nineteen Ninety [Member]", "terseLabel": "1990 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety nine.", "label": "Nineteen Ninety Nine [Member]", "terseLabel": "1999 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety one.", "label": "Nineteen Ninety One [Member]", "terseLabel": "1991 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety seven.", "label": "Nineteen Ninety Seven [Member]", "terseLabel": "1997 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety six.", "label": "Nineteen Ninety Six [Member]", "terseLabel": "1996 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety three .", "label": "Nineteen Ninety Three [Member]", "terseLabel": "1993 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety two.", "label": "Nineteen Ninety Two [Member]", "terseLabel": "1992 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyTwoOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyTwoOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety two.", "label": "Nineteen Ninety Two One [Member]", "terseLabel": "1992 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenNinetyTwoTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenNinetyTwoTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "1992 - 2 [Member]", "label": "Nineteen Ninety Two Two [Member]", "documentation": "Nineteen ninety two two." } } }, "auth_ref": [] }, "mpw_NineteenSeventeenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventeenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventeen .", "label": "Nineteen Seventeen [Member]", "terseLabel": "1917 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy eight.", "label": "Nineteen Seventy Eight [Member]", "terseLabel": "1978 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy Five.", "label": "Nineteen Seventy Five [Member]", "terseLabel": "1975 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy four.", "label": "Nineteen Seventy Four [Member]", "terseLabel": "1974 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy.", "label": "Nineteen Seventy [Member]", "terseLabel": "1970 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy nine.", "label": "Nineteen Seventy Nine [Member]", "terseLabel": "1979 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen Seventy One.", "label": "Nineteen Seventy One [Member]", "terseLabel": "1971 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy seven.", "label": "Nineteen Seventy Seven [Member]", "terseLabel": "1977 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy six.", "label": "Nineteen Seventy Six [Member]", "terseLabel": "1976 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy three.", "label": "Nineteen Seventy Three [Member]", "terseLabel": "1973 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSeventyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSeventyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy two.", "label": "Nineteen Seventy Two [Member]", "terseLabel": "1972 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty eight.", "label": "Nineteen Sixty Eight [Member]", "terseLabel": "1978 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty five.", "label": "Nineteen Sixty Five [Member]", "terseLabel": "1965 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty four.", "label": "Nineteen Sixty Four [Member]", "terseLabel": "1964 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty.", "label": "Nineteen Sixty [Member]", "terseLabel": "1960 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen Sixty Nine.", "label": "Nineteen Sixty Nine [Member]", "terseLabel": "1969 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty seven.", "label": "Nineteen Sixty Seven [Member]", "terseLabel": "1967 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty six.", "label": "Nineteen Sixty Six [Member]", "terseLabel": "1966 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenSixtyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenSixtyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty two.", "label": "Nineteen Sixty Two [Member]", "terseLabel": "1962 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenThirteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenThirteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen thirteen.", "label": "Nineteen Thirteen [Member]", "terseLabel": "1913 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenThirtyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenThirtyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "1935 [Member]", "label": "Nineteen Thirty Five [Member]", "terseLabel": "1935 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenThirtyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen thirty.", "label": "Nineteen Thirty [Member]", "terseLabel": "1930 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty five.", "label": "Nineteen Twenty Five [Member]", "terseLabel": "1925 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty four.", "label": "Nineteen Twenty Four [Member]", "terseLabel": "1924 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty.", "label": "Nineteen Twenty [Member]", "terseLabel": "1920 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty nine.", "label": "Nineteen Twenty Nine [Member]", "terseLabel": "1929 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "1927 [Member]", "documentation": "Nineteen Twenty Seven.", "label": "Nineteen Twenty Seven [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty six.", "label": "Nineteen Twenty Six [Member]", "terseLabel": "1926 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenTwentyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen Twenty Two.", "label": "Nineteen Twenty Two [Member]", "terseLabel": "1922 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenZeroOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenZeroOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen zero one.", "label": "Nineteen Zero One [Member]", "verboseLabel": "1901 [Member]", "terseLabel": "1901 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenZeroSixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenZeroSixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen zero six.", "label": "Nineteen Zero Six [Member]", "terseLabel": "1906 [Member]" } } }, "auth_ref": [] }, "mpw_NineteenZeroZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NineteenZeroZeroMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nineteen zero zero.", "label": "Nineteen Zero Zero [Member]", "terseLabel": "1900 [Member]" } } }, "auth_ref": [] }, "mpw_NonCashActivitiesRightOfUseAssetsObtainedInExchangeForLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonCashActivitiesRightOfUseAssetsObtainedInExchangeForLeaseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Non-cash activities right of use assets obtained in exchange for lease.", "label": "Non Cash Activities Right Of Use Assets Obtained In Exchange For Lease [Abstract]", "terseLabel": "Non-cash activities - Right-of-use assets obtained in exchange for lease obligations:" } } }, "auth_ref": [] }, "mpw_NonCashImpairmentCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonCashImpairmentCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash impairment charge", "label": "Non-cash Impairment Charge", "documentation": "Non-cash impairment charge." } } }, "auth_ref": [] }, "mpw_NonCashRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonCashRent", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Non cash rent.", "label": "Non Cash Rent", "terseLabel": "Non-cash rent" } } }, "auth_ref": [] }, "mpw_NonCashRevenueFromDebtAndEquitySecuritiesReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonCashRevenueFromDebtAndEquitySecuritiesReceived", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Non-cash revenue from debt and equity securities received", "label": "Non Cash Revenue From Debt And Equity Securities Received", "documentation": "Non-cash revenue from debt and equity securities received." } } }, "auth_ref": [] }, "mpw_NonCashStraightLineRentWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonCashStraightLineRentWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash straight-line rent write-offs", "label": "Non-cash Straight-line Rent Write-offs", "documentation": "Non-cash straight-line rent write-offs." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r1058" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r1027", "r1039", "r1049", "r1066", "r1075" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1056" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1055" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r1066" ] }, "mpw_NonRule10B51ArrModifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonRule10B51ArrModifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non Rule 10b51 Arr Modified Flag", "documentation": "Non rule 10b51 arr modified flag." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1086" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1086" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Total International [Member]", "label": "Non-US [Member]", "terseLabel": "Foreign [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r1243", "r1245", "r1246", "r1248" ] }, "mpw_NoncashInvestingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NoncashInvestingItemsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental schedule of non-cash investing activities:", "label": "Noncash Investing Items [Abstract]", "documentation": "Noncash investing items." } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Issuance of non-controlling interest", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r21", "r90", "r186" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interests [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r104", "r500", "r1150", "r1151", "r1152", "r1241" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total other (expense) income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "mpw_NonrecourseSecuredDebtPercentageOfAssetValue": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NonrecourseSecuredDebtPercentageOfAssetValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nonrecourse secured debt percentage of asset value.", "label": "Nonrecourse Secured Debt Percentage Of Asset Value", "terseLabel": "Nonrecourse secured debt percentage of asset value" } } }, "auth_ref": [] }, "mpw_NorthlandMOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NorthlandMOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Northland, MO.", "label": "Northland M O [Member]", "terseLabel": "Northland, MO [Member]" } } }, "auth_ref": [] }, "mpw_NorwalkCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NorwalkCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Norwalk, CA.", "label": "Norwalk C A [Member]", "terseLabel": "Norwalk, CA [Member]" } } }, "auth_ref": [] }, "mpw_NorwoodAndTexarkanaProjectsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NorwoodAndTexarkanaProjectsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Norwood And Texarkana Projects [Member]", "documentation": "Norwood And Texarkana Projects." } } }, "auth_ref": [] }, "mpw_NorwoodMAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NorwoodMAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Norwood, MA.", "label": "Norwood M A [Member]", "terseLabel": "Norwood, MA [Member]" } } }, "auth_ref": [] }, "mpw_NottinghamUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NottinghamUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nottingham United Kingdom.", "label": "Nottingham United Kingdom [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "auth_ref": [] }, "mpw_NottinghamUnitedKingdomOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NottinghamUnitedKingdomOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nottingham, UK.", "label": "Nottingham United Kingdom One [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "auth_ref": [] }, "mpw_NottinghamUnitedKingdomTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NottinghamUnitedKingdomTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Nottingham, UK.", "label": "Nottingham United Kingdom Two [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "auth_ref": [] }, "mpw_NumberOfAdditionalLeasedProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfAdditionalLeasedProperties", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of additional leased properties.", "label": "Number Of Additional Leased Properties", "terseLabel": "Number of additional leased properties" } } }, "auth_ref": [] }, "mpw_NumberOfAncillaryPropertiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfAncillaryPropertiesSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of ancillary properties sold.", "label": "Number Of Ancillary Properties Sold", "terseLabel": "Number of ancillary properties sold" } } }, "auth_ref": [] }, "us-gaap_NumberOfBusinessesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfBusinessesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of Businesses Acquired", "terseLabel": "Number of facilities acquired", "documentation": "The number of businesses acquired by the entity during the period." } } }, "auth_ref": [] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "mpw_NumberOfDirectFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfDirectFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of direct financing leases.", "label": "Number Of Direct Financing Leases", "terseLabel": "Number of direct financing leases" } } }, "auth_ref": [] }, "mpw_NumberOfFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfFacilities", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfFacilitiesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilities acquired", "label": "Number Of Facilities Acquired", "documentation": "Number of facilities acquired," } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of facilities sold.", "label": "Number Of Facilities Sold", "terseLabel": "Number of facilities sold" } } }, "auth_ref": [] }, "mpw_NumberOfFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of financing leases.", "label": "Number Of Financing Leases", "terseLabel": "Number of financing leases" } } }, "auth_ref": [] }, "mpw_NumberOfHospitalsSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfHospitalsSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of hospitals sold.", "label": "Number Of Hospitals Sold", "terseLabel": "Number of hospitals sold" } } }, "auth_ref": [] }, "mpw_NumberOfLeasedFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfLeasedFacilities", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of leased facilities.", "label": "Number Of Leased Facilities", "terseLabel": "Number of leased facilities" } } }, "auth_ref": [] }, "mpw_NumberOfLeasedProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfLeasedProperties", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of leased properties.", "label": "Number Of Leased Properties", "terseLabel": "Number of leased properties" } } }, "auth_ref": [] }, "mpw_NumberOfOperationsSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfOperationsSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of operations sold.", "label": "Number Of Operations Sold", "terseLabel": "Number of operations sold" } } }, "auth_ref": [] }, "mpw_NumberOfOperators": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfOperators", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of operators.", "label": "Number Of Operators", "terseLabel": "Number of operators" } } }, "auth_ref": [] }, "mpw_NumberOfOtherDevelopmentProjects": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfOtherDevelopmentProjects", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other development projects", "label": "Number Of Other Development Projects", "documentation": "Number of other development projects." } } }, "auth_ref": [] }, "mpw_NumberOfOtherDomesticProperty": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfOtherDomesticProperty", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other domestic property", "label": "Number of Other Domestic Property", "documentation": "Number of other domestic property." } } }, "auth_ref": [] }, "mpw_NumberOfProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfProperties", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of Properties", "label": "Number Of Properties", "terseLabel": "Number of properties" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesLeased": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfPropertiesLeased", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties leased", "label": "Number Of Properties Leased", "documentation": "Number of properties leased." } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfPropertiesSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of properties sold.", "label": "Number Of Properties Sold", "terseLabel": "Number of properties sold" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesVacant": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfPropertiesVacant", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of properties vacant.", "label": "Number of Properties Vacant", "terseLabel": "Number of properties vacant" } } }, "auth_ref": [] }, "mpw_NumberOfReLeasedProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfReLeasedProperties", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of re-leased properties.", "label": "Number Of Re Leased Properties", "terseLabel": "Number of re-leased properties" } } }, "auth_ref": [] }, "us-gaap_NumberOfRealEstateProperties": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfRealEstateProperties", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Number of Real Estate Properties", "terseLabel": "Number of real estate assets acquired", "documentation": "The number of real estate properties owned as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_NumberOfRemainingFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "NumberOfRemainingFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of remaining facilities sold", "label": "Number of Remaining Facilities Sold", "documentation": "Number of remaining facilities sold." } } }, "auth_ref": [] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of States in which Entity Operates", "terseLabel": "Number of states", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "stpr_OH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "OH", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ohio [Member]", "label": "OHIO" } } }, "auth_ref": [] }, "mpw_ObligationsToTenantsAndOtherLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ObligationsToTenantsAndOtherLeaseLiabilities", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Obligations to tenants and other lease liabilities.", "label": "Obligations To Tenants And Other Lease Liabilities", "terseLabel": "Obligations to tenants and other lease liabilities" } } }, "auth_ref": [] }, "mpw_OdessaTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OdessaTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Odessa Texas.", "label": "Odessa Texas [Member]", "terseLabel": "Odessa, TX [Member]" } } }, "auth_ref": [] }, "mpw_OgdenUtahMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OgdenUtahMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ogden Utah.", "label": "Ogden Utah [Member]", "terseLabel": "Ogden, UT [Member]" } } }, "auth_ref": [] }, "mpw_OklahomaCityOKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OklahomaCityOKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Oklahoma City, OK.", "label": "Oklahoma City O K [Member]", "terseLabel": "Oklahoma City, OK [Member]" } } }, "auth_ref": [] }, "mpw_OlatheKansasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OlatheKansasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Olathe, Kansas.", "label": "Olathe Kansas [Member]", "terseLabel": "Olathe, KS [Member]" } } }, "auth_ref": [] }, "mpw_OnCampusMedicalOfficeBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OnCampusMedicalOfficeBuildingsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "On campus medical office buildings.", "label": "On Campus Medical Office Buildings [Member]", "terseLabel": "On Campus Medical Office Buildings [Member]" } } }, "auth_ref": [] }, "mpw_OperatingAndFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OperatingAndFinanceLeaseLiability", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Operating and finance lease liability.", "label": "Operating And Finance Lease Liability", "totalLabel": "Total lease liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r670", "r993" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": "mpw_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "verboseLabel": "Operating Leases, Present value of lease liabilities", "totalLabel": "Operating Lease, Liability, Total", "terseLabel": "Operating leases", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r661" ] }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease liability." } } }, "auth_ref": [ "r662" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows used for operating leases", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r665", "r672" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating leases", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r660" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r662" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r675", "r993" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term", "verboseLabel": "Operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r674", "r993" ] }, "mpw_OperatingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OperatingLeasesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "lang": { "en-us": { "role": { "documentation": "Operating Leases [Member]", "label": "Operating Leases [Member]", "terseLabel": "Operating Leases [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Gross NOL carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r98" ] }, "mpw_OperatingLossCarryforwardsExpirationYear": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OperatingLossCarryforwardsExpirationYear", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards, expiration year.", "label": "Operating Loss Carryforwards Expiration Year", "terseLabel": "Expiration periods" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsValuationAllowance", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "parentTag": "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards, Valuation Allowance", "negatedLabel": "Valuation allowance", "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r96" ] }, "mpw_OperatingPartnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OperatingPartnershipMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Operating partnership.", "label": "Operating Partnership [Member]", "terseLabel": "Operating Partnership [Member]" } } }, "auth_ref": [] }, "mpw_OperatorConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OperatorConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Operator concentration risk.", "label": "Operator Concentration Risk [Member]", "terseLabel": "Operator Concentration Risk [Member]" } } }, "auth_ref": [] }, "mpw_OrdinaryDividendPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OrdinaryDividendPerShare", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "lang": { "en-us": { "role": { "documentation": "Ordinary dividend per share.", "label": "Ordinary Dividend Per Share", "terseLabel": "Ordinary dividend" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganization" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r139", "r184", "r804", "r805" ] }, "mpw_OrpingtonUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OrpingtonUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Orpington United Kingdom.", "label": "Orpington United Kingdom [Member]", "terseLabel": "Orpington, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets", "terseLabel": "Other assets", "totalLabel": "Total other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r191", "r264", "r757", "r1011" ] }, "us-gaap_OtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsAbstract", "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]" } } }, "auth_ref": [] }, "mpw_OtherAssetsByFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherAssetsByFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets By Facility [Member]", "documentation": "Other assets by facility." } } }, "auth_ref": [] }, "mpw_OtherAssetsByOperatorMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherAssetsByOperatorMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets by Operator [Member]", "documentation": "Other assets by operator." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssets" ], "lang": { "en-us": { "role": { "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Assets", "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r122", "r126" ] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation gain (loss)", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "verboseLabel": "Foreign currency translation gain (loss)", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r153", "r638", "r639", "r642" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "terseLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r274", "r277" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Reclassification of foreign currency translation loss from AOCI", "terseLabel": "Reclassification of foreign currency translation loss from AOCI", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation." } } }, "auth_ref": [ "r7", "r8", "r153", "r278", "r641" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "mpw_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (loss) gain on interest rate swaps, net of tax", "documentation": "Other comprehensive income unrealized gain (loss) on derivatives net of tax.", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax", "verboseLabel": "Unrealized gain (loss) on interest rate swaps, net of tax" } } }, "auth_ref": [] }, "mpw_OtherCorporateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherCorporateAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Other corporate assets include leasehold improvements associated with our corporate office space, furniture and fixtures, equipment, software, deposits, etc.", "label": "Other Corporate Assets", "terseLabel": "Other corporate assets" } } }, "auth_ref": [] }, "mpw_OtherDomesticAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherDomesticAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Domestic Assets [Member]", "documentation": "Other domestic assets." } } }, "auth_ref": [] }, "mpw_OtherFinancingLeasesNetOfAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherFinancingLeasesNetOfAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "documentation": "Other financing leases, net of allowance for credit loss.", "label": "Other Financing Leases Net Of Allowance For Credit Loss", "terseLabel": "Other financing leases (net of allowance for credit loss)" } } }, "auth_ref": [] }, "mpw_OtherInternationalAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherInternationalAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other International Assets [Member]", "documentation": "Other international assets." } } }, "auth_ref": [] }, "mpw_OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other investment on secured loan with credit facility collateral", "label": "Other Investment On Secured Loan with Credit Facility Collateral", "documentation": "Other investment on secured loan with credit facility collateral." } } }, "auth_ref": [] }, "mpw_OtherLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Other loan.", "label": "Other Loan", "terseLabel": "Other loan to affiliates", "verboseLabel": "Other loan to affiliates" } } }, "auth_ref": [] }, "mpw_OtherLoansAndAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherLoansAndAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Other loans and assets.", "label": "Other Loans And Assets [Member]", "terseLabel": "Other Loans and Assets [Member]" } } }, "auth_ref": [] }, "mpw_OtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Other Loans", "label": "Other Loans [Member]", "terseLabel": "Other Loans [Member]" } } }, "auth_ref": [] }, "mpw_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Noncash Income (Expense)", "negatedLabel": "Other adjustments", "totalLabel": "Other Noncash Income (Expense), Total", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r167" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 2.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Other (expense) income", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Other Nonoperating Income (Expense), Total", "terseLabel": "Other (including fair value adjustments on securities)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r162" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "mpw_OtherOperatorsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherOperatorsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Operators [Member]", "documentation": "Other operators." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1058" ] }, "mpw_OtherTenantUpdatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OtherTenantUpdatesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Tenant Updates [Member]", "documentation": "Other tenant updates." } } }, "auth_ref": [] }, "mpw_OttumwaIAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OttumwaIAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ottumwa, IA.", "label": "Ottumwa I A [Member]", "terseLabel": "Ottumwa, IA [Member]" } } }, "auth_ref": [] }, "mpw_OuluFinlandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OuluFinlandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Oulu, Finland.", "label": "Oulu, Finland [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1025", "r1037", "r1047", "r1073" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r1028", "r1040", "r1050", "r1076" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1028", "r1040", "r1050", "r1076" ] }, "mpw_OverlandParkKansasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OverlandParkKansasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Overland park, Kansas.", "label": "Overland Park Kansas [Member]", "terseLabel": "Overland Park, KS [Member]" } } }, "auth_ref": [] }, "mpw_OverlookTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "OverlookTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Overlook, TX", "label": "Overlook T X [Member]", "terseLabel": "Overlook, TX [Member]" } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "stpr_PA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "PA", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Pennsylvania [Member]", "label": "PENNSYLVANIA" } } }, "auth_ref": [] }, "country_PT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "PT", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "PORTUGAL", "terseLabel": "Portugal [Member]" } } }, "auth_ref": [] }, "mpw_PalestineTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PalestineTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Palestine, Texas.", "label": "Palestine Texas [Member]", "terseLabel": "Palestine, TX [Member]" } } }, "auth_ref": [] }, "mpw_ParkerCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ParkerCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Parker, CO.", "label": "Parker C O [Member]", "terseLabel": "Parker, CO [Member]" } } }, "auth_ref": [] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Partner Type [Axis]", "terseLabel": "Partner Type", "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r91", "r819" ] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Partner Type of Partners' Capital Account, Name [Domain]", "terseLabel": "Partner Type of Partners' Capital Account, Name", "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r179", "r819" ] }, "us-gaap_PartnersCapitalAccountRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnersCapitalAccountRedemptions", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Partners' Capital Account, Redemptions", "terseLabel": "Redemption of common units", "negatedLabel": "Redemption of MOP units", "documentation": "Total change in each class of partners' capital accounts during the year due to redemptions and adjustments to redemption value. All partners include general, limited and preferred partners." } } }, "auth_ref": [ "r178", "r179" ] }, "us-gaap_PartnersCapitalNotesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnersCapitalNotesDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnerSCapital" ], "lang": { "en-us": { "role": { "label": "Partners' Capital Notes Disclosure [Text Block]", "terseLabel": "Common Stock/Partner's Capital", "documentation": "The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units." } } }, "auth_ref": [ "r175" ] }, "mpw_PascoWashingtonMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PascoWashingtonMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Pasco, Washington.", "label": "Pasco Washington [Member]", "terseLabel": "Pasco, WA [Member]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1054" ] }, "mpw_PayableDueToParentCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PayableDueToParentCompany", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Payable due to parent company", "label": "Payable Due To Parent Company", "verboseLabel": "Payable due to Medical Properties Trust, Inc.", "terseLabel": "Payable due to Medical Properties Trust, Inc." } } }, "auth_ref": [] }, "mpw_PaydownOnDebtInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PaydownOnDebtInstruments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Pay down of debt instruments", "label": "Paydown On Debt Instruments", "documentation": "Paydown on debt instruments." } } }, "auth_ref": [] }, "mpw_PaymentsForCapitalAdditionsAndOtherInvestmentsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PaymentsForCapitalAdditionsAndOtherInvestmentsNet", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Payments for capital additions and other investments net.", "label": "Payments For Capital Additions And Other Investments Net", "negatedLabel": "Capital additions and other investments, net" } } }, "auth_ref": [] }, "mpw_PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Payments for proceeds from lease deposits and other obligations to tenants.", "label": "Payments For Proceeds From Lease Deposits And Other Obligations To Tenants", "negatedLabel": "Lease deposits and other obligations to tenants" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock / unit", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r47" ] }, "us-gaap_PaymentsOfOrdinaryDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfOrdinaryDividends", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends / Distribution paid", "totalLabel": "Payments of Ordinary Dividends, Total", "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings." } } }, "auth_ref": [ "r47" ] }, "mpw_PaymentsOfPartialCashRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PaymentsOfPartialCashRent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Partial cash rent Payments", "label": "Payments of Partial Cash Rent", "documentation": "Payments of partial cash rent." } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "terseLabel": "Unit vesting - satisfaction of tax withholdings", "negatedLabel": "Stock / Unit vesting - satisfaction of tax withholdings", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r293" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment for acquisition", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r45", "r587" ] }, "us-gaap_PaymentsToAcquireLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireLoansReceivable", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Loans Receivable", "negatedLabel": "Investment in loans receivable", "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services." } } }, "auth_ref": [ "r44" ] }, "us-gaap_PaymentsToAcquireRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRealEstate", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Real Estate", "negatedLabel": "Cash paid for acquisitions and other related investments", "totalLabel": "Payments to Acquire Real Estate, Total", "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner." } } }, "auth_ref": [ "r164" ] }, "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToFundLongtermLoansToRelatedParties", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Loan facility funded shares", "label": "Payments to Fund Long-Term Loans to Related Parties", "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates." } } }, "auth_ref": [ "r1132", "r1219" ] }, "mpw_PearlandTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PearlandTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Pearland, TX.", "label": "Pearland T X [Member]", "terseLabel": "Pearland, TX [Member]" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r1057" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1057" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1056" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r1066" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r1059" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1055" ] }, "mpw_PercentageOfAssetsInComplianceWithTermsOfLease": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfAssetsInComplianceWithTermsOfLease", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of assets in compliance with terms of lease", "label": "Percentage of Assets in Compliance with Terms of Lease", "documentation": "Percentage of assets in compliance with terms of lease." } } }, "auth_ref": [] }, "mpw_PercentageOfAssetsRepresentingPropertiesLeasedAndLoanToInternationJointVentures": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfAssetsRepresentingPropertiesLeasedAndLoanToInternationJointVentures", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of assets representing properties leased and loan to internation joint ventures", "label": "Percentage of Assets Representing Properties Leased and Loan to Internation Joint Ventures", "documentation": "Percentage of assets representing properties leased and loan to internation joint ventures." } } }, "auth_ref": [] }, "mpw_PercentageOfDeferedRentReceivable": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfDeferedRentReceivable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of defered rent receivable.", "label": "Percentage of Defered Rent Receivable", "terseLabel": "Percentage of defered rent" } } }, "auth_ref": [] }, "mpw_PercentageOfDiscountOnInvestment": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfDiscountOnInvestment", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of discount on investment.", "label": "Percentage of Discount on Investment", "terseLabel": "Percentage of discount on investment" } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on basis of adjusted operating funds.", "label": "Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds", "terseLabel": "Percentage of dividends which could be paid from adjusted operating funds" } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnSeniorUnsecuredNotes": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfDividendsPayableOnSeniorUnsecuredNotes", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on senior unsecured notes.", "label": "Percentage Of Dividends Payable On Senior Unsecured Notes", "terseLabel": "Percentage of dividends which could be paid from operation funds" } } }, "auth_ref": [] }, "mpw_PercentageOfIncreaseInSharePrice": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfIncreaseInSharePrice", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of increase in share price", "label": "Percentage Of Increase In Share Price", "documentation": "Percentage of increase in share price." } } }, "auth_ref": [] }, "mpw_PercentageOfLeasedAssetsOwned": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfLeasedAssetsOwned", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of leased assets owned", "label": "Percentage of Leased Assets Owned", "documentation": "Percentage of leased assets owned." } } }, "auth_ref": [] }, "mpw_PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of ordinary taxable income to be distributed for REIT qualification.", "label": "Percentage Of Ordinary Taxable Income To Be Distributed For Real Estate Investment Trust Qualification", "terseLabel": "Percentage of ordinary taxable income to be distributed for real estate investment trust qualification" } } }, "auth_ref": [] }, "mpw_PercentageOfPropertiesOccupiedByTenants": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfPropertiesOccupiedByTenants", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of properties occupied by tenants.", "label": "Percentage of Properties Occupied By Tenants", "terseLabel": "Percentage of properties occupied by tenants" } } }, "auth_ref": [] }, "mpw_PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of taxable income to be distributed for federal income tax exemption.", "label": "Percentage Of Taxable Income To Be Distributed For Federal Income Tax Exemption", "terseLabel": "Percentage of taxable income to be distributed for federal income tax assumption" } } }, "auth_ref": [] }, "mpw_PercentageOfVacantOnLeasedProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PercentageOfVacantOnLeasedProperty", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vacant on leased property.", "label": "Percentage Of Vacant On Leased Property", "terseLabel": "Percentage of vacant on leased property" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]", "terseLabel": "Performance-Based Awards [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "mpw_PerthAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PerthAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Perth, Australia.", "label": "Perth Australia [Member]", "terseLabel": "Perth, Australia [Member]" } } }, "auth_ref": [] }, "mpw_PetersburgVAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PetersburgVAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Petersburg, VA.", "label": "Petersburg V A [Member]", "terseLabel": "Petersburg, VA [Member]" } } }, "auth_ref": [] }, "mpw_PhoenixAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PhoenixAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Phoenix, AZ.", "label": "Phoenix A Z [Member]", "terseLabel": "Phoenix, AZ [Member]" } } }, "auth_ref": [] }, "mpw_PhoenixAZOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PhoenixAZOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Phoenix, AZ one.", "label": "Phoenix A Z One [Member]", "terseLabel": "Phoenix, AZ [Member]" } } }, "auth_ref": [] }, "mpw_PhpHoldingsEquityInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PhpHoldingsEquityInvestmentMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "PHP Holdings Equity Investment [Member]", "documentation": "Php holdings equity investment." } } }, "auth_ref": [] }, "mpw_PhpHoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PhpHoldingsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "PHP Holdings [Member]", "label": "PHP Holdings [Member]", "documentation": "PHP Holdings [Member]" } } }, "auth_ref": [] }, "mpw_PipelineHealthSystemMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PipelineHealthSystemMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Pipeline health system.", "label": "Pipeline Health System [Member]", "terseLabel": "Pipeline Health System [Member]" } } }, "auth_ref": [] }, "mpw_PlanoTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PlanoTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Plano, TX.", "label": "Plano T X [Member]", "terseLabel": "Plano, TX [Member]" } } }, "auth_ref": [] }, "us-gaap_PledgingPurposeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Axis]", "documentation": "Information by pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r711", "r990", "r995", "r1099" ] }, "us-gaap_PledgingPurposeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Domain]", "documentation": "Pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r711", "r990", "r995", "r1099" ] }, "mpw_PoliclinicoDiMonzaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PoliclinicoDiMonzaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Policlinico di Monza.", "label": "Policlinico di Monza [Member]", "terseLabel": "Policlinico di Monza [Member]" } } }, "auth_ref": [] }, "mpw_PooleUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PooleUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Poole United Kingdom.", "label": "Poole United Kingdom [Member]", "terseLabel": "Poole, UK [Member]", "verboseLabel": "Poole, England [Member]" } } }, "auth_ref": [] }, "mpw_PoplarBluffMissouriMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PoplarBluffMissouriMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Poplar Bluff, Missouri.", "label": "Poplar Bluff Missouri [Member]", "terseLabel": "Poplar Bluff, MO [Member]" } } }, "auth_ref": [] }, "mpw_PortArthurTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PortArthurTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Port Arthur, TX.", "label": "Port Arthur T X [Member]", "terseLabel": "Port Arthur, TX [Member]" } } }, "auth_ref": [] }, "mpw_PortHuronMIMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PortHuronMIMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Port Huron MI.", "label": "Port Huron M I [Member]", "terseLabel": "Port Huron, MI" } } }, "auth_ref": [] }, "mpw_PositiveHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PositiveHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "documentation": "Positive Hundred Basis Points.", "label": "Positive Hundred Basis Points [Member]", "terseLabel": "+ 100 Basis Points [Member]" } } }, "auth_ref": [] }, "mpw_PostFallsIdahoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PostFallsIdahoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Post Falls Idaho.", "label": "Post Falls Idaho [Member]", "terseLabel": "Post Falls Idaho" } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Par Value [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r997", "r998", "r1001", "r1002", "r1003", "r1004", "r1237", "r1241" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r146", "r493" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r146", "r843" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r146", "r843", "r861", "r1241", "r1242" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r146", "r761", "r994" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaids and other assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "mpw_PrepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrepaymentsOfLinesOfCredit", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid term loan", "label": "Prepayments Of Lines Of Credit", "documentation": "Prepayments of lines of credit." } } }, "auth_ref": [] }, "mpw_PrestonUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrestonUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Preston UK.", "label": "Preston U K [Member]", "terseLabel": "Preston, UK [Member]" } } }, "auth_ref": [] }, "mpw_PrimeFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrimeFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Prime facilities.", "label": "Prime Facilities [Member]", "terseLabel": "Prime Facilities [Member]" } } }, "auth_ref": [] }, "mpw_PrimeHealthCareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrimeHealthCareServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Prime Health Care Services.", "label": "Prime Health Care Services [Member]", "terseLabel": "Prime [Member]" } } }, "auth_ref": [] }, "mpw_PrimeHealthcareServicesIncFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrimeHealthcareServicesIncFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Prime Healthcare Services, Inc. facilities.", "label": "Prime Healthcare Services, Inc. Facilities [Member]", "terseLabel": "Prime Healthcare Services, Inc. Facilities [Member]" } } }, "auth_ref": [] }, "mpw_PrimotopHoldingsSARLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrimotopHoldingsSARLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Primotop holdings s.a.r.l.", "label": "Primotop Holdings S A R L [Member]", "terseLabel": "Primotop Holdings S.a.r.l. [Member]" } } }, "auth_ref": [] }, "mpw_PrincesRisboroughUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrincesRisboroughUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Princes Risborough United Kingdom.", "label": "Princes Risborough United Kingdom [Member]", "terseLabel": "Princes Risborough, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r1124" ] }, "mpw_PrioryGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PrioryGroupMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Priory Group.", "label": "Priory Group [Member]", "terseLabel": "Priory Group [Member]", "verboseLabel": "Priory [Member]" } } }, "auth_ref": [] }, "srt_ProFormaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProFormaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Pro Forma [Member]", "terseLabel": "Pro Forma [Member]", "documentation": "Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information." } } }, "auth_ref": [ "r331", "r1095", "r1096" ] }, "mpw_ProceedFromSaleOfInterestInSyndicatedTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProceedFromSaleOfInterestInSyndicatedTermLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Proceed from sale of interest in syndicated term loan", "label": "Proceed from Sale of Interest in Syndicated Term Loan", "documentation": "Proceed from sale of interest in syndicated term loan." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromCollectionOfLoansReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Collection of Loans Receivable", "terseLabel": "Principal received on loans receivable", "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from sale and return of equity investment", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r295", "r1131" ] }, "us-gaap_ProceedsFromIssuanceOfCommonLimitedPartnersUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonLimitedPartnersUnits", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Limited Partners Units", "terseLabel": "Proceeds from sale of units, net of offering costs", "documentation": "The cash inflow from the issuance of common limited partners units during the period." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of common shares, net of offering costs", "verboseLabel": "Proceeds from sale of common shares / units, net of offering costs", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from term debt, net of discount", "totalLabel": "Proceeds from Issuance of Long-Term Debt, Total", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r46", "r808" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Addition loan collateralized by equity", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from expected secured debt", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r46" ] }, "us-gaap_ProceedsFromLoanOriginations1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLoanOriginations1", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from interest-bearing mortgage loan", "label": "Proceeds from Loan Originations", "documentation": "Cash inflow associated with loan origination (the process when securing a mortgage for a piece of real property) or lease origination." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ProceedsFromLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Loans", "documentation": "Cash received from principal payments made on loans related to operating activities." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing activities, Payment of debt refinancing and deferred financing costs", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r1098", "r1133" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "Revolving credit facilities, net", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfMortgageLoansHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfMortgageLoansHeldForSale", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale, Loan, Mortgage, Held-for-Sale", "terseLabel": "Proceeds from sale of mortgage loans", "documentation": "The cash inflow from sales of loans that are secured with real estate mortgages and are held with the intention to resell in the near future." } } }, "auth_ref": [ "r49", "r50" ] }, "mpw_ProceedsFromSaleOfNoncontrollingInterestsInTenantAndHospitals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProceedsFromSaleOfNoncontrollingInterestsInTenantAndHospitals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of noncontrolling interests in tenant and hospitals", "label": "Proceeds from Sale of Noncontrolling Interests in Tenant and Hospitals", "documentation": "Proceeds from sale of noncontrolling interests in tenant and hospitals." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherInvestments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of investment", "label": "Proceeds from Sale of Other Investments", "documentation": "Amount of cash inflow from the sale of investments classified as other." } } }, "auth_ref": [ "r1097" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Net proceeds from sale of real estate", "totalLabel": "Proceeds from Sale of Productive Assets, Total", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r163" ] }, "us-gaap_ProceedsFromSaleOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Real Estate", "terseLabel": "Proceeds from sale of facilities", "verboseLabel": "Expected cash proceeds on transaction close", "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period." } } }, "auth_ref": [ "r163" ] }, "mpw_ProceedsFromTheSaleOfFirstTranchePrepay": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProceedsFromTheSaleOfFirstTranchePrepay", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the sale of first tranche prepay", "label": "Proceeds from the Sale of First Tranche Prepay", "documentation": "Proceeds from the sale of first tranche prepay." } } }, "auth_ref": [] }, "mpw_ProceedsReceivedToPaydownOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProceedsReceivedToPaydownOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds received to paydown outstanding loan", "label": "Proceeds Received To Paydown Outstanding Loan", "documentation": "Proceeds received to paydown outstanding loan." } } }, "auth_ref": [] }, "mpw_ProceedsToPaydownOfActualOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProceedsToPaydownOfActualOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds to paydown of actual outstanding loan", "label": "Proceeds To Paydown Of Actual Outstanding Loan", "documentation": "Proceeds to paydown of actual outstanding loan." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Net (loss) income", "terseLabel": "Net (loss) income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r261", "r279", "r281", "r294", "r299", "r319", "r329", "r330", "r352", "r365", "r371", "r373", "r414", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r589", "r592", "r593", "r620", "r632", "r754", "r769", "r816", "r863", "r880", "r881", "r969", "r991", "r992", "r1010", "r1128", "r1171" ] }, "mpw_PropertyIncludingHeldForSaleMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PropertyIncludingHeldForSaleMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Property including held for sale.", "label": "Property Including Held For Sale [Member]", "terseLabel": "Property Including Held for Sale [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Estimated Useful Lives of Related Real Estate and Other Assets", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r172" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Weighted average useful lives of related real estate and other assets", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "mpw_PropertyRelatedExpensesAndWriteOffStraightLineRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PropertyRelatedExpensesAndWriteOffStraightLineRent", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "lang": { "en-us": { "role": { "documentation": "Property-related Expenses and Write-off Straight Line Rent", "label": "Property-related Expenses and Write-off Straight Line Rent", "terseLabel": "Property-related expenses" } } }, "auth_ref": [] }, "mpw_PropertyRelatedMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PropertyRelatedMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Property related.", "label": "Property Related [Member]", "terseLabel": "Property-related [Member]" } } }, "auth_ref": [] }, "mpw_ProspectMedicalHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProspectMedicalHoldingsIncMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Prospect Medical Holdings Inc.", "label": "Prospect Medical Holdings Inc [Member]", "terseLabel": "Prospect [Member]" } } }, "auth_ref": [] }, "mpw_ProspectMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ProspectMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Prospect.", "label": "Prospect [Member]", "terseLabel": "Prospect [Member]" } } }, "auth_ref": [] }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLeaseAndOtherLosses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Provision for Loan, Lease, and Other Losses, Total", "label": "Provision for Loan, Lease, and Other Losses", "terseLabel": "Provision (recovery) for credit loss", "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value." } } }, "auth_ref": [ "r10", "r18", "r203" ] }, "us-gaap_ProvisionForLoanLossesExpensed": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLossesExpensed", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for credit loss, net", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable." } } }, "auth_ref": [ "r430", "r749" ] }, "mpw_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PublicOfferingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Public\u200b offering.\u200b", "label": "Public Offering [Member]", "terseLabel": "Public Offering [Member]" } } }, "auth_ref": [] }, "mpw_PurchaseOfNonControllingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "PurchaseOfNonControllingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Purchase of non controlling interest.", "label": "Purchase Of Non Controlling Interest", "terseLabel": "Acquisition of non-controlling interest" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1054" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r1054" ] }, "mpw_QualifiedBusinessIncomeDeductionDividendsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "QualifiedBusinessIncomeDeductionDividendsPerShare", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Qualified business income deduction dividends per share.", "label": "Qualified Business Income Deduction Dividends Per Share", "terseLabel": "Section 199A Dividends" } } }, "auth_ref": [] }, "mpw_RaleighNCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RaleighNCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Raleigh, NC.", "label": "Raleigh N C [Member]", "terseLabel": "Raleigh, NC [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r504", "r512", "r541", "r542", "r543", "r702", "r729", "r790", "r832", "r833", "r889", "r895", "r898", "r899", "r918", "r955", "r956", "r970", "r979", "r987", "r996", "r999", "r1168", "r1175", "r1224", "r1225", "r1226", "r1227", "r1228" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r504", "r512", "r541", "r542", "r543", "r702", "r729", "r790", "r832", "r833", "r889", "r895", "r898", "r899", "r918", "r955", "r956", "r970", "r979", "r987", "r996", "r999", "r1168", "r1175", "r1224", "r1225", "r1226", "r1227", "r1228" ] }, "mpw_ReadingUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReadingUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Reading, United Kingdom.", "label": "Reading United Kingdom [Member]", "terseLabel": "Reading, United Kingdom [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAbstract", "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RealEstateAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAccumulatedDepreciation", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation", "terseLabel": "Accumulated Depreciation", "negatedLabel": "Accumulated depreciation", "periodStartLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Beginning Balance", "periodEndLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Ending Balance", "documentation": "Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r946" ] }, "mpw_RealEstateAccumulatedDepreciationCapitalExpendituresAndTransfersFromConstructionInProgress": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAccumulatedDepreciationCapitalExpendituresAndTransfersFromConstructionInProgress", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate accumulated depreciation capital expenditures and transfers from construction in progress.", "label": "Real Estate Accumulated Depreciation Capital Expenditures And Transfers From Construction In Progress", "terseLabel": "Transfers from construction in progress" } } }, "auth_ref": [] }, "mpw_RealEstateAccumulatedDepreciationForeignCurrencyTranslationDifference": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAccumulatedDepreciationForeignCurrencyTranslationDifference", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate accumulated depreciation, foreign currency translation difference.", "label": "Real Estate Accumulated Depreciation Foreign Currency Translation Difference", "negatedLabel": "Other" } } }, "auth_ref": [] }, "us-gaap_RealEstateAccumulatedDepreciationRealEstateSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAccumulatedDepreciationRealEstateSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold", "negatedLabel": "Depreciation on disposed property", "documentation": "Amount of decrease to accumulated depreciation for real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r951" ] }, "mpw_RealEstateAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAcquisitions", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate acquisitions.", "label": "Real Estate Acquisitions", "terseLabel": "Acquisitions" } } }, "auth_ref": [] }, "mpw_RealEstateAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAdditions", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate additions.", "label": "Real Estate Additions", "terseLabel": "Additions" } } }, "auth_ref": [] }, "srt_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationAmountOfEncumbrances", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances", "terseLabel": "Encumbrances", "documentation": "Amount of lien or mortgage outstanding on real estate investment properties for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r234", "r942" ] }, "srt_RealEstateAndAccumulatedDepreciationByPropertyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationByPropertyTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]", "terseLabel": "Real Estate And Accumulated Depreciation By Property [Table]", "documentation": "Disclosure of information about real estate investments and accompanying accumulated depreciation for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r230", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950" ] }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "parentTag": "us-gaap_RealEstateGrossAtCarryingValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount", "terseLabel": "Buildings at cost", "documentation": "Amount before accumulated depreciation of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest." } } }, "auth_ref": [ "r945" ] }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfLand", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "parentTag": "us-gaap_RealEstateGrossAtCarryingValue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount", "terseLabel": "Land at cost", "documentation": "Amount of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest." } } }, "auth_ref": [ "r945" ] }, "mpw_RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCostsAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCostsAdjustments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "SEC Schedule III, Real estate and accumulated depreciation, costs capitalized subsequent to acquisition, carrying costs including adjustments.", "label": "Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs Adjustments", "terseLabel": "Additions subsequent to acquisition, carrying costs" } } }, "auth_ref": [] }, "mpw_RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImpairmentAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImpairmentAdjustments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "SEC Schedule III, Real Estate and Accumulated Depreciation, Costs Capitalized Subsequent to Acquisition, Impairment Adjustments", "label": "Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Impairment Adjustments", "terseLabel": "Additions subsequent to acquisition, Improvements" } } }, "auth_ref": [] }, "srt_RealEstateAndAccumulatedDepreciationDateAcquired1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationDateAcquired1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Date Acquired", "terseLabel": "Date Acquired", "documentation": "Date real estate investment property was acquired for entities with a substantial portion of business acquiring and holding investment real estate, in YYYY-MM-DD format." } } }, "auth_ref": [ "r240", "r948" ] }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Name of Property [Axis]", "terseLabel": "Name of Property", "documentation": "Information by name of property." } } }, "auth_ref": [ "r232", "r253", "r952", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256" ] }, "srt_RealEstateAndAccumulatedDepreciationDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationDisclosureAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]" } } }, "auth_ref": [] }, "srt_RealEstateAndAccumulatedDepreciationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSCHEDULEIIIREALESTATEINVESTMENTSANDACCUMULATEDDEPRECIATION" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Text Block]", "terseLabel": "SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION", "documentation": "The entire disclosure of real estate investments and associated accumulated depreciation for entities with a significant portion of their business acquiring and holding investment real estate." } } }, "auth_ref": [ "r242", "r954" ] }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements", "terseLabel": "Initial costs, buildings", "documentation": "Initial cost of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest." } } }, "auth_ref": [ "r943" ] }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfLand", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land", "terseLabel": "Initial costs, land", "documentation": "Initial cost of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest." } } }, "auth_ref": [ "r943" ] }, "us-gaap_RealEstateAndAccumulatedDepreciationLifeUsedForDepreciation1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAndAccumulatedDepreciationLifeUsedForDepreciation1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation", "terseLabel": "Life on which depreciation in latest income statements is computed (Years)", "documentation": "Useful life on which depreciation was computed for entities with a substantial portion of business acquiring and holding investment real estate, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r949" ] }, "srt_RealEstateAndAccumulatedDepreciationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]", "terseLabel": "SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r230", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950" ] }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "Name of Property [Domain]", "terseLabel": "Name of Property", "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center." } } }, "auth_ref": [ "r232", "r952", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256" ] }, "mpw_RealEstateAndAccumulatedDepreciationPropertyDescription": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndAccumulatedDepreciationPropertyDescription", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real Estate And Accumulated Depreciation Property Description", "label": "Real Estate And Accumulated Depreciation Property Description", "terseLabel": "Type of property" } } }, "auth_ref": [] }, "mpw_RealEstateAndAccumulatedDepreciationYearOfConstruction": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndAccumulatedDepreciationYearOfConstruction", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real Estate And Accumulated Depreciation Year Of Construction", "label": "Real Estate And Accumulated Depreciation Year Of Construction", "terseLabel": "Date of Construction" } } }, "auth_ref": [] }, "mpw_RealEstateAndDepreciationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndDepreciationPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Real estate and depreciation.", "label": "Real Estate And Depreciation Policy [Text Block]", "terseLabel": "Real Estate and Depreciation" } } }, "auth_ref": [] }, "mpw_RealEstateAndOtherImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAndOtherImpairmentCharges", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": -1.0, "order": 1.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Real estate and other impairment charges", "negatedLabel": "Real estate and other impairment charges, net", "terseLabel": "Real estate and other impairment charges, net", "documentation": "Real estate and other impairment charges.", "label": "Real Estate And Other Impairment Charges" } } }, "auth_ref": [] }, "mpw_RealEstateAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Assets [Abstract]", "label": "Real Estate Assets [Abstract]", "terseLabel": "Real estate assets" } } }, "auth_ref": [] }, "mpw_RealEstateAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Real estate assets accumulated amortization.", "label": "Real Estate Assets Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "auth_ref": [] }, "mpw_RealEstateAssetsAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateAssetsAccumulatedDepreciation", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate assets accumulated depreciation.", "label": "Real Estate Assets Accumulated Depreciation", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period" } } }, "auth_ref": [] }, "us-gaap_RealEstateCostOfRealEstateSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateCostOfRealEstateSold", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold", "negatedLabel": "Dispositions", "documentation": "Amount of real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r951" ] }, "mpw_RealEstateDepreciationAndAmortizationMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateDepreciationAndAmortizationMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate depreciation and amortization.", "label": "Real Estate Depreciation And Amortization [Member]", "terseLabel": "Real Estate Depreciation and Amortization [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstateDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities" ], "lang": { "en-us": { "role": { "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate and Other Activities", "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures." } } }, "auth_ref": [ "r205", "r206", "r207", "r208", "r209" ] }, "srt_RealEstateFederalIncomeTaxBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RealEstateFederalIncomeTaxBasis", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis", "terseLabel": "Aggregate cost for federal income tax purposes", "documentation": "Cost basis of real estate investments for federal income tax purposes for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r233", "r953" ] }, "mpw_RealEstateFinancingByThirdPartySeller": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateFinancingByThirdPartySeller", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate financing by third party seller.", "label": "Real Estate Financing By Third Party Seller", "terseLabel": "Real estate financing by third party seller" } } }, "auth_ref": [] }, "us-gaap_RealEstateGrossAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateGrossAtCarryingValue", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total at cost", "documentation": "Amount, before accumulated depreciation, of real estate investment by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Excludes real estate not held as investment or interest." } } }, "auth_ref": [ "r945" ] }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "terseLabel": "Investments in unconsolidated real estate joint ventures", "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments." } } }, "auth_ref": [ "r1232" ] }, "mpw_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "label": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "terseLabel": "Investments in Unconsolidated Real Estate Joint Ventures [Member]" } } }, "auth_ref": [] }, "mpw_RealEstateLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateLeaseMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate lease.", "label": "Real Estate Lease [Member]", "terseLabel": "Real Estate [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstateOtherDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateOtherDeductions", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Deduction", "negatedLabel": "Other", "documentation": "Amount of other deductions to real estate investments, excluding sales, for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r951" ] }, "mpw_RealEstatePartnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstatePartnershipMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Real estate partnership.", "label": "Real Estate Partnership [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstatePropertiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstatePropertiesAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Real Estate Property Ownership [Axis]", "terseLabel": "Real Estate Property Ownership", "documentation": "Information by ownership of the property." } } }, "auth_ref": [] }, "us-gaap_RealEstatePropertiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstatePropertiesDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Real Estate Properties [Domain]", "terseLabel": "Real Estate Properties", "documentation": "Represents categories of ownership of real estate properties." } } }, "auth_ref": [] }, "mpw_RealEstateSecuredLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RealEstateSecuredLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Secured loan amount", "label": "Real Estate Secured Loan", "documentation": "Real estate secured loan." } } }, "auth_ref": [] }, "us-gaap_ReceivablesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Receivables, Fair Value Disclosure", "terseLabel": "Interest and rent receivables, Fair value", "totalLabel": "Receivables, Fair Value Disclosure, Total", "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables." } } }, "auth_ref": [ "r199", "r1212" ] }, "mpw_ReclassificationOfInterestRateSwapGainToEarningsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReclassificationOfInterestRateSwapGainToEarningsNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "negatedLabel": "Reclassification of interest rate swap gain to earnings, net of tax", "terseLabel": "Reclassification of interest rate swap gain to earnings, net of tax", "label": "Reclassification Of Interest Rate Swap Gain To Earnings, Net Of Tax", "documentation": "Reclassification of interest rate swap gain to earnings, net of tax." } } }, "auth_ref": [] }, "mpw_ReconstitutionOfAssetRelatedToProspect": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReconstitutionOfAssetRelatedToProspect", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Reconstitution of asset", "label": "Reconstitution Of Asset Related To Prospect", "documentation": "Reconstitution of asset related to prospect." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r1020", "r1032", "r1042", "r1068" ] }, "mpw_RecoveryOfPreviouslyReservedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RecoveryOfPreviouslyReservedInterest", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Recovery of previously reserved interest", "label": "Recovery Of Previously Reserved Interest", "documentation": "Recovery of previously reserved interest." } } }, "auth_ref": [] }, "mpw_ReddingCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReddingCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Redding, California.", "label": "Redding California [Member]", "terseLabel": "Redding, CA [Member]" } } }, "auth_ref": [] }, "mpw_RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redevelopment of recovery receivables on damage to the original facility", "label": "Redevelopment Of Recovery Receivables On Damage to the Original Facility", "documentation": "Redevelopment of recovery receivables on damage to the original facility." } } }, "auth_ref": [] }, "mpw_RehabilitationHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RehabilitationHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rehabilitation hospital.", "label": "Rehabilitation Hospital [Member]", "terseLabel": "Rehabilitation Hospital", "verboseLabel": "Rehabilitation Facilities [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "terseLabel": "Related Party", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r511", "r689", "r690", "r836", "r837", "r838", "r839", "r840", "r860", "r862", "r886" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "terseLabel": "Related Party", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r511", "r689", "r690", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r836", "r837", "r838", "r839", "r840", "r860", "r862", "r886", "r1220" ] }, "mpw_RelatedPartyTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RelatedPartyTransactionsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions [Member]", "label": "Related Party Transactions [Member]", "terseLabel": "Related Party Transactions [Member]" } } }, "auth_ref": [] }, "mpw_RemainingEquityInvestmentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RemainingEquityInvestmentPercentage", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "netLabel": "Remaining equity investment percentage", "label": "Remaining Equity Investment Percentage", "documentation": "Remaining equity investment percentage." } } }, "auth_ref": [] }, "mpw_RemscheidGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RemscheidGermanyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Remscheid, Germany,", "label": "Remscheid Germany [Member]", "terseLabel": "Remscheid, Germany [Member]" } } }, "auth_ref": [] }, "mpw_RentAndInterestObligationsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RentAndInterestObligationsDue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent and interest obligations due", "label": "Rent and Interest Obligations Due", "documentation": "Rent and interest obligations due." } } }, "auth_ref": [] }, "mpw_RentAndInterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RentAndInterestPaid", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent and interest paid", "label": "Rent and Interest Paid", "documentation": "Rent and interest paid." } } }, "auth_ref": [] }, "mpw_RentBilled": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RentBilled", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "documentation": "Rent billed", "label": "Rent Billed", "terseLabel": "Rent billed" } } }, "auth_ref": [] }, "mpw_RentalRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RentalRevenue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rental revenue", "label": "Rental Revenue", "documentation": "Rental Revenue." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-Term Debt", "negatedLabel": "Payments of term debt", "totalLabel": "Repayments of Long-Term Debt, Total", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r48", "r811" ] }, "mpw_RepaymentsOfMortgageLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RepaymentsOfMortgageLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of mortgage loan", "label": "Repayments Of Mortgage Loan", "documentation": "Repayments of mortgage loan." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherLongTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Repayments of Other Long-Term Debt", "terseLabel": "Repayments of other loan", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r48" ] }, "us-gaap_RepaymentsOfOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment received on credit facility availed", "label": "Repayments of Other Short-Term Debt", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r48" ] }, "mpw_RepaymentsOfRemainingShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RepaymentsOfRemainingShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment received on credit facility availed, total amount", "label": "Repayments Of Remaining Short Term Debt", "documentation": "Repayments of remaining short term debt." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSeniorDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument paid off", "label": "Repayments of Senior Debt", "totalLabel": "Repayments of Senior Debt, Total", "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period." } } }, "auth_ref": [ "r48" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r303", "r304", "r476", "r495", "r691", "r961", "r962" ] }, "mpw_ReserveOfStraightLineRentReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReserveOfStraightLineRentReceivablesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Reserve of Straight-line Rent Receivables [Member]", "documentation": "Reserve of straight-line rent receivables." } } }, "auth_ref": [] }, "mpw_ReserveOfUnpaidInterestReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReserveOfUnpaidInterestReceivablesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Reserve of Unpaid Interest Receivables [Member]", "documentation": "Reserve of unpaid interest receivables." } } }, "auth_ref": [] }, "mpw_ReserveOfUnpaidRentAndLeaseIncentivesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReserveOfUnpaidRentAndLeaseIncentivesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Reserve of Unpaid Rent and Lease Incentives [Member]", "documentation": "Reserve of unpaid rent and lease incentives." } } }, "auth_ref": [] }, "mpw_ReserveOfUnpaidRentAndStraightLineRentReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReserveOfUnpaidRentAndStraightLineRentReceivablesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Reserve of Unpaid Rent and Straight-line Rent Receivables [Member]", "documentation": "Reserve of unpaid rent and straight-line rent receivables." } } }, "auth_ref": [] }, "us-gaap_ResidualValueOfLeasedAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResidualValueOfLeasedAsset", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Residual Value of Leased Asset", "terseLabel": "Carrying value of lease requiring residual value guarantee", "totalLabel": "Residual Value of Leased Asset, Total", "documentation": "Amount of residual asset covered by residual value guarantee. Excludes guarantee considered to be lease payments for lessor." } } }, "auth_ref": [ "r683" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r1021", "r1033", "r1043", "r1069" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r1022", "r1034", "r1044", "r1070" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r1029", "r1041", "r1051", "r1077" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash, included in Other assets at end of period", "periodStartLabel": "Restricted cash, included in Other assets at beginning of period", "totalLabel": "Restricted Cash and Cash Equivalents, Total", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r51", "r190", "r262", "r297", "r760" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]", "periodEndLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "periodStartLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage." } } }, "auth_ref": [ "r297" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Retained (deficit) earnings", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Distributions in excess of net income", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r149", "r178", "r764", "r797", "r802", "r812", "r844", "r994" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Retained (Deficit) Earnings [Member]", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r256", "r315", "r316", "r317", "r320", "r328", "r330", "r419", "r425", "r550", "r551", "r552", "r572", "r573", "r601", "r604", "r605", "r608", "r618", "r793", "r795", "r818", "r1241" ] }, "mpw_ReturnOfCapitalPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ReturnOfCapitalPerShare", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "lang": { "en-us": { "role": { "documentation": "Return of capital per share", "label": "Return Of Capital Per Share", "terseLabel": "Return of capital" } } }, "auth_ref": [] }, "mpw_RevenueForRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RevenueForRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue for rent and interest", "label": "Revenue For Rent and Interest", "documentation": "Revenue for rent and interest." } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r864", "r957", "r965" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 }, "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Revenues", "totalLabel": "Total revenues", "terseLabel": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r288", "r299", "r353", "r354", "r364", "r369", "r370", "r374", "r375", "r377", "r414", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r632", "r754", "r1171" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues" } } }, "auth_ref": [] }, "mpw_RevenuesEarnedFromTenants": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RevenuesEarnedFromTenants", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues earned from tenants", "label": "Revenues Earned from Tenants", "documentation": "Revenues earned from tenants." } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "mpw_RichmondTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RichmondTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Richmond, TX.", "label": "Richmond T X [Member]", "terseLabel": "Richmond, TX [Member]" } } }, "auth_ref": [] }, "mpw_RichmondVirginiaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RichmondVirginiaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Richmond, Virginia.", "label": "Richmond Virginia [Member]", "terseLabel": "Richmond, VA [Member]" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases", "verboseLabel": "Changes in right-of-use asset", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r673", "r993" ] }, "mpw_RightOfUseAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RightOfUseAssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Right of use assets.", "label": "Right Of Use Assets [Abstract]", "terseLabel": "Right of use assets:" } } }, "auth_ref": [] }, "mpw_RingwoodAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RingwoodAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ringwood, Australia.", "label": "Ringwood Australia [Member]", "terseLabel": "Ringwood, Australia [Member]" } } }, "auth_ref": [] }, "mpw_RivertonWyomingMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RivertonWyomingMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Riverton, Wyoming.", "label": "Riverton Wyoming [Member]", "terseLabel": "Riverton, WY [Member]" } } }, "auth_ref": [] }, "mpw_RoaringSpringsPAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RoaringSpringsPAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Roaring Springs, PA.", "label": "Roaring Springs P A [Member]", "terseLabel": "Roaring Springs, PA [Member]" } } }, "auth_ref": [] }, "mpw_RochdaleMAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RochdaleMAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rochdale, MA.", "label": "Rochdale M A [Member]", "terseLabel": "Rochdale, MA [Member]" } } }, "auth_ref": [] }, "mpw_RochdaleMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RochdaleMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rochdale, Massachusetts.", "label": "Rochdale Massachusetts [Member]", "terseLabel": "Rochdale, MA [Member]" } } }, "auth_ref": [] }, "mpw_RochdaleUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RochdaleUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rochdale, UK.", "label": "Rochdale United Kingdom [Member]", "terseLabel": "Rochdale, UK [Member]" } } }, "auth_ref": [] }, "mpw_RockledgeFLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RockledgeFLMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rockledge, FL.", "label": "Rockledge F L [Member]", "terseLabel": "Rockledge, FL [Member]" } } }, "auth_ref": [] }, "mpw_RoelandParkKansasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RoelandParkKansasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Roeland Park, Kansas.", "label": "Roeland Park Kansas [Member]", "terseLabel": "Roeland Park, KS [Member]" } } }, "auth_ref": [] }, "mpw_RomfordUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RomfordUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Romford, UK.", "label": "Romford U K [Member]", "terseLabel": "Romford, UK [Member]" } } }, "auth_ref": [] }, "mpw_RosenbergTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RosenbergTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rosenberg Texas.", "label": "Rosenberg Texas [Member]", "terseLabel": "Rosenberg, TX [Member]" } } }, "auth_ref": [] }, "mpw_RowleyUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RowleyUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Rowley, UK.", "label": "Rowley U K [Member]", "terseLabel": "Rowley, UK [Member]" } } }, "auth_ref": [] }, "mpw_RoystonUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "RoystonUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Royston, UK.", "label": "Royston U K [Member]", "terseLabel": "Royston, UK [Member]" } } }, "auth_ref": [] }, "mpw_Rule10B51ArrMofifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "Rule10B51ArrMofifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b51 Arr Mofified Flag", "documentation": "Rule 10b51 arr mofified flag." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1086" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1086" ] }, "stpr_SC": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "SC", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "label": "SOUTH CAROLINA", "terseLabel": "South Carolina [Member]", "verboseLabel": "Cayce, South Carolina [member]" } } }, "auth_ref": [] }, "us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense", "terseLabel": "Depreciation", "documentation": "Amount of depreciation expense of real estate investments for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r951" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r377", "r1100" ] }, "mpw_SaltLakeCityUTMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SaltLakeCityUTMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Salt Lake City, UT.", "label": "Salt Lake City U T [Member]", "terseLabel": "Salt Lake City, UT [Member]" } } }, "auth_ref": [] }, "mpw_SanAntonioTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SanAntonioTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "San Antonio TX.", "label": "San Antonio T X [Member]", "terseLabel": "San Antonio, TX [Member]" } } }, "auth_ref": [] }, "mpw_SanAntonioTXOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SanAntonioTXOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "San Antonio T X One.", "label": "San Antonio T X One [Member]", "terseLabel": "San Antonio, TX [Member]" } } }, "auth_ref": [] }, "mpw_SanBernardinoCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SanBernardinoCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "San Bernardino, CA.", "label": "San Bernardino C A [Member]", "terseLabel": "San Bernardino, CA [Member]" } } }, "auth_ref": [] }, "mpw_SanDiegoCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SanDiegoCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "San Diego, CA.", "label": "San Diego C A [Member]", "terseLabel": "San Diego, CA [Member]" } } }, "auth_ref": [] }, "mpw_SanDimasCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SanDimasCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "San Dimas, CA.", "label": "San Dimas C A [Member]", "terseLabel": "San Dimas, CA [member]" } } }, "auth_ref": [] }, "mpw_SantaMariaDeFeiraPTMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SantaMariaDeFeiraPTMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Santa Maria de Feira PT.", "label": "Santa Maria De Feira P T [Member]", "terseLabel": "Santa Maria de Feira, PT [Member]" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Forecast", "label": "Forecast [Member]", "terseLabel": "Forecast [Member]", "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact." } } }, "auth_ref": [ "r513", "r1112", "r1153" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r331", "r513", "r1095", "r1153" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r100", "r101", "r583" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Net Assets Acquired", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r100", "r101" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Income Tax Benefit (Expense)", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r182" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Basic Terms of Senior Unsecured Notes", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r35", "r86", "r89", "r131", "r132", "r134", "r137", "r176", "r177", "r975", "r977", "r1142" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of Debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r181" ] }, "mpw_ScheduleOfDevelopmentProjectsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScheduleOfDevelopmentProjectsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of development projects.", "label": "Schedule Of Development Projects Table [Text Block]", "terseLabel": "Summary of Status on Current Development Projects" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Earnings Per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1154" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureEarningsPerShareunitCalculationOfEarningsPerShareParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule Of Earnings Per Share Basic By Common Class [Table]", "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share." } } }, "auth_ref": [ "r54", "r57", "r335", "r339", "r341" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r180" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r411", "r412", "r413" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r299", "r411", "r412", "r413", "r414", "r632" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r261", "r299", "r411", "r412", "r413", "r414", "r632" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r623", "r624" ] }, "mpw_ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of future minimum rental payments for leases sublease receivable and net payments.", "label": "Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments Table [Text Block]", "terseLabel": "Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Nonvested Share Activity [Table Text Block]", "terseLabel": "Stock-based Award Activity", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherAssetsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOtherAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Assets [Table Text Block]", "terseLabel": "Summary of Other Assets", "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets." } } }, "auth_ref": [] }, "mpw_ScheduleOfPerShareDistributionsToStockholdersTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of per share distributions to stockholders.", "label": "Schedule Of Per Share Distributions To Stockholders Table [Text Block]", "terseLabel": "Schedule of Per Share Distributions to Stockholders" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]", "terseLabel": "Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations", "documentation": "Tabular disclosure of a sensitivity analysis or stress test showing the hypothetical effect on the fair value of the transferor's interests in transferred financial assets (including any servicing assets or servicing liabilities) of two or more unfavorable variations from the expected levels for each key assumption that is reported, independently determined from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test." } } }, "auth_ref": [ "r1229" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r515", "r516", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r83", "r84", "r85", "r86", "r87", "r88", "r89", "r176", "r177", "r178", "r266", "r267", "r268", "r350", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r808", "r809", "r810", "r811", "r979", "r1094", "r1137" ] }, "mpw_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of supplemental balance sheet information related to leases.", "label": "Schedule Of Supplemental Balance Sheet Information Related To Leases Table [Text Block]", "terseLabel": "Summary of Supplemental Balance Sheet Information" } } }, "auth_ref": [] }, "mpw_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of supplemental cash flow information related to leases.", "label": "Schedule Of Supplemental Cash Flow Information Related To Leases Table [Text Block]", "terseLabel": "Summary of Supplemental Cash Flow Information" } } }, "auth_ref": [] }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIValuationAndQualifyingAccounts" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II: Valuation and Qualifying Accounts", "documentation": "The entire disclosure for valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r229", "r314" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r108", "r109", "r112", "r113", "r115", "r590", "r591", "r594", "r595", "r710", "r711", "r712" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Carrying Value and Classification of the Assets and Maximum Exposure", "label": "Schedule of Variable Interest Entities [Table Text Block]", "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r108", "r109", "r112", "r113", "r115" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Amortization Expense from Existing Lease Intangible Assets", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r77" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Concentrations of Credit Risk", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r60", "r61", "r64", "r65", "r129", "r189" ] }, "mpw_ScionHealthMasterLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ScionHealthMasterLeaseMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "ScionHealth master lease.", "label": "Scion Health Master Lease [Member]", "terseLabel": "ScionHealth Master Lease [Member]" } } }, "auth_ref": [] }, "mpw_SebastianFlMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SebastianFlMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sebastian FL.", "label": "Sebastian Fl [Member]", "terseLabel": "Sebastian Fl" } } }, "auth_ref": [] }, "mpw_SecuredLoanPeriod": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SecuredLoanPeriod", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Secured loan period", "label": "Secured Loan Period", "documentation": "Secured Loan Period" } } }, "auth_ref": [] }, "mpw_SecuredTermLoanDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SecuredTermLoanDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Secured term loan due 2024", "label": "Secured Term Loan Due Two Thousand Twenty Four [Member]", "documentation": "Secured term loan due two thousand twenty four." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1013" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1016" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r377", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r456", "r457", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r973", "r1102", "r1235" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical", "documentation": "Geographical area." } } }, "auth_ref": [ "r230", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r375", "r376", "r823", "r827", "r829", "r890", "r896", "r903", "r921", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r958", "r980", "r999", "r1178", "r1235" ] }, "mpw_SeniorUnsecuredTermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeniorUnsecuredTermLoanFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Senior unsecured term loan facility.", "label": "Senior Unsecured Term Loan Facility [Member]", "terseLabel": "Senior Unsecured Term Loan Facility [Member]" } } }, "auth_ref": [] }, "mpw_ServiceBasedAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ServiceBasedAwardsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Service-Based Awards [Member]", "label": "Service Based Awards [Member]", "terseLabel": "Service-Based Awards [Member]" } } }, "auth_ref": [] }, "mpw_SeventeenFourteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeventeenFourteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Seventeen Fourteen.", "label": "Seventeen Fourteen [Member]", "terseLabel": "1714 [Member]" } } }, "auth_ref": [] }, "mpw_SeventeenHundredMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeventeenHundredMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Seventeen hundred.", "label": "Seventeen Hundred [Member]", "terseLabel": "1700 [Member]" } } }, "auth_ref": [] }, "mpw_SeventeenNinetyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeventeenNinetyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Seventeen ninety.", "label": "Seventeen Ninety [Member]", "terseLabel": "1790 [Member]" } } }, "auth_ref": [] }, "mpw_SeventeenNinetySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeventeenNinetySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Seventeen nineteen six.", "label": "Seventeen Ninety Six [Member]", "terseLabel": "1796 [Member]" } } }, "auth_ref": [] }, "mpw_SeventeenSeventyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SeventeenSeventyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Seventeen seventy.", "label": "Seventeen Seventy [Member]", "terseLabel": "1770 [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense", "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total", "terseLabel": "Stock / (Unit)-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Share-based compensation arrangement by share based payment award, expected service period (in years)", "verboseLabel": "Stock award service period in years", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r988" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Stock awards vesting period in years", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r988" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r515", "r516", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee", "terseLabel": "Maximum number of shares of common stock that may be awarded", "documentation": "The highest quantity of shares an employee can purchase under the plan per period." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Reserved an additional shares of common stock for awards under the Equity Incentive Plan", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Reserved shares of new common stock for awards under the Equity Incentive Plan", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r989" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock remaining for future stock awards transferred to the equity incentive plan", "terseLabel": "Aggregate common stock granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Awarded, Shares", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r526" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Awarded, Weighted Average Value at Award Date", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r536" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental expense of stock awards", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification." } } }, "auth_ref": [ "r547" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Nonvested awards at end of year, Shares", "periodStartLabel": "Nonvested awards at beginning of the year, Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited, Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited, Weighted Average Value at Award Date", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Nonvested awards at end of year, Weighted Average Value at Award Date", "periodStartLabel": "Nonvested awards at beginning of the year, Weighted Average Value at Award Date", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Stock-based awards, fair value", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r537" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested, Shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Vested, Weighted Average Value at Award Date", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "mpw_ShareholderLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ShareholderLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Shareholder Loan.", "label": "Shareholder Loan [Member]" } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "mpw_SharonPAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SharonPAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sharon PA.", "label": "Sharon P A [Member]", "terseLabel": "Sharon, PA [Member]" } } }, "auth_ref": [] }, "mpw_ShawneeKansasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ShawneeKansasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Shawnee, Kansas.", "label": "Shawnee Kansas [Member]", "terseLabel": "Shawnee, KS [Member]" } } }, "auth_ref": [] }, "mpw_SheffieldUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SheffieldUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sheffield, UK.", "label": "Sheffield U K [Member]", "terseLabel": "Sheffield, UK [Member]" } } }, "auth_ref": [] }, "mpw_ShermanTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ShermanTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sherman, Texas.", "label": "Sherman Texas [Member]", "terseLabel": "Sherman, TX [Member]" } } }, "auth_ref": [] }, "mpw_SignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SignificantAccountingPoliciesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Line Items]", "terseLabel": "Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "mpw_SignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SignificantAccountingPoliciesTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Table]", "terseLabel": "Significant Accounting Policies [Table]" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r168", "r298" ] }, "mpw_SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Six point three seven five percentage senior unsecured notes due two thousand twenty four.", "label": "Six Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "6.375% Senior Unsecured Notes due 2024 [Member]" } } }, "auth_ref": [] }, "srt_SouthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SouthAmericaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "South America [Member]", "terseLabel": "South America [Member]", "documentation": "Continent of South America." } } }, "auth_ref": [ "r1243", "r1245", "r1246", "r1248" ] }, "mpw_SouthamptonUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SouthamptonUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Southampton, UK.", "label": "Southampton U K [Member]", "terseLabel": "Southampton, UK [Member]" } } }, "auth_ref": [] }, "mpw_SpartaHoldcoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpartaHoldcoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Sparta Holdco Member", "label": "Sparta Holdco [Member]", "terseLabel": "Sparta Holdco [Member]" } } }, "auth_ref": [] }, "mpw_SpartanburgSCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpartanburgSCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Spartanburg SC.", "label": "Spartanburg S C [Member]", "terseLabel": "Spartanburg, SC [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneHealthOpcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpringstoneHealthOpcoLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Springstone Health Opco, LLC.", "label": "Springstone Health Opco, LLC [Member]", "terseLabel": "Springstone Health Opco, LLC [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneIncAndInternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpringstoneIncAndInternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "documentation": "Springstone inc and international joint venture.", "label": "Springstone Inc And International Joint Venture [Member]", "terseLabel": "Springstone Inc. and International Joint Venture [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpringstoneIncMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "documentation": "Springstone Inc.", "label": "Springstone Inc [Member]", "terseLabel": "Springstone Inc. [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpringstoneLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Springstone, LLC.", "label": "Springstone, LLC [Member]", "terseLabel": "Springstone [Member]" } } }, "auth_ref": [] }, "mpw_SpringstoneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SpringstoneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Springstone [Member]", "label": "Springstone [Member]", "documentation": "Springstone." } } }, "auth_ref": [] }, "mpw_StAlbansParkAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StAlbansParkAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "St. Albans Park, Australia.", "label": "St Albans Park Australia [Member]", "terseLabel": "St. Albans Park, Australia [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r259", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r377", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r453", "r456", "r457", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r973", "r1102", "r1235" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r23", "r37", "r256", "r284", "r285", "r286", "r315", "r316", "r317", "r320", "r328", "r330", "r349", "r419", "r425", "r500", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r605", "r606", "r608", "r618", "r643", "r644", "r645", "r646", "r647", "r648", "r688", "r793", "r794", "r795", "r818", "r883" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r230", "r243", "r375", "r376", "r823", "r827", "r829", "r890", "r896", "r903", "r921", "r935", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r958", "r980", "r999", "r1178", "r1235" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r315", "r316", "r317", "r349", "r731", "r806", "r820", "r834", "r836", "r837", "r838", "r839", "r840", "r843", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r856", "r857", "r858", "r859", "r860", "r862", "r864", "r865", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r883", "r1000" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r331", "r513", "r1095", "r1096", "r1153" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "http://medicalpropertiestrust.com/20231231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossIncome" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r315", "r316", "r317", "r349", "r731", "r806", "r820", "r834", "r836", "r837", "r838", "r839", "r840", "r843", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r856", "r857", "r858", "r859", "r860", "r862", "r864", "r865", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r883", "r1000" ] }, "mpw_StewardAndInternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardAndInternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Steward and International Joint Venture [Member]", "label": "Steward and International Joint Venture [Member]", "documentation": "Steward and International Joint Venture." } } }, "auth_ref": [] }, "mpw_StewardEquityInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardEquityInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward Equity Investment.", "label": "Steward Equity Investment [Member]", "terseLabel": "Steward Equity Investment [Member]" } } }, "auth_ref": [] }, "mpw_StewardHealthCareSystemLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardHealthCareSystemLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Steward [Member]", "documentation": "Steward Health Care System LLC.", "label": "Steward Health Care System L L C [Member]", "terseLabel": "Steward Health Care System LLC [Member]" } } }, "auth_ref": [] }, "mpw_StewardLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward Loan Investment.", "label": "Steward Loan Investment [Member]", "terseLabel": "Steward Loan Investment [Member]" } } }, "auth_ref": [] }, "mpw_StewardMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward.", "label": "Steward [Member]", "terseLabel": "Steward [Member]", "verboseLabel": "Steward (Macquarie Transaction) [Member]" } } }, "auth_ref": [] }, "mpw_StewardsEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StewardsEquityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Steward's Equity [Member]", "label": "Steward's Equity [Member]", "documentation": "Steward's equity." } } }, "auth_ref": [] }, "mpw_StirlingScotlandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StirlingScotlandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Stirling, Scotland.", "label": "Stirling Scotland [Member]", "terseLabel": "Stirling, Scotland [Member]" } } }, "auth_ref": [] }, "mpw_StirlingUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StirlingUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Stirling, UK.", "label": "Stirling U K [Member]", "terseLabel": "Stirling, UK [Member]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r1024", "r1036", "r1046", "r1072" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Conversion of LTIP units to common units (shares)", "verboseLabel": "Conversion of LTIP units to common units", "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r23", "r86", "r146", "r147", "r178" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Proceeds from offering (net of offering costs) (shares)", "verboseLabel": "Number of share sold", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r23", "r146", "r147", "r178", "r808", "r883", "r927" ] }, "mpw_StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period, shares, stock vesting and amortization of stock-based compensation.", "label": "Stock Issued During Period Shares Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Proceeds from offering (net of offering costs)", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r23", "r146", "r147", "r178", "r818", "r883", "r927", "r1010" ] }, "mpw_StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting and amortization of stock based compensation.", "label": "Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock-based compensation" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting satisfaction of tax withholding.", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding", "terseLabel": "Stock (Unit) vesting - satisfaction of tax withholding" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding shares", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding Shares", "terseLabel": "Stock (Unit) vesting - satisfaction of tax withholding (shares)" } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramExpirationDate", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date", "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Shares", "terseLabel": "Stock repurchase, Shares", "negatedLabel": "Repurchase of units (shares)", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r23", "r146", "r147", "r178", "r811", "r883", "r928" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Value", "terseLabel": "Stock repurchase, Value", "negatedLabel": "Repurchase of units", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r23", "r146", "r147", "r178", "r818", "r883", "r928", "r1010" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent", "totalLabel": "Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital)", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r147", "r150", "r151", "r169", "r845", "r861", "r884", "r885", "r994", "r1011", "r1139", "r1164", "r1213", "r1241" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Equity / Capital", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r104", "r105", "r116", "r256", "r257", "r285", "r315", "r316", "r317", "r320", "r328", "r419", "r425", "r500", "r550", "r551", "r552", "r572", "r573", "r601", "r603", "r604", "r605", "r606", "r608", "r618", "r643", "r644", "r648", "r688", "r794", "r795", "r815", "r845", "r861", "r884", "r885", "r929", "r1010", "r1139", "r1164", "r1213", "r1241" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Equity / Capital" } } }, "auth_ref": [] }, "mpw_StocktonCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StocktonCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Stockton, California.", "label": "Stockton California [Member]", "terseLabel": "Stockton, California [Member]" } } }, "auth_ref": [] }, "mpw_StraightLineRentAndOtherWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentAndOtherWriteOff", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent and other write-off", "label": "Straight-line Rent And Other Write-off", "documentation": "Straight-line rent and other write-off." } } }, "auth_ref": [] }, "mpw_StraightLineRentAndOtherWriteOffNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentAndOtherWriteOffNetOfTax", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent and other write-off net off tax.", "label": "Straight Line Rent And Other Write Off Net Of Tax", "terseLabel": "Straight-line rent and other write-off, net of tax" } } }, "auth_ref": [] }, "mpw_StraightLineRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentReceivable", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent receivable", "label": "Straight Line Rent Receivable", "terseLabel": "Straight-line rent receivables" } } }, "auth_ref": [] }, "mpw_StraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent receivables", "label": "Straight-Line Rent Receivables", "documentation": "Straight-line rent receivables." } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentRevenueAndOther", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent revenue and other.", "label": "Straight Line Rent Revenue And Other", "negatedLabel": "Straight-line rent revenue and other" } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueNetOfWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentRevenueNetOfWriteOffs", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "documentation": "Straight line rent revenue net of write offs.", "label": "Straight Line Rent Revenue Net Of Write Offs", "terseLabel": "Straight-line rent" } } }, "auth_ref": [] }, "mpw_StraightLineRentWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StraightLineRentWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "straight-line rent write-offs.", "label": "straight-Line Rent Write-Offs", "terseLabel": "Straight-line rent write-offs" } } }, "auth_ref": [] }, "mpw_StrathpineAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "StrathpineAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Strathpine, Australia.", "label": "Strathpine Australia [Member]", "terseLabel": "Strathpine, Australia [Member]" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceived", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received.", "label": "Sub Lease Lease Payments To Be Received", "negatedTotalLabel": "Amounts To Be Received From Subleases, Total undiscounted minimum lease payments" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedFiveYears": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedFiveYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts To Be Received From Subleases, 2028", "documentation": "Sub lease lease payments to be received five years.", "label": "Sub Lease Lease Payments To Be Received Five Years" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedFourYears": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedFourYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts To Be Received From Subleases, 2027", "documentation": "Sub lease lease payments to be received four years.", "label": "Sub Lease Lease Payments To Be Received Four Years" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedNextTwelveMonths", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts To Be Received From Subleases, 2024", "documentation": "Sub lease lease payments to be received next twelve months.", "label": "Sub Lease Lease Payments To Be Received Next Twelve Months" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedThereafter", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received thereafter.", "label": "Sub Lease Lease Payments To Be Received Thereafter", "negatedLabel": "Amounts To Be Received From Subleases, Thereafter" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedThreeYears": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedThreeYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts To Be Received From Subleases, 2026", "documentation": "Sub lease lease payments to be received three years.", "label": "Sub Lease Lease Payments To Be Received Three Years" } } }, "auth_ref": [] }, "mpw_SubLeaseLeasePaymentsToBeReceivedTwoYears": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SubLeaseLeasePaymentsToBeReceivedTwoYears", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts To Be Received From Subleases, 2025", "documentation": "Sub lease lease payments to be received two years.", "label": "Sub Lease Lease Payments To Be Received Two Years" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "lang": { "en-us": { "role": { "label": "Sublease Income", "negatedLabel": "Sublease income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r671", "r993" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r649", "r694" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r649", "r694" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r649", "r694" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r649", "r694" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r649", "r694" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r693", "r695" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "mpw_SummaryOfDetailsRelatedToInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SummaryOfDetailsRelatedToInvestmentsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Summary of Details Related to Investments [Table Text Block]", "documentation": "Summary of details related to investments." } } }, "auth_ref": [] }, "mpw_SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Summary of investments in unconsolidated operating entities.", "label": "Summary Of Investments In Unconsolidated Operating Entities [Table Text Block]", "terseLabel": "Summary of Investments in Unconsolidated Operating Entities" } } }, "auth_ref": [] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Schedule of Net NOL and Other Tax Attribute Carryforwards", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r97" ] }, "mpw_SummaryOfOperatingResultsFromPropertiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SummaryOfOperatingResultsFromPropertiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Summary of Operating results from properties.", "label": "Summary Of Operating Results From Properties [Table Text Block]", "terseLabel": "Summary of Operating Results from Properties" } } }, "auth_ref": [] }, "mpw_SunnybankAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SunnybankAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sunnybank, Australia.", "label": "Sunnybank Australia [Member]", "terseLabel": "Sunnybank, Australia [Member]" } } }, "auth_ref": [] }, "mpw_SupplementalScheduleOfNonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SupplementalScheduleOfNonCashFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "label": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "terseLabel": "Supplemental schedule of non-cash financing activities:" } } }, "auth_ref": [] }, "mpw_SurreyUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SurreyUnitedKingdomMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Surrey, United Kingdom.", "label": "Surrey, United Kingdom [Member]", "terseLabel": "Surrey, UK [Member]" } } }, "auth_ref": [] }, "mpw_SussexNJMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SussexNJMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Sussex, NJ.", "label": "Sussex N J [Member]", "terseLabel": "Sussex, NJ [Member]" } } }, "auth_ref": [] }, "mpw_SwindonUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SwindonUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Swindon, UK.", "label": "Swindon U K [Member]", "terseLabel": "Swindon, UK [Member]" } } }, "auth_ref": [] }, "mpw_SwissHealthcareRealEstateCompanyInfracoreSAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SwissHealthcareRealEstateCompanyInfracoreSAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Swiss Healthcare Real Estate Company Infracore SA.", "label": "Swiss Healthcare Real Estate Company Infracore S A [Member]", "terseLabel": "Infracore [Member]" } } }, "auth_ref": [] }, "mpw_SwissMedicalNetworkMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SwissMedicalNetworkMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Swiss medical network.", "label": "Swiss Medical Network [Member]", "terseLabel": "Swiss Medical Network [Member]" } } }, "auth_ref": [] }, "mpw_SyndicatedTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "SyndicatedTermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Syndicated Term Loan [Member]", "documentation": "Syndicated term loan.", "label": "Syndicated Term Loan [Member]" } } }, "auth_ref": [] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "TX", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "TEXAS", "terseLabel": "Texas [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r1065" ] }, "mpw_TadleyUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TadleyUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Tadley, UK.", "label": "Tadley U K [Member]", "terseLabel": "Tadley, UK [Member]" } } }, "auth_ref": [] }, "mpw_TauntonMAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TauntonMAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Taunton, MA.", "label": "Taunton M A [Member]", "terseLabel": "Taunton, MA [Member]" } } }, "auth_ref": [] }, "mpw_TaxEffectedNetOperatingLossCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TaxEffectedNetOperatingLossCarryforward", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "parentTag": "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "lang": { "en-us": { "role": { "documentation": "Tax effected net operating loss carryforward.", "label": "Tax Effected Net Operating Loss Carryforward", "terseLabel": "Tax-effected NOL carryforwards" } } }, "auth_ref": [] }, "mpw_TaxRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TaxRateChanges", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Tax rate changes and other", "label": "Tax rate changes", "documentation": "Tax rate changes" } } }, "auth_ref": [] }, "mpw_TempeAZMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TempeAZMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Tempe AZ.", "label": "Tempe A Z [Member]", "terseLabel": "Tempe, AZ [Member]" } } }, "auth_ref": [] }, "mpw_TermBenchmarkLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermBenchmarkLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Term Benchmark Loans.", "label": "Term Benchmark Loans [Member]" } } }, "auth_ref": [] }, "mpw_TermBenchmarkLoansOrRfrLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermBenchmarkLoansOrRfrLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Term Benchmark Loans or RFR Loans.", "label": "Term Benchmark Loans or RFR Loans [Member]" } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermLoanDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty five.", "label": "Term Loan Due Two Thousand Twenty Five [Member]", "terseLabel": "Term loan due 2025" } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermLoanDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty four.", "label": "Term Loan Due Two Thousand Twenty Four [Member]", "terseLabel": "Term loan due 2024" } } }, "auth_ref": [] }, "mpw_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan [Member]", "verboseLabel": "Term Loans [Member]" } } }, "auth_ref": [] }, "mpw_TermLoanOnSaleOfTranchePrepay": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermLoanOnSaleOfTranchePrepay", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan", "label": "Term Loan on Sale of Tranche Prepay", "documentation": "Term loan on sale of tranche prepay." } } }, "auth_ref": [] }, "mpw_TermLoanReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermLoanReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan", "label": "Term Loan Receivable", "documentation": "Term loan receivable." } } }, "auth_ref": [] }, "mpw_TermOfFederalIncomeTaxAtCorporateRatesOnFailureToQualifyAsRealEstateInvestmentTrust": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TermOfFederalIncomeTaxAtCorporateRatesOnFailureToQualifyAsRealEstateInvestmentTrust", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Term Of Federal Income Tax At Corporate Rates On Failure To Qualify As Real Estate Investment Trust", "label": "Term Of Federal Income Tax At Corporate Rates On Failure To Qualify As Real Estate Investment Trust", "terseLabel": "Number of years of federal income tax at corporate rates on failure to qualify as REIT" } } }, "auth_ref": [] }, "mpw_TexarkanaTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TexarkanaTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Texarkana TX.", "label": "Texarkana T X [Member]", "terseLabel": "Texarkana, Texas [Member]" } } }, "auth_ref": [] }, "mpw_TexasAndMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TexasAndMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "TEXAS And MASSACHUSETTS [Member]", "documentation": "TEXAS And MASSACHUSETTS." } } }, "auth_ref": [] }, "mpw_TheWoodlandsTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TheWoodlandsTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "The woodlands Texas.", "label": "The Woodlands Texas [Member]", "terseLabel": "The Woodlands, TX [Member]" } } }, "auth_ref": [] }, "mpw_ThorntonCOMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThorntonCOMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Thornton, CO.", "label": "Thornton C O [Member]", "terseLabel": "Thornton, CO [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.500% Senior Unsecured Notes due 2031 [Member]", "documentation": "Three point five zero zero percentage senior unsecured notes due two thousand thirty one.", "label": "Three Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Thirty One [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point six nine two percentage senior unsecured notes due two thousand twenty eight.", "label": "Three Point Six Nine Two Percentage Senior Unsecured Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "3.692% Senior Unsecured Notes due 2028 [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Senior Unsecured Notes due 2030 [Member]", "documentation": "Three point three seven five percentage senior unsecured notes due two thousand thirty.", "label": "Three Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Thirty [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.325% Senior Unsecured Notes due 2025 [Member]", "documentation": "Three point three two five percentage senior unsecured notes due two thousand twenty five.", "label": "Three Point Three Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Five [Member]" } } }, "auth_ref": [] }, "mpw_ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Threshold ownership percentage for inter-company balances and transactions elimination.", "label": "Threshold Ownership Percentage For Inter Company Balances And Transactions Elimination", "terseLabel": "Threshold ownership percentage for inter company balances and transactions elimination" } } }, "auth_ref": [] }, "mpw_TimeBasedAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TimeBasedAwardsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Time Based Awards", "label": "Time Based Awards [Member]", "terseLabel": "Time-Based Awards [Member]" } } }, "auth_ref": [] }, "mpw_ToledoOhMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ToledoOhMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Toledo, OH [Member]", "label": "Toledo Oh [Member]", "terseLabel": "Toledo, OH [Member]" } } }, "auth_ref": [] }, "mpw_TomballTXMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TomballTXMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Tomball, TX.", "label": "Tomball T X [Member]", "terseLabel": "Tomball, TX [Member]" } } }, "auth_ref": [] }, "mpw_TorquayUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TorquayUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Torquay, UK.", "label": "Torquay U K [Member]", "terseLabel": "Torquay, UK [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1057" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r1064" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r1085" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r1087" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r489", "r498", "r609", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r772", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1159", "r1160", "r1161", "r1162" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r1088" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r1089" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1087" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r1087" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r1090" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r1088" ] }, "mpw_TurkuFinlandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TurkuFinlandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Turku, Finland.", "label": "Turku, Finland [Member]", "terseLabel": "Turku, Finland [Member]" } } }, "auth_ref": [] }, "mpw_TwentyTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwentyTwentyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2023 [Member]", "label": "Twenty Twenty Three [Member]", "documentation": "Twenty twenty three." } } }, "auth_ref": [] }, "mpw_TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point five five zero percentage senior unsecured notes due two thousand twenty three.", "label": "Two Point Five Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Three [Member]", "terseLabel": "2.550% Senior Unsecured Notes due 2023 [Member]" } } }, "auth_ref": [] }, "mpw_TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point five zero zero percentage senior unsecured notes due two thousand twenty six.", "label": "Two Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "2.500% Senior Unsecured Notes due 2026 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandEightMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand eight.", "label": "Two Thousand Eight [Member]", "terseLabel": "2008 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandEighteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandEighteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen.", "label": "Two Thousand Eighteen [Member]", "terseLabel": "2018 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandElevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand eleven.", "label": "Two Thousand Eleven [Member]", "terseLabel": "2011 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFifteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFifteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand fifteen.", "label": "Two Thousand Fifteen [Member]", "terseLabel": "2015 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFifteenOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFifteenOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand fifteen one.", "label": "Two Thousand Fifteen One [Member]", "terseLabel": "2015 One [Member]", "verboseLabel": "2015 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand five.", "label": "Two Thousand Five [Member]", "terseLabel": "2005 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFourMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand four.", "label": "Two Thousand Four [Member]", "terseLabel": "2004 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFourteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFourteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand fourteen.", "label": "Two Thousand Fourteen [Member]", "terseLabel": "2014 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandFourteenTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandFourteenTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2014-2 [Member]", "label": "Two Thousand Fourteen Two [Member]", "documentation": "Two thousand fourteen two." } } }, "auth_ref": [] }, "mpw_TwoThousandMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand.", "label": "Two Thousand [Member]", "terseLabel": "2000 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandNineMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand nine.", "label": "Two Thousand Nine [Member]", "terseLabel": "2009 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandNineteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandNineteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand nineteen.", "label": "Two Thousand Nineteen [Member]", "terseLabel": "2019 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand one .", "label": "Two Thousand One [Member]", "terseLabel": "2001 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandSevenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand seven.", "label": "Two Thousand Seven [Member]", "terseLabel": "2007 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandSeventeenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandSeventeenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand seventeen.", "label": "Two Thousand Seventeen [Member]", "terseLabel": "2017 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandSixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandSixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand six.", "label": "Two Thousand Six [Member]", "terseLabel": "2006 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandSixteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandSixteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand Sixteen.", "label": "Two Thousand Sixteen [Member]", "terseLabel": "2016 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandSixteenOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandSixteenOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand sixteen one.", "label": "Two Thousand Sixteen One [Member]", "terseLabel": "2016 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand ten.", "label": "Two Thousand Ten [Member]", "terseLabel": "2010 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandThirteenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandThirteenMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand thirteen.", "label": "Two Thousand Thirteen [Member]", "terseLabel": "2013 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand three.", "label": "Two Thousand Three [Member]", "terseLabel": "2003 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTwelveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTwelveMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twelve.", "label": "Two Thousand Twelve [Member]", "terseLabel": "2012 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTwentyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTwentyMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty.", "label": "Two Thousand Twenty [Member]", "terseLabel": "2020 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTwentyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTwentyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one.", "label": "Two Thousand Twenty One [Member]", "terseLabel": "2021 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTwentyTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty two.", "label": "Two Thousand Twenty Two [Member]", "terseLabel": "2022 [Member]" } } }, "auth_ref": [] }, "mpw_TwoThousandTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoThousandTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Two thousand two.", "label": "Two Thousand Two [Member]", "terseLabel": "2002 [Member]" } } }, "auth_ref": [] }, "mpw_TwoWaterlandPrivateEquityFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "TwoWaterlandPrivateEquityFundsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Waterland Fund [Member]", "label": "Two Waterland Private Equity Funds [Member]", "documentation": "Two waterland private equity funds." } } }, "auth_ref": [] }, "us-gaap_TypeOfAdoptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfAdoptionMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Domain]", "terseLabel": "Accounting Standards Update", "documentation": "Amendment to accounting standards." } } }, "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r319", "r320", "r321", "r322", "r331", "r378", "r379", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r454", "r550", "r551", "r552", "r570", "r571", "r572", "r573", "r584", "r585", "r586", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r628", "r629", "r633", "r634", "r635", "r636", "r650", "r651", "r656", "r657", "r658", "r659", "r684", "r685", "r686", "r687", "r688", "r733", "r734", "r735", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r588" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Total U.S. [Member]", "label": "UNITED STATES", "terseLabel": "U.S. [Member]" } } }, "auth_ref": [] }, "stpr_UT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "UT", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "UTAH", "terseLabel": "Utah [Member]" } } }, "auth_ref": [] }, "us-gaap_UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums", "terseLabel": "Unamortized loan issue costs", "documentation": "Amount of deferred fees paid by borrowers and unamortized costs incurred to originate loans and leases, unamortized loan commitments and loan syndication fees, and premiums over or discounts from face amounts of loans that are being amortized into income as an adjustment to yield. Excludes amounts for loans and leases covered under loss sharing agreements." } } }, "auth_ref": [ "r72" ] }, "mpw_UnbilledRentAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UnbilledRentAccruals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled rent accruals", "label": "Unbilled Rent Accruals", "documentation": "Unbilled rent accruals." } } }, "auth_ref": [] }, "mpw_UndistributedEarningAllocatedToParticipatingSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UndistributedEarningAllocatedToParticipatingSecurities", "crdr": "debit", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "documentation": "Undistributed earning allocated to participating securities.", "label": "Undistributed Earning Allocated To Participating Securities", "negatedLabel": "Participating securities\u2019 share in earnings" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r1084" ] }, "mpw_UnpaidRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UnpaidRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid rent and interest", "label": "Unpaid Rent and Interest", "documentation": "Unpaid rent and interest." } } }, "auth_ref": [] }, "mpw_UnpaidRentOrInterestReceivablesAndStraightLineRentReceivablesReserved": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UnpaidRentOrInterestReceivablesAndStraightLineRentReceivablesReserved", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherTenantMattersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid rent or interest receivables and straight-line rent receivables reserved", "label": "Unpaid rent or Interest Receivables and Straight-Line Rent Receivables Reserved", "documentation": "Unpaid rent or interest receivables and straight-line rent receivables reserved." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Uncertain tax position liabilities and related interest or penalties", "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r560" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt", "terseLabel": "Amount of senior unsecured debt", "totalLabel": "Unsecured Debt, Total", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r29", "r196", "r1234" ] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebtMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt [Member]", "terseLabel": "Senior Unsecured Notes [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "mpw_UnsecuredRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UnsecuredRevolvingCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Unsecured Revolving Credit Facility [Member]", "label": "Unsecured Revolving Credit Facility [Member]", "terseLabel": "Unsecured Revolving Credit Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unusual Risk or Uncertainty, Nature [Axis]", "terseLabel": "Unusual Risk or Uncertainty, Nature", "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unusual Risk or Uncertainty, Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature", "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r66", "r67", "r68", "r218", "r219", "r220", "r221" ] }, "mpw_UskUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "UskUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Usk, UK.", "label": "Usk U K [Member]", "terseLabel": "Usk, UK [Member]" } } }, "auth_ref": [] }, "mpw_ValenciaSpainMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ValenciaSpainMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Valencia, Spain.", "label": "Valencia Spain [Member]", "terseLabel": "Valencia, Spain [Member]" } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation Allowance, Deferred Tax Asset [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward." } } }, "auth_ref": [ "r1143", "r1144", "r1145", "r1147", "r1148" ] }, "us-gaap_ValuationAllowancesAndReservesBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesBalance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Year", "periodStartLabel": "Balance at Beginning of Year", "documentation": "Amount of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r307", "r313" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Additions, Charged Against Operations", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense." } } }, "auth_ref": [ "r310" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Addition, Charged to Other Accounts", "verboseLabel": "Tax valuation allowances recorded as part of purchase price allocation", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense." } } }, "auth_ref": [ "r311" ] }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDeductions", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Deductions, Net Recoveries/Write-offs", "documentation": "Amount of decrease in valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r312" ] }, "us-gaap_ValuationAllowancesAndReservesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves", "documentation": "Valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r307", "r308", "r309", "r312", "r313" ] }, "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)", "terseLabel": "Increase (decrease) in valuation allowances", "totalLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease), Total", "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r1149" ] }, "us-gaap_ValuationAllowancesAndReservesRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesRecoveries", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery", "terseLabel": "Credit loss recovery related to loan paydowns", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized." } } }, "auth_ref": [ "r1146" ] }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type", "documentation": "Information by valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r307", "r308", "r309", "r312", "r313" ] }, "srt_ValuationAndQualifyingAccountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ValuationTechniqueAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Approach and Technique [Axis]", "documentation": "Information by valuation approach and technique." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ValuationTechniqueDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfDetailsRelatedToInvestmentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Approach and Technique [Domain]", "documentation": "Valuation approach and technique." } } }, "auth_ref": [ "r25" ] }, "mpw_VancouverWAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VancouverWAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Vancouver, WA [Member]", "label": "Vancouver, W A [Member]", "documentation": "Vancouver, WA." } } }, "auth_ref": [] }, "us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Amount", "label": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure", "totalLabel": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure, Total", "documentation": "Difference between the carrying amount of assets and liabilities in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the variable interest entity (VIE) and the reporting entity's maximum exposure to loss as a result of its involvement with the VIE, where the reporting entity is not the VIE's primary beneficiary." } } }, "auth_ref": [ "r110" ] }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum Loss Exposure", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)." } } }, "auth_ref": [ "r111", "r114" ] }, "mpw_VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Investments", "label": "Variable Interest Entity Equity Investments Maximum Loss Exposure Amount", "documentation": "Variable interest entity equity investments maximum loss exposure amount." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r590", "r591", "r594", "r595", "r710", "r711", "r712" ] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "mpw_VariableInterestEquityInvestmentsCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VariableInterestEquityInvestmentsCarryingAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Investments Carrying Amount", "label": "Variable Interest Equity Investments Carrying Amount.", "documentation": "Variable interest equity investments carrying amount." } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "mpw_VestingBasedOnMarketPerformanceConditionsSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VestingBasedOnMarketPerformanceConditionsSharesMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "documentation": "Vesting based on market/performance conditions shares [member]", "label": "Vesting Based On Market Performance Conditions Shares [Member]", "terseLabel": "Vesting Based on Market/Performance Conditions [Member]" } } }, "auth_ref": [] }, "mpw_VestingBasedOnServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VestingBasedOnServiceMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "lang": { "en-us": { "role": { "documentation": "Vesting based on service [member]", "label": "Vesting Based On Service [Member]", "terseLabel": "Vesting Based on Service [Member]" } } }, "auth_ref": [] }, "mpw_VibraMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "VibraMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "lang": { "en-us": { "role": { "documentation": "Vibra.", "label": "Vibra [Member]", "terseLabel": "Vibra [Member]" } } }, "auth_ref": [] }, "mpw_ViseuPortugalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ViseuPortugalMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Viseu, Portugal.", "label": "Viseu Portugal [Member]", "terseLabel": "Viseu, Portugal [Member]" } } }, "auth_ref": [] }, "mpw_WantirnaAustraliaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WantirnaAustraliaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Wantirna, Australia.", "label": "Wantirna Australia [Member]", "terseLabel": "Wantirna, Australia [Member]" } } }, "auth_ref": [] }, "mpw_WarrenOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WarrenOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Warren, OH.", "label": "Warren O H [Member]", "terseLabel": "Warren, OH [Member]" } } }, "auth_ref": [] }, "mpw_WaterlandPrivateEquityFundAffiliateMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WaterlandPrivateEquityFundAffiliateMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Waterland Private Equity Fund Affiliate [Member]", "documentation": "Waterland private equity fund affiliate." } } }, "auth_ref": [] }, "mpw_WaterlandPrivateEquityFundVIICVMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WaterlandPrivateEquityFundVIICVMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Waterland Private Equity Fund VII C.V.", "label": "Waterland Private Equity Fund V I I C V [Member]", "terseLabel": "Waterland Private Equity Fund VII C.V. [Member]", "verboseLabel": "Waterland Private Equity Fund VII C.V. [Member]" } } }, "auth_ref": [] }, "mpw_WatsonvilleCAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WatsonvilleCAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Watsonville, CA.", "label": "Watsonville C A [Member]", "terseLabel": "Watsonville, CA [Member]" } } }, "auth_ref": [] }, "mpw_WatsonvilleCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WatsonvilleCaliforniaMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Watsonville California.", "label": "Watsonville California [Member]", "terseLabel": "Watsonville, California [Member]" } } }, "auth_ref": [] }, "mpw_WebsterTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WebsterTexasMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Webster, Texas.", "label": "Webster Texas [Member]", "terseLabel": "Webster, TX [Member]" } } }, "auth_ref": [] }, "mpw_WeightedAverageDiscountRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WeightedAverageDiscountRateAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate.", "label": "Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted-average discount rate:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares (units) outstanding diluted", "totalLabel": "Diluted weighted-average common shares", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r334", "r343" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares (units) outstanding basic", "verboseLabel": "Basic weighted-average common shares", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r333", "r343" ] }, "mpw_WeightedAverageRemainingLeaseTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WeightedAverageRemainingLeaseTermAbstract", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term.", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted-average remaining lease term:" } } }, "auth_ref": [] }, "mpw_WestChesterOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WestChesterOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "West Chester, OH.", "label": "West Chester O H [Member]", "terseLabel": "West Chester, OH [Member]" } } }, "auth_ref": [] }, "mpw_WestJordanUTMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WestJordanUTMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "West Jordan, UT.", "label": "West Jordan U T [Member]", "terseLabel": "West Jordan, UT [Member]" } } }, "auth_ref": [] }, "mpw_WestMidlandsUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WestMidlandsUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "West Midlands, UK [Member]", "label": "West Midlands, U K [Member]", "documentation": "West Midlands, UK." } } }, "auth_ref": [] }, "mpw_WestMonroeLAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WestMonroeLAMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "West Monroe LA.", "label": "West Monroe L A [Member]", "terseLabel": "West Monroe, LA [Member]" } } }, "auth_ref": [] }, "mpw_WestValleyCityUTMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WestValleyCityUTMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "West valley city, UT.", "label": "West Valley City U T [Member]", "terseLabel": "West Valley City, UT [Member]" } } }, "auth_ref": [] }, "mpw_WichitaKSMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WichitaKSMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Wichita, KS.", "label": "Wichita K S [Member]", "terseLabel": "Wichita, KS [Member]" } } }, "auth_ref": [] }, "mpw_WillenhallUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WillenhallUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Willenhall, UK.", "label": "Willenhall U K [Member]", "terseLabel": "Willenhall, UK [Member]" } } }, "auth_ref": [] }, "mpw_WinchesterUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WinchesterUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Winchester, UK.", "label": "Winchester U K [Member]", "terseLabel": "Winchester, UK [Member]" } } }, "auth_ref": [] }, "mpw_WindsorUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WindsorUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Windsor, UK.", "label": "Windsor U K [Member]", "terseLabel": "Windsor, UK [Member]" } } }, "auth_ref": [] }, "mpw_WokingUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WokingUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Woking, UK.", "label": "Woking U K [Member]", "terseLabel": "Woking, UK [Member]" } } }, "auth_ref": [] }, "mpw_WorkingCapitalLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WorkingCapitalLoans", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital loans", "label": "Working Capital Loans", "documentation": "Working capital loans." } } }, "auth_ref": [] }, "mpw_WorthingUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WorthingUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Worthing, UK.", "label": "Worthing U K [Member]", "terseLabel": "Worthing, UK [Member]" } } }, "auth_ref": [] }, "mpw_WriteOffOfBilledAndStraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "WriteOffOfBilledAndStraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Write off of billed and straight-line rent receivables.", "label": "Write off of Billed and Straight-Line Rent Receivables", "terseLabel": "Write off of billed and straight-line rent receivables" } } }, "auth_ref": [] }, "mpw_YorkUKMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "YorkUKMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "York, UK.", "label": "York U K [Member]", "terseLabel": "York, UK [Member]" } } }, "auth_ref": [] }, "mpw_YoungstownOHMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "YoungstownOHMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "lang": { "en-us": { "role": { "documentation": "Youngstown OH.", "label": "Youngstown O H [Member]", "terseLabel": "Youngstown, OH [Member]" } } }, "auth_ref": [] }, "mpw_ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20231231", "localname": "ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20231231/taxonomy/role/DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20231231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Zero point nine nine three percentage senior unsecured notes due two thousand twenty six.", "label": "Zero Point Nine Nine Three Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "0.993% Senior Unsecured Notes due 2026 [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-16" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(1)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479601/815-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.12)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "11B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481598/310-20-45-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481696/310-30-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "b", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.DD)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479601/815-10-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.11)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "970", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//970/tableOfContent" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "972", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//972/tableOfContent" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "974", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//974/tableOfContent" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "976", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//976/tableOfContent" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "978", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//978/tableOfContent" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-1" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-2" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481123/840-20-35-2" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-3" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479607/944-360-50-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(c)", "Publisher": "SEC" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Publisher": "SEC" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "5", "Publisher": "SEC" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "6", "Publisher": "SEC" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Publisher": "SEC" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "6", "Publisher": "SEC" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "7", "Publisher": "SEC" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "8", "Publisher": "SEC" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column B", "Publisher": "SEC" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column D", "Publisher": "SEC" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column E", "Publisher": "SEC" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column F", "Publisher": "SEC" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Publisher": "SEC" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "5", "Subsection": "04", "Paragraph": "c", "Subparagraph": "Schedule III", "Publisher": "SEC" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481724/830-30-40-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-7" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r957": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r958": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r959": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r960": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r961": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r962": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r963": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r964": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r965": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r966": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r967": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r968": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r969": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r970": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r971": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r972": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r973": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r974": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r975": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r976": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r977": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r978": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r979": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r980": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r981": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r982": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r983": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r984": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r985": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r986": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r987": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r988": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r989": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r990": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r991": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r1012": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r1013": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1014": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1015": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r1016": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1017": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1018": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1019": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1020": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1021": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1022": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1023": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1024": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1025": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1026": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1027": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1028": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1029": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1030": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r1031": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1032": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1033": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1034": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1035": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1036": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1037": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1038": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1039": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1040": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1041": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1042": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1043": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1044": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1045": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1046": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1047": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1048": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1049": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1050": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1051": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1052": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1053": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1054": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1055": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1056": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1057": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1058": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1059": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1060": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1061": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1062": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1063": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1064": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1065": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1066": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1067": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1068": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1069": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1070": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1071": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1072": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1073": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1074": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1075": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1076": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1077": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1078": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1079": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1080": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1081": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1082": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1083": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1084": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1085": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1086": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1087": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1088": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1089": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1090": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1091": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1092": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1093": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1094": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r1095": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r1096": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 6.L.1)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-4" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "11", "Subsection": "03", "Publisher": "SEC" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1130": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(S-X 210.12-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479341/842-30-25-11" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" } } }